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ABSTRACT 
Low-density lipoproteins (LDL) are heterogeneous nanoparticles containing 
one copy of apolipoprotein B (~550 kDa) and thousands of lipids. LDL are the 
main plasma carriers of cholesterol and the major risk factor for atherosclerosis, 
the number one cause of death in the developed world. In atherosclerosis, LDL 
lipids are deposited in the arterial intima. Fusion of modified LDL in the arterial 
wall is an important underexplored triggering event in early atherosclerosis. 
Previous studies from our laboratory showed that thermal denaturation 
mimics LDL remodeling and fusion, and revealed the kinetic origin of LDL stability. 
Here, we report the first quantitative kinetic analysis of LDL stability. We show that 
LDL denaturation monitored by turbidity follows a sigmoidal time course that is 
unique among lipoproteins, suggesting that slow conformational changes in apoB 
precede lipoprotein fusion. High activation energy of LDL denaturation, Ea~100 
kcal/mol, indicates disruption of extensive protein-protein and protein-lipid 
vii 
 
interactions involving large apoB domains.  
Next, we combined size-exclusion chromatography, gel electrophoresis and 
electron microscopy to show that dimerization is a common early step preceding 
LDL fusion. Monoclonal antibody binding studies indicated that -helices in the 
N-terminal 1 domain of apoB undergo conformational changes at early stages 
of LDL aggregation and fusion. A Better understanding of these structural 
changes that prime LDL for fusion is required, as it may help control this 
pathogenic process before it occurs.  
We applied the kinetic approach to test how selected factors that are 
expected to contribute to LDL fusion in vivo affect the rate of LDL fusion and 
rupture in vitro. The results show that LDL fusion accelerates at pH<7, which may 
contribute to LDL retention in acidic atherosclerotic lesions. Fusion also 
accelerates upon increasing LDL concentration in near-physiologic range, which 
likely contributes to atherogenesis. Further, we showed that thermal stability of 
LDL decreases with increasing particle size, indicating that the pro-atherogenic 
properties of small dense LDL do not result from their enhanced fusion. Our work 
provides the first kinetic approach to measuring LDL stability and suggests that 
lipid-lowering therapies that reduce LDL concentration but increase the particle 
size may have opposite effects on LDL fusion. 
viii 
 
TABLE OF CONTENTS 
Title page                 i 
Copyright page                ii 
Readers’ Approval page              iii 
Dedication                 iv 
Acknowledgements               v 
Abstract                  vi 
Table of contents               viii 
List of figures                xiv 
List of abbreviations               xviii 
CHAPTER 1  INTRODUCTION   
1.1 Brief Overview of Lipoprotein Composition, Structure and Metabolism  1  
1.2 LDL Heterogeneity and Small Dense LDL          8 
1.3 LDL are the Strongest Causative Risk Factors for Atherosclerosis   10 
1.4  LDL Aggregation, Fusion and Lipid Droplet Formation are Pro-Atherogenic  
                   12 
1.5  LDL Aggregation and Fusion in vivo and in vitro       15 
1.6  Biochemical Modifications Driving LDL Aggregation and Fusion    17 
1.6.1 LDL Hydrolysis             19 
1.6.2 LDL oxidation              28 
1.6.3 LDL glycation              33 
1.6.4 Prolonged storage             34 
1.6.5 Other biochemical modifications of LDL        36 
1.7 Proteins, Lipids, Small Molecules and Polymers that Promote  
    or Prevent LDL Aggregation and Fusion          37 
ix 
1.7.1 Ceramide               37 
1.7.2 Free fatty acids              38 
1.7.3 Albumin               41 
1.7.4 Exchangeable apolipoproteins          42 
1.7.5 Estradiol              44 
1.7.6 Amphipathic polymers           46 
1.8 Physical Perturbations that Cause LDL Aggregation and Fusion    47 
1.8.1 Mechanical stress            47 
1.8.2 Thermal and chemical denaturation         48 
1.8.3 Solvent ionic conditions            51 
1.8.4 Lipoprotein crowding            52 
1.8.5 LDL thermal denaturation as an experimental model for  
LDL remodeling             53 
1.9  Detection of LDL Aggregation, Fusion and Lipid Droplet Formation    54 
1.9.1 Methods to distinguish between lipoprotein aggregation and  
fusion                  55 
1.9.2 Methods to determine size distribution in lipoproteins in solution     59   
1.9.3 Monitoring lipoprotein aggregation, fusion and lipid droplet  
     formation in real time                 62 
1.10 LDL Stability Is Determined By Kinetic Barriers            63 
 
CHAPTER 2  MATERIALS AND METHODS 
2.1 Sample Preparation                   70 
2.1.1 Density gradient ultracentrifugation             70 
2.1.2 Isolation of human plasma LDL              72 
x 
2.1.3 Separation of LDL subclasses on the basis of particle size  
and density               74 
2.2  Circular Dichroism Spectroscopy and Turbidity Measurements         74 
2.2.1 Far-UV Circular Dichroism               75 
2.2.2 Near-UV Circular Dichroism                78 
2.2.3 Turbidity measurements                 82 
2.2.4 Melting experiments                 84 
2.2.5 Kinetic temperature-jump experiments             86 
2.3  Quantitative Kinetic Analysis of LDL Thermal Stability           88 
2.4  Negative-Stain Electron Microscopy                         90 
2.5  Cryo-Electron Microscopy                 92 
2.6  Gel Electrophoresis: Non-Denaturing and SDS-PAGE           93 
2.7 Western Blotting                    94 
2.8 Size-Exclusion Chromatography                96 
2.9  Ion-Exchange Chromatography                 98 
2.10 Differential Scanning Calorimetry                98 
2.11 Drop Tensiometry                  102 
2.12 Competitive Enzyme-Linked Immunosorbent Assay          104 
 
CHAPTER 3  KINETIC ANALYSIS OF LDL THERMAL STABILITY 
3.1  Background and Challenges in LDL Stability Studies          108 
3.2  Standard Condition for LDL Kinetic Analysis Using Temperature-Jumps     110 
3.3  Sigmoidal Time Course of LDL Denaturation            113 
3.4 Quantitative Kinetic Analysis of LDL Thermal Stability          114 
3.5 Unique Features of LDL Denaturation Kinetics and the Role of ApoB       117 
xi 
 
CHAPTER 4  STRUCTURAL STUDIES OF LDL FUSION 
4.1  Background and Challenges                123 
4.2 Approach to Study the Structural Changes During Thermal Denaturation  
    of LDL                     125 
4.2.1 Possible changes in secondary structure           126 
4.2.2 Changes in the particle size by non-denaturing gel electrophoresis 127 
4.2.3 Changes in the particle morphology by negative-stain electron  
        microscopy                  130 
4.3  Early Stages of LDL Thermal Denaturation: Aggregation and Fusion       131 
4.3.1 Size-exclusion chromatography studies of the lag phase      133 
4.3.2 Negative-stain EM studies of Peak II suggest LDL pairing   135      
4.3.3 Chemical denaturation and aging lead to formation of Peak II  137 
4.4 Possible Origins of Peak II                  139 
4.4.1 Formation of Peak II is not due to disulfide bonding         139 
4.4.2 Formation of Peak II is not limited to a particular particle size     140 
4.4.3 Formation of Peak II is not associated with electronegative LDL     143 
4.4.4 Lipolysis does not account for Peak II formation         145 
4.4.5 Conformational changes in apoB revealed by Western blotting     148 
4.4.6 Quantitative assay of mAb binding to LDL using competitive ELISA   153 
4.4.7 Mapping Mb24 epitope on the lipovitellin-based homology model  
of apoB N-domain                156 
4.4.8 Summary and future studies              163 
 
CHAPTER 5  FACTORS AFFECTING STRUCTURAL STABILITY OF LDL 
xii 
5.1  Concentration Dependence of LDL Fusion             165 
5.1.1 LDL denaturation is a high-order reaction            166 
5.1.2 Comparison with other lipoproteins            169 
5.1.3 Physiological relevance                171 
5.2  Effects of Particle Size on LDL Thermal Stability           172 
5.2.1 Background and rationale              172 
5.2.2 Separation of LDL subclasses by size and density         174 
5.2.3 Thermal stability studies               174 
5.2.4 Comparison with other lipoproteins            177 
5.2.5 LDL subclasses interact with each other during thermal denaturation 179 
5.2.6 Elevated atherogeneity of small dense LDL does not result 
     from their enhanced fusion             180 
5.2.7 Physiologic implications               182 
5.3  Electrostatic Effects on LDL Thermal Stability            183 
5.3.1 Rationale                  183 
5.3.2 Effects of pH on LDL stability              185 
5.3.3 Relevance to acidic environment in atherosclerotic lesions      187 
5.3.4 Effects of salt                 190 
5.4 Effects of HDL and apoA-I on LDL transitions            192 
 5.4.1 Experimental stability studies              192 
5.4.2 Discussion and future directions              197 
5.5  Summary of Factors That Affect LDL Fusion            198 
 
CHAPTER 6  SUMMARY AND FUTURE STUDIES           200 
APPENDIX 1 Effects of freezing and storage on LDL structural integrity  204 
xiii 
APPENDIX 2 Interfacial properties of VLDL studied by drop tensiometry     208 
REFERENCES                    215 
CURRICULUM VITAE              240 
 
  
xiv 
LIST OF FIGURES 
 
Figure 1.1 Schematic illustrations of LDL structure        3 
Figure 1.2 Simplified diagram showing pathways of lipoprotein metabolism  6 
Figure 1.3 Pathway of LDL whole-particle endocytosis mediated by LDLR  7 
Figure 1.4 Schematic illustration of the response-to-retention paradigm   11 
Figure 1.5 Electron micrograph showing a cellular lipid droplet and  
extracellular droplets found in a human aortic lesion    13 
Figure 1.6 LDL aggregation, fusion and lipid droplet formation     18 
Figure 1.7 Reactions catalyzed by various lipases that are involved 
           in LDL modifications            20 
Figure 1.8 The enzymatic role of lipoprotein lipase in the remodeling of VLDL 
           to form IDL and LDL            25 
Figure 1.9 Stability studies showing that heat-induced LDL fusion is  
           decreased upon oxidation           31 
Figure 1.10 Free fatty acids promote LDL fusion        40 
Figure 1.11 Chemical structures of lipids and other molecules mentioned 
           in this dissertation            45 
Figure 1.12 LDL fusion is a thermodynamically irreversible kinetically controlled 
           process               49 
Figure 1.13  A model of LDL structure determined by cryo-EM to 22 Å  
            resolution              57 
Figure 1.14 Representative size-exclusion chromatography data of LDL and  
           the product of their thermal denaturation       60 
Figure 1.15 An integrated approach for the analysis of morphologic LDL  
xv 
transitions               64 
Figure 1.16 Near-UV CD provides a convenient way to monitor the  
           formation of LDL-derived lipid droplets upon heating     66 
Figure 1.17 Free energy diagram illustrating kinetic stabilization of lipoproteins 68 
Figure 2.1 Illustration of gradient density centrifugation used to isolate   
           lipoproteins from human plasma         71 
Figure 2.2 Agarose gel electrophoresis of isolated VLDL, HDL and LDL   73 
Figure 2.3 Characteristic spectra of α-helix, β-sheet and random coil   76 
Figure 2.4 Near-UV CD spectra of intact and ruptured human HDL and of the 
           major HDL protein, apoA-I           80 
Figure 2.5  Negative near-UV CD peak is induced upon LDL or VLDL  
rupture and coalescence into lipid droplets        81 
Figure 2.6 Representative melting data of LDL        87 
Figure 2.7 Representative temperature-jump data of LDL      89 
Figure 2.8 Arrhenius analysis of LDL heat denaturation      91 
Figure 2.9 Domain architecture of apoB and epitope map of monoclonal  
           antibodies used in this dissertation         95 
Figure 2.10 Size-exclusion chromatography to isolate LDL differing in size  97 
Figure 2.11 Ion-exchange chromatography to isolate electronegative LDL  99 
Figure 2.12 Schematic illustration of the drop tensiometer      103 
Figure 2.13 Competitive ELISA, a diagram showing a step-by-step procedure  106 
Figure 3.1 Temperature-jump turbidity data recorded from LDL under various 
    experimental conditions            112 
Figure 3.2 Quantitative kinetic analysis of HDL stability      115 
Figure 3.3 Quantitative kinetic analysis of VLDL stability      116 
xvi 
Figure 3.4 Kinetic analysis of thermal stability of human LDL     118 
Figure 4.1 Far-UV CD spectra of total LDL at various stages of thermal  
           denaturation              128 
Figure 4.2 Non-denaturing and SDS PAGE of total plasma LDL at various  
stages of thermal denaturation         129 
Figure 4.3 Electron micrographs of negatively-stained total plasma LDL at 
    various stages of thermal denaturation          132 
Figure 4.4 Morphological analysis of LDL at early stages of heat denaturation 134 
Figure 4.5 Negative-stain electron micrographs of Peak II      136 
Figure 4.6 LDL storage or chemical denaturation lead to formation of Peak II 138 
Figure 4.7 Peak II is not diminished in the presence of dithiothreitol   141 
Figure 4.8 Peak II is associated with LDL subclasses of various density or size 144 
Figure 4.9 Formation of Peak II is not associated with electronegative LDL  146 
Figure 4.10 Heating increase the net negative charge of LDL     147 
Figure 4.11 Peak II formation does not result from lipolysis of LDL    149 
Figure 4.12  Monoclonal antibodies used in this dissertation and their epitopes 
            in apoB               151 
Figure 4.13 Immunochemical analysis of LDL at an early stage of thermal  
            denaturation             152 
Figure 4.14 Competitive ELISA of intact and heated LDL      155 
Figure 4.15 A homology model of apoB6.4-13 derived from the X-ray crystal  
structure of lipovitellin               158 
Figure 4.16 Prediction of amyloidogenic segments in the N-terminal domain of  
human apoB              160 
Figure 5.1 Melting experiments involving LDL at different concentrations  167 
xvii 
Figure 5.2 Temperature jump data recorded from LDL samples at  
different concentrations           168 
Figure 5.3 Characterization of LDL subclasses isolated from single-donor  
plasma                  175 
Figure 5.4 Effect of the particle size on LDL stability assessed in melting  
experiments              176 
Figure 5.5 Kinetic experiments showing the non-additive behavior of LDL 
   subclasses              181 
Figure 5.6 Mildly acidic pH destabilize LDL in melting experiments    186 
Figure 5.7  Kinetic experiments showing the pH-dependence of LDL fusion  
 and rupture              188 
Figure 5.8 Effects of phosphate buffer concentration on thermal stability of LDL 191 
Figure 5.9 Effects of HDL and apolipoproteins on thermal stability of LDL  194 
Figure A.1 Characterization of intact and frozen-thawed LDL in the presence 
 of 10% sucrose             206 
Figure A.2 Lipoprotein adsorption to the triolein/water interface and its  
response to stress compression and re-expansion        211 
Figure A.3 VLDL adsorption to the triolein/water interface and the volume  
change of triolein drop due to fusion        213 
 
  
xviii 
LIST OF ABBREVIATIONS 
apoA-I: apolipoprotein A-I              2 
apoB: apolipoprotein B               2 
apoC-I: apolipoprotein C-I             192 
BSA: bovine serum albumin             105 
CD: circular dichroism              30 
CE: cholesteryl ester               1 
DSC: differential scanning calorimetry           98 
DTT: dithiothreitol               140 
EDTA: ethylenediaminetetraacetic acid          35 
ELISA: enzyme-linked immunosorbent assay         104 
EM: electron microscopy              14 
FFA: free fatty acids                2 
HDL: high-density lipoproteins             1 
IDL: intermediate-density lipoproteins            1 
IEC: ion-exchange chromatography           98 
LDL: low-density lipoproteins             1 
LDL+: electro-positive LDL (normal LDL)          98 
LDL-: electro-negative LDL             98 
LDLR: LDL receptor               5 
Lyso-PC: lyso- phosphatidylcholine           21 
mAb: monoclonal antibody             126 
NDGE: non-denaturing gel electrophoresis          93 
PAGE: polyacrylamide gel electrophoresis          30 
PBS/PBST: phosphate buffer saline / phosphate buffer saline containing Tween 105 
xix 
PC: phosphatidylcholine              17 
PEG: polyethylene glycol              37 
PLA2: phospholipase A2              21 
PLC: phospholipase C              22 
PVDF: polyvinylidene difluoride            94 
SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis   72 
SEC: size-exclusion chromatography           36 
TG: triacylglycerol                1 
T-jump: temperature-jump             86 
TLC: thin layer chromatography            148 
VLDL: very low-density lipoproteins            1 
 
1 
CHAPTER 1   INTRODUCTION 
1.1  Brief Overview of Lipoprotein Composition, Structure and 
Metabolism 
Lipoproteins are nanomolecular assemblies of lipids and proteins that 
transport lipids in the water-based circulation throughout the body of vertebrates 
and insects (Chapman, 1986). Plasma lipoproteins are either spherical or 
discoidal particles. Spherical particles contain an apolar lipid core consisting 
mainly of cholesteryl esters (CE) and triacylglycerols (TG), along with an 
amphipathic surface comprised of polar lipids (mainly phospholipids and 
cholesterol) and specific proteins (termed apolipoproteins). Plasma lipoproteins 
are grouped into five major classes based on their size and buoyant density: 
chylomicrons (density ρ<0.95 g/ml, diameter d>100 nm), very low-density 
lipoproteins (VLDL, ρ=0.95-1.006 g/ml, d=30-80 nm), intermediate-density 
lipoproteins (IDL, ρ=1.006-1.019 g/ml, d=25-50 nm), low-density lipoproteins (LDL, 
ρ=1.019-1.063 g/ml, d=19-25 nm), and high-density lipoproteins (HDL, 
ρ=1.063-1.21 g/ml, d=5-15 nm) (Chapman, 1986). Each of these major classes is 
comprised of heterogeneous particles that are further subdivided into subclasses, 
such as LDL1 (large), LDL2 (medium) and LDL3 (small) (Austin et al., 1988).  
The main focus of this thesis work is on LDL that are the major plasma 
2 
carriers of cholesterol in the form of CE (Figure 1.1A) (Goldstein and Brown, 
1976). Each LDL particle is coated with one copy of apolipoprotein B (apoB) that 
comprises >95% of its total protein content (Segrest et al., 2001). ApoB is a 
glycoprotein of about 550 KDa, one of the largest known proteins, which is 
permanently associated with its parent particle (Segrest et al., 2001). Amino acid 
sequence analysis predicts five major domains in apoB (Segrest et al., 2001). 
This pentadomain architecture of apoB is demonstrated in Figure 1.1B. 
Lipoprotein metabolism involves three major interconnected pathways: 
chylomicron pathway, HDL pathway, and VLDL/IDL/LDL pathway (Illingworth, 
1993). In the chylomicron pathway, the enterocytes in the intestine absorb dietary 
fat and package it into chylomicrons, which are then transported to the peripheral 
tissues via blood. In muscle and adipose tissues, lipoprotein lipase breaks down 
TG in chylomicrons, and the released free fatty acids (FFA) enter these tissues. 
The resulting chylomicron remnants are subsequently taken up by the liver.  
In the HDL pathway, intestine and liver secret lipid-free apolipoprotein A-I 
(apoA-I), which then recruits phospholipids and cholesterol via the interaction with 
ATP-binding cassette transporter A1 and forms nascent discoidal HDL. This 
process is anti-atherogenic since nascent HDL and lipid-poor apoA-I promote the  
3 
Figure 1.1  Schematic illustrations of LDL structure. (A) Cartoon 
representation of LDL. LDL are spherioidal particles with an average diameter of 
22 nm. Each particle has a polar surface (yellow) that confers solubility, and an 
apolar core (grey). Each LDL particle is comprised of one copy of apoB (magenta) 
that encircles the surface, and thousands of lipid molecules. Apolar lipids, mainly 
CE (on average ~1600 molecules per LDL particle) and TG (~170 molecules), 
reside in the core of the particle, while polar lipids, mainly PC (~500 molecules) 
and sphingomyelin (~200 molecules), reside on the surface. Unesterified 
cholesterol (~600 molecules) is distributed between the core and surface.  
(B) Diagram of the pentapartite structure of apoB (adapted from Segrest et al., 
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2001). Top: the five domains of apoB are: N-terminal globular domain βα1 that 
encompasses residues 1-1000; β1 domain that encompasses residues 
1001-2000; α2 domain (approximately 2075-2575); β2 domain (2571-4000); and 
α3 domain (4100-4536). Bottom: structural details proposed for specific regions of 
apoB. The amphipathic α-helical structure (indicated as AH) is illustrated as grey 
bars, and amphipathic  β-strand structure is illustrated as parallel vertical lines. 
βα1 is a lipovitellin (LV)-homology domain with three predicted β-sheets (βC:B, 
βA:B, and βB:B), and a predicted α-helix (α:B). The α2 and α3 domains contain 
class A and Y amphipathic α-helices (AH). The β2 domain contains three 
proline-rich clusters (open squares), an identified disulfide bond between the 
cysteines 3,167 and 3,297 (indicated as S-S), and three positively-charged 
α-helices (site A, B and C shown in small grey bars). Among them, site B 
(residues from 3345 to 3377-3404) is proposed to be the primary LDLR binding 
site (Segrest et al., 2001). 
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efflux of cholesterol from peripheral cells, including arterial macrophages, to the 
liver for catabolism and excretion. During metabolism, free cholesterol in nascent 
HDL is esterified by lecithin-cholesterol acyltransferase, and the CE produced in 
this reaction move to the particle core, leading to HDL maturation. Mature HDL 
are spherical particles with CE and TG sequestered in the core. CE carried by 
HDL are returned to the liver directly via the scavenger receptor class B type I, or 
indirectly by transfer to LDL/VLDL via cholesterol ester transfer protein and is 
excreted from the body via bile (Small, 1992; Zannis, 2005).  
In the VLDL/IDL/LDL pathway, apoB in liver recruits lipids to form and secrete 
VLDL, which undergo lipolysis by lipoprotein lipase to form IDL and, eventually, 
LDL (Figure 1.2). Under normal conditions, LDL is recognized by the LDL receptor 
(LDLR) on the surface of hepatocytes and other cells (Brown and Goldstein, 
1986). LDL are catabolized via the LDLR-mediated whole-particle endocytosis, 
and degraded in the lysosomes (Goldstein and Brown, 1985; Davis et al., 1987; 
Soutar and Naoumova, 2007) (Figure 1.3). This process is non-atherogenic since 
it lowers the rate of cell cholesterol biosynthesis (Brown and Goldstein, 1986; 
Yokoyama et al., 1993). In addition, some LDL can be modified (e.g. oxidized or 
hydrolyzed) and cleared by the scavenger receptors on the surface of monocytes 
or macrophages. The latter process does not lower the rate of cholesterol  
6 
Figure 1.2  Simplified diagram showing pathways of lipoprotein metabolisms 
(adapted from Gao, 2010). All lipoproteins, including chylomicrons (CM), 
very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and 
high-density lipoproteins (HDL) are represented as yellow spheres with their 
apolipoproteins shown in green. In the CM pathway (left), dietary fats are 
transported in the plasma by CM and the remnants are taken up by the liver. In 
the HDL pathway (right and center), lipid-poor apoA-I promotes efflux of 
cholesterol from peripheral tissues back to the liver. In the VLDL/LDL pathway 
(center), the liver secrets TG-rich VLDL whose TG are hydrolyzed by lipoprotein 
lipase, eventually leading to VLDL remodling into CE-rich LDL. LDL are taken up 
by LDLR on the surface of liver cells and peripheral tissues. 
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Figure 1.3  Pathway of LDL whole-particle endocytosis mediated by LDLR 
(adapted from Soutar and Naoumova, 2007). LDLR on the cell surface binds 
specific sites on apoB. After binding, LDL together with LDLR are internalized by 
endocytosis via clathrin-coated pits (Brown and Goldstein, 1986). They are 
transported to the endosome, where the acidic environment leads to the 
dissociation of LDLR from LDL (Davis et al., 1986). LDLR is recycled back to the 
cell surface while the LDL particle is eventually degraded in the lysosome (Brown 
and Goldstein, 1986). Accumulation of cholesterol in the cell inactivates a 
transcription factor, sterol regulatory element binding protein (SREBP), and 
lowers the biosysthesis of cholesterol and LDLR (Yokoyama et al., 1993). 
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biosynthesis and is pro-atherogenic (Acton et al., 1996).  
 
1.2  LDL Heterogeneity and Small Dense LDL  
  The main focus of this dissertation is the structure and stability of human 
plasma LDL. In contrast to HDL and VLDL that contain multiple copies of 
exchangeable (water-soluble) apolipoproteins, each LDL particle contains only 
one copy of the non-exchangeable (insoluble) apoB as its major protein. 
Therefore, LDL form a relatively homogeneous population of particles as 
compared to other lipoprotein classes. Nevertheless, human plasma LDL form 
distinct subclasses differing in density (1.019-1.063 g/ml), size (d=19-25 nm), 
charge, lipid composition, and apoB conformation (Krauss and Burke, 1982; 
McNamara et al., 1996; Berneis and Krauss, 2002).  
LDL are produced from heterogeneous VLDL precursors (Packard and 
Shepherd, 1997). This heterogeneity, along with enzymatic modifications, 
contributes to the formation of discrete LDL subclasses (Hurt-Camejo et al., 2000). 
A direct precursor-product relationship between large TG-rich VLDL and small, 
dense LDL (or LDL3) is suggested by a stable isotope kinetic study (Rutledge et 
al., 1995). This relationship is consistent with the early studies of LDL 
9 
heterogeneity showing that subjects with LDL of increased density have increased 
levels of serum TG and decreased levels of HDL cholesterol (Swinkels et al., 
1989). The current consensus is that small, dense LDL have increased 
pro-atherogenic properties, and elevated level of these particles is a risk factor for 
coronary artery disease (Kwiterovich, 2002). The increased pro-atherogenic 
properties of small, dense LDL may result from their increased affinity for the 
arterial proteoglycans and/or increased propensity to undergo post-translational 
modifications such as oxidation (Kwiterovich, 2002).  
The structural details underlying functional differences among LDL 
subclasses are not well understood. Analysis of the chemical composition of LDL 
subclasses revealed that the surface area covered by apoB is different in various 
subclasses (McNamara et al., 1996), suggesting that the altered apoB 
conformation may be the reason why small, dense LDL are particularly vulnerable 
to oxidation and have increased affinity for arterial proteoglycans (Bancells et al., 
2011). 
To-date, there is no “gold standard” method for isolation and characterization 
of LDL subfractions (Chung et al., 2009). One of the commonly used methods is 
separation of LDL into three subclasses by density gradient ultracentrifugation, in 
which LDL1 are isolated in the density range 1.025-1.034 g/ml, LDL2 at 
10 
1.034-1.044 g/ml, and LDL3 at 1.044-1.060 g/ml (Packard and Shepherd, 1997). 
This method was used to separate LDL subclasses in my work.     
 
1.3  LDL are the Strongest Causative Risk Factors for Atherosclerosis 
The plasma levels of LDL cholesterol correlate strongly with the risk of 
developing atherosclerosis (Kwiterovich, 2000), which claims over 2,200 lives 
daily in the USA and is the leading cause of death in the developed world (Roger 
et al., 2012). According to the “response-to-retention” paradigm, atheroslcerosis is 
initiated upon LDL binding and retention by extracellular matrix components, such 
as proteoglycans, in the arterial wall (Williams and Tabas, 1995; Williams and 
Tabas, 1998) (Figure 1.4). The retained lipoproteins undergo various 
modifications, including oxidation, lipolysis and proteolysis by resident hydrolytic 
and oxidative enzymes (Lu and Gursky, 2013). These modified LDL aggregate 
and fuse, forming extracellular lipid droplets and vesicles (Oorni et al., 2000). LDL 
fusion further augments LDL retention in the arterial wall, triggering a cascade of 
pro-inflammatory and pro-apoptotic responses. Monocytes enter the 
subendothelium and differentiate into macrophages that take up the retained and 
modified LDL, eventually becoming cholesterol-laden foam cells. Furthermore,  
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Figure 1.4  Schematic illustration of the response-to-retention paradigm 
(adapted from Tabas et al., 2007). According to this paradigm, atherosclerosis is 
initiated by the retention of LDL (yellow circles) in the arterial wall upon binding to 
subendothelial extracellular matrix molecules, particularly proteoglycans. The 
retained LDL are then modified by resident hydrolytic and oxidative enzymes, 
which triggers a series of pro-atherogenic responses. In particular, monocytes 
enter the subendothelium, differentiate into macrophages, and ingest the modified 
LDL to become cholesterol-laden foam cells. As the lesion progresses, 
macrophages die and other cells can migrate to the lesion site, promoting plaque 
development. The earliest stages of this pathogenic process can be reversed by 
lowering plasma LDL and VLDL (large orange arrows). 
  
 
LP: lipoprotein
VSMC: vesicular smooth 
muscle cells
MØ: macrophage
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inflammatory cells enter the lesion, and smooth muscle cells also migrate into 
intima, together promoting the formation of plaques (Williams and Tabas, 1995; 
Tabas et al., 2007). Cholesterol derived from the platelets of thrombi also 
contributes to the cholesterol burden of atherosclerotic lesions (Akkerman, 2008).  
The initial sign of atherosclerosis is the appearance of cholesterol-rich 
extracellular lipid droplets in the subendothelial space (Figure 1.5). Biochemical 
and morphological analysis of such droplets from human atherosclerotic lesions 
suggests that they are derived mainly from the entrapped LDL (Guyton et al., 
1990; Oorni et al., 2000). Animal model studies strongly support this conclusion 
and show that accumulation of extracellular lipid droplets can be experimentally 
reproduced in rabbit arterial intima within hours after injection of large amounts of 
human LDL into the circulation, as well as in isolated rabbit cardiac valves upon 
incubation with human LDL (Nievelstein et al., 1991; Nievelstein-Post et al., 1994). 
Hence, the precursor-product relationship between LDL and cholesterol-rich 
extracellular lipid droplets in early atherosclerosis is well-established. 
 
1.4  LDL Aggregation, Fusion and Lipid Droplet Formation are 
Pro-Atherogenic 
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Figure 1.5  Electron micrograph showing a cellular lipid droplet (asterisk) and 
extracellular droplets (arrows) found in a human aortic lesion (adopted from 
Guyton et al., 1994). The diameter of most extracellular lipid droplets ranges from 
100 to 400 nm. 
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Although the molecular mechanisms of LDL retention and lipid droplet 
formation in the arterial subendothelium are not fully understood, it is increasingly 
clear from studies by the groups of Kovanen, Camejo and Hurt-Camejo, 
Sanchez-Quezada, Parasassi and others that aggregation and fusion of modified 
LDL prevent their exit from the arterial wall and contribute to atherosclerosis 
(Guyton, 1994; Paananen et al., 1995; Pentikainen et al., 1996; Camejo et al., 
1998; Hurt-Camejo et al., 2000; Oorni et al., 2000; Parasassi et al., 2008; 
Bancells et al., 2010). Several lines of evidence support the presence of LDL 
aggregates in the arterial wall (Hoff and Morton, 1985; Aviram et al., 1995) and 
their involvement in LDL retention by arterial proteoglycans during atherogenesis. 
For example, Frank and colleagues used freeze-etch electron microscopy (EM) to 
show that aortic intima in Watanabe heritable hyperlipidemic and cholesterol-fed 
rabbits contained aggregated lipoproteins bound to the subendothelial matrix 
(Frank and Fogelman, 1989). Steinbrecher and colleagues reported that LDL 
aggregates isolated from atherosclerotic lesions induced macrophage foam cell 
formation in a process independent of LDL uptake by scavenger receptors 
(Steinbrecher and Lougheed, 1992). In addition, aggregated LDL have been 
reported to induce cholesterol accumulation in coronary vascular smooth muscle 
cells and turn them into foam cells, possibly by up-regulating the level of 
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LDLR-related protein (Llorente-Cortes and Badimon, 2005). These and other 
studies convincingly showed that LDL aggregation, fusion and coalescence into 
lipid droplets are important triggering events in early atherosclerosis. 
 
1.5  LDL Aggregation and Fusion in vivo and in vitro  
In contrast to modified LDL, native LDL do not readily aggregate or fuse under 
physiological conditions, suggesting that lipoprotein modifications drive these 
transitions (Goldstein et al., 1979). The accepted view is that such major 
modifications in vivo include apoB proteolysis, LDL lipolysis, oxidation and 
glycation. Many aspects of these reactions remain unclear, e. g. how do the 
apparently distinct biochemical modifications exert similar structural responses in 
LDL? Is there a synergy among numerous factors that influence LDL fusion? 
Which enzymatic or non-enzymatic modifications are particularly important in 
promoting or preventing LDL fusion in vivo? What are the specific steps in LDL 
aggregation, fusion and lipid droplet formation, and what therapeutic agents can 
block these pathogenic processes? These and other unanswered questions 
reflect the fact that atherosclerosis is a very complex chronic disease that can be 
influenced by an immense number of factors, many of which are not well 
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understood. Some of these questions regarding molecular mechanisms of LDL 
fusion and its important determinants are addressed in this PhD work. 
In a complementary approach, in vitro studies can provide tractable 
experimental models to determine how individual factors, alone or in combination, 
influence LDL aggregation, fusion and lipid droplet formation. A wide variety of 
chemical and physical perturbations in the protein and lipid moieties can induce 
LDL aggregation, fusion, and coalescence into lipid droplets. These perturbations 
include brief vortexing (Khoo et al., 1988) or prolonged exposure to elevated 
temperatures (Jayaraman et al., 2005a). Although such in vitro treatments do not 
necessarily mimic physiological conditions, they provide useful model systems to 
study the immensely complex process and elucidate its molecular mechanism. 
The results of such in vitro studies can provide sharper insights into the structural 
basis underlying LDL aggregation, fusion and lipid droplet formation upon various 
biophysical and biochemical modifications. Such studies enable us to quantify the 
rate and the extent of these LDL reactions (Chapter 3), and help design strategies 
aimed to hamper or even block these pathogenic processes, which is the ultimate 
goal of my thesis work. 
Since the major focus of this dissertation is on LDL fusion, the remainder of 
this chapter provides an overview of various biochemical and biophysical 
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modifications of LDL as well as small molecules that can promote or prevent LDL 
fusion. In this dissertation, I try to differentiate between LDL aggregation, fusion 
and coalescence into lipid droplets whenever possible (Figure 1.6). However, 
many published experimental studies do not clearly make this distinction; in these 
instances, we use the term preferred by the authors, or refer to it as “aggregation 
and fusion”. 
 
1.6  Biochemical Modifications Driving LDL Aggregation and Fusion 
On average, one LDL particle contains 1,600 molecules of CE and 170 of TG 
sequestered in the apolar core; 700 molecules of phosphatidylcholine (PC) and 
200 molecules of sphingomyelin in the amphipathic surface; and 600 molecules of 
unesterified cholesterol distributed both in the core and surface (Oorni et al., 
2000). Modifications of the lipid composition (mainly PC and sphingomyelin) that 
produce an imbalance between the core and the surface can result in loss of 
structural integrity and particle aggregation or fusion. 
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Figure 1.6  LDL aggregation, fusion and lipid droplet formation (Lu and 
Gursky, 2013). The upper panels show cartoon representations of intact, 
aggregated and fused LDL in cross-section. The lower panels show 
negative-stain electron micrographs of intact, aggregated, fused LDL, and 
LDL-derived lipid droplets (see details in Chapter 4). LDL aggregation probably 
involves changes in the conformation of the protein and lipid moieties but not 
necessarily in the particle size. Fusion merges the contents of two or more LDL 
particles to form an enlarged lipoprotein. Rupture involves lipoprotein 
disintegration and release of the apolar core lipids that coalesce into droplets. 
Both fused and ruptured LDL tend to aggregate. Enhanced uptake of aggregated 
and fused LDL and lipid droplets by macrophages leads to formation of foam cells 
and initiates atherosclerosis. 
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1.6.1 LDL Hydrolysis   
Lipolysis by sphingomyelinase: Sphingomyelinase hydrolyzes sphingomyelin 
to phosphocholine and ceramide (Figure 1.7E). Secretory sphingomyelinase is a 
zinc-dependent acidic metalloenzyme secreted by macrophages and smooth 
muscle cells, which is found in the arterial intima (Marathe et al., 1999). This 
enzyme hydrolyses LDL sphingomyelin that accounts for up to 30% of 
phospholipids on LDL surface (Nelson and Freeman, 1960). Upon hydrolysis, 
water-soluble phosphocholine is released from the surface while water-insoluble 
ceramide is retained in the core of LDL. This leads to the increase in the apolar 
core lipids at the expense of the polar surface lipids, resulting in a hydrophobic 
mismatch between the core and surface, which is expected to cause lipoprotein 
fusion. In fact, ceramide accumulation leads to LDL fusion (described in 1.7.1). 
LDL fusion upon sphingomyelinase reaction in vivo is supported by the 
observation that aggregated LDL in atherosclerotic lesions are enriched in 
ceramide (Schissel et al., 1996a). Moreover, treatment of isolated LDL with 
sphingomyelinase can induce lipoprotein aggregation and fusion in vitro 
(Pentikainen et al., 1996; Oorni et al., 1998). These observations suggest that 
secretory SMase can contribute to atherosclerosis by mediating LDL fusion. 
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Figure 1.7  Reactions catalyzed by various lipases that are involved in LDL 
modifications (images from www. Worthington-biochem.com) 
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Lipolysis by phospholipase A2: Phospholipase A2 (PLA2)-superfamily 
enzymes hydrolyze sn-2 acyl bond in PC to generate FFA and lyso-PC (Figure 
1.7A), which are important mediators of inflammation (Corson, 2009). Secretory 
non-pancreatic PLA2, which is secreted by endothelial cells and macrophages, is 
found in the arterial intima of atherosclerotic and healthy subjects, and is 
associated with extracellular matrix and lipid droplets (Jonsson-Rylander et al., 
2008). Lipoprotein-associated PLA2, which is secreted by leucocytes, is 
associated with circulating lipoproteins and macrophages in atherosclerotic 
plaques (Davis et al., 2008). Importantly, type-II secretory non-pancreatic PLA2 
and lipoprotein-associated PLA2 preferentially hydrolyze oxidized PC in 
lipoproteins and serve as biomarkers of atherosclerosis (Davis et al., 2008). 
Earlier studies reported that LDL lipolysis by PLA2 in the presence of serum 
albumin, which removes FFA from LDL, results in lipoprotein aggregation but not 
fusion (Oorni et al., 1998). Later studies showed that if FFA produced by PLA2 are 
not removed, lipoprotein coalescence into lipid droplets is greatly enhanced 
(Jayaraman et al., 2011). Furthermore, lipolysis by secretory non-pancreatic PLA2 
was reported to induce fusion of the proteoglycan-bound lipoproteins, thereby 
enhancing their retention in the arterial wall (Hakala et al., 2001). Thus, multiple 
lines of evidence indicate that LDL hydrolysis by PLA2-family enzymes contributes 
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to atherosclerosis by inducing LDL aggregation, fusion and retention by arterial 
proteoglycans. Notably, several studies reported that PLA2 is preferentially 
enriched in small, dense LDL (Hurt-Camejo et al., 2000) and in electronegative 
LDL (Bancells et al., 2010). The latter probably reflects the accumulation of 
negatively-charged FFA that is the hydrolytic product of phospholipids by PLA2. 
These findings suggest that PLA2 potentially contributes to the enhanced 
pro-atherogenic properties of small dense LDL and electronegative LDL. 
 
Lipolysis by phospholipase C: Phospholipase C (PLC) hydrolyzes PC to 
generate phosphocholine and diacylglycerol (Figure 1.7B). Polar phosphocholine 
is released while apolar diacylglycerol is re-distributed from the lipoprotein surface 
to the core. This lipid re-distribution generates hydrophobic mismatch between 
the core and surface that is expected to promote lipoprotein aggregation and 
fusion. In fact, LDL aggregation and fusion upon PLC hydrolysis, which was first 
observed in 1989 (Suits et al., 1989), became a standard technique to induce 
these LDL transitions in vitro. Notably, the authors also found that aggregated and 
fused LDL were taken up much faster by macrophages as compared to normal 
LDL, which helped establish the link between LDL aggregation, fusion and 
atherogenesis (Suits et al., 1989). Recent report suggests that, similar to PLA2, 
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PLC is preferentially associated with electronegative LDL in plasma (Bancells et 
al., 2010; Sanchez-Quesada et al., 2012), which may potentially contribute to the 
enhanced pro-atherogenic properties of these particles. Other studies showed 
that PLC-induced LDL aggregation and fusion can be prevented by exchangeable 
(water-soluble) apolipoproteins that have high affinity for lipid surfaces (Khoo et 
al., 1990). This observation supports the idea that lipoprotein fusion upon PLC 
hydrolysis results from the surface exposure of hydrophobic lipid moieties. 
 
Lipolysis by cholesterol esterase: Cholesterol esterase hydrolyzes cholesterol 
esters, the most abundant lipids in LDL core (Figure 1.7C). In contrast to LDL that 
contain mainly esterified cholesterol, biochemical analysis of lipid droplets 
isolated from atherosclerotic lesions detected mainly unesterified cholesterol 
(Kruth, 1985). To understand the precursor-product relationship between LDL and 
lesional lipid droplets, Kruth and colleagues hydrolyzed LDL by using cholesterol 
esterase (Chao et al., 1992). For hydrolysis to proceed, the enzyme needs to gain 
access to the lipoprotein core. Native LDL did not provide such access and hence, 
were not readily hydrolyzed by cholesterol esterase. However, core lipids became 
accessible to hydrolysis upon apoB proteolysis on LDL surface. Upon completion 
of hydrolysis, LDL were converted to liposome-like structures that were chemically 
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and morphologically similar to the extracellular lipid droplets in atherosclerotic 
lesions. This supports the precursor-product relationship between LDL and 
extracellular lipid droplets (Chao et al., 1992). 
 
Lipoprotein lipase: Lipoprotein lipase exerts both enzymatic and 
non-enzymatic effects that contribute to lipoprotein remodeling in vivo. In its 
catalytically active dimeric form, lipoprotein lipase hydrolyses triacylglycerol into 
di- and monoacylglycerol and FFA (Figure 1.7D). This reaction is key to the 
metabolism of triacylglycerol-rich lipoproteins such as VLDL that are metabolic 
precursors of LDL (Mead et al., 2002). The enzymatic action of lipoprotein lipase 
on VLDL is an obligatory early step in VLDL catabolism to LDL and is largely 
anti-atherogenic (Figure 1.8) (Guha and Gursky, 2010). Notably, lipid core 
hydrolysis depletes the core and expands the surface, generating excess surface 
components (apolar lipids and apolipoproteins) that dissociate from VLDL in the 
form of small particles that join the plasma pool of HDL (Musliner et al., 1991). 
This contrasts with the hydrolysis by PLA2, PLC or sphingomyelinase, which 
depletes the surface lipids and promotes lipoprotein fusion. Therefore, in contrast 
to PLA2, PLC or sphingomyelinase that induce lipoprotein fusion, enzymatic 
action of lipoprotein lipase is expected to promote lipoprotein fission.  
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Figure 1.8  The enzymatic role of lipoprotein lipase in the remodeling of VLDL 
into IDL and LDL (adapted from Guha et al., 2010). Upon their secretion by the 
liver, VLDL are remodeled by lipoprotein lipase (LpL) that is tethered to the 
capillary endothelium. LpL hydrolyzes TG and produces di- and 
mono-acylglycerol and FFA. This process shrinks the particle core and generates 
excess surface components that dissociates from VLDL in the form of 
apoE-containing small particles that join the plasma pool of HDL. The products of 
VLDL hydrolysis (i.e. IDL) are cleared from circulation by receptors such as LDL 
receptor-related protein (LRP) and LDLR. Alternatively, IDL are remodeled by 
hepatic lipase (HL) and/or by cholesterol ester transfer protein (CETP). The 
resulting LDL are then taken up by LDLR. 
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Endothelial lipoprotein lipase that is anchored to the arterial endothelium via a 
flexible linker hydrolyses VLDL triacylglycerols in vivo. As a structural anchor, the 
enzyme can bind lipoproteins and link them to subendothelial proteoglycans and 
various cell surface receptors, enhancing LDL retention in the subendothelial 
space (Goldberg, 1996). In contrast to the anti-atherogenic properties of its 
enzymatic function, the anchoring function of lipoprotein lipase on LDL, which 
enhances LDL retention in the arterial wall, is pro-atherogenic. Furthermore, LDL 
affinity for lipoprotein lipase was reported to increase upon LDL oxidation 
(Auerbach et al., 1996), probably because native LDL preferentially bind to the 
monomeric catalytically inactive enzyme, whereas oxidized LDL bind to the 
dimeric catalytically active form (Pentikainen et al., 2000). Structural studies 
suggested that LDL binding to lipoprotein lipase is mediated entirely by the lipids 
and does not involve apoB (Pentikainen et al., 2000). An in vitro study showed 
that lipoprotein lipase can induce LDL aggregation at higher than equimolar ratios 
of the enzyme to LDL (Walters and Wrenn, 2011). This suggests that lipoprotein 
aggregation in these experiments was due to the non-enzymatic anchoring action 
of lipoprotein lipase.  
 
ApoB proteolysis: A single copy of apoB comprises over 95% of LDL protein 
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content and covers more than 20% of the LDL surface (McNamara et al., 1996). 
This large multi-domain protein of 4536 amino acids directs LDL metabolism and 
serves as a structural scaffold and an important functional ligand for LDL 
interactions with LDLR and with arterial proteoglycans. Therefore, even partial 
loss of apoB upon proteolysis can influence functional interactions of LDL and 
cause further conformational changes in the protein and lipid, leading to 
reorganization of the entire particle. This can influence interactions between LDL 
particles and augment their aggregation, fusion and lipid droplet formation. 
Therefore, apoB proteolysis is a potential mechanism for generating extracellular 
lipid droplets. 
Kovanen and colleagues observed that incubation with exocytosed rat mast 
cell granules can convert LDL into lipid droplets (Kovanen and Kokkonen, 1991) 
whose morphology resembles that of the extracellular lipid droplets found in 
atherosclerotic lesions (Guyton et al., 1990). Two neutral proteases, chymase and 
carboxypeptidase A, were responsible for apoB degradation and lipid droplet 
formation in these experiments. Tests of additional proteases that cleave apoB 
revealed two distinct effects. Plasmin, kallikrein and thrombin, whose action on 
LDL led to apoB fragmentation without release of proteolytic fragments, did not 
cause LDL fusion; in contrast, trypsin, α-chymotrypsin and pronase, whose action 
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led to apoB fragmentation followed by release of proteolytic fragments from LDL 
surface, triggering LDL fusion (Piha et al., 1995). The authors concluded that LDL 
fusion after proteolysis occurs only upon dissociation of proteolytic fragments 
from the lipoprotein surface (Pentikainen et al., 1996). 
 
1.6.2 LDL oxidation  
Oxidative modification hypothesis of atherosclerosis originated over 30 years 
ago from observations that oxidized LDL are toxic to cultured cells (Henriksen et 
al., 1979; Hessler et al., 1979; Hessler et al., 1983; Morel et al., 1983) and are 
readily ingested via the scavenger receptors by macrophages, converting them 
into foam cells (Henriksen et al., 1981; Henriksen et al., 1983; Steinbrecher et al., 
1984). The latter was attributed to oxidative modifications in apoB, which impair 
its interactions with LDLR and enhance LDL binding to macrophage scavenger 
receptors. Later studies showed that LDL can be oxidized in the circulation and in 
the arterial wall (Jurgens et al., 1987; Steinberg et al., 1989; Heinecke, 1997). The 
pathogenic properties of oxidized LDL have been attributed to their ability to 
support foam cell formation, as well as aid the recruitment of circulating 
monocytes to the arterial initima, induce platelet aggregation, and produce other 
29 
pro-inflammatory and pro-thrombotic effects (reviewed in (Stocker and Keaney, 
2004). The molecular basis underlying these effects is difficult to establish 
because of the complexity of LDL oxidation that involves an immense number of 
possible modifications to various lipid and protein moieties. The problem is further 
compounded by the heterogeneity of plasma LDL and the products of their 
oxidation. These products depend upon the oxidants used, the extent of oxidation, 
the biochemical composition of intact LDL that can vary from batch to batch (e. g. 
the amount of antioxidants such as carotenoids in LDL core), and many other 
factors that are beyond the scope of this dissertaion. As a result of this extreme 
biochemical complexity, the topic remains controversial. The controversy is further 
compounded by the clinical trials that failed to show beneficial effects of 
antioxidants such as vitamin E in cardiovascular disease (Kris-Etherton et al., 
2004). Excellent reviews of this topic have been published recently (Steinberg, 
2009; Steinberg and Witztum, 2010; Yoshida and Kisugi, 2010). Here, we briefly 
outline the role of oxidation in aggregation and fusion of LDL, which is also not 
free from controversy. 
One of the mechanisms responsible for the enhanced uptake of oxidized LDL 
by macrophages is their increased tendency to aggregate (Oorni et al., 2000). 
LDL aggregation and enhanced uptake by macrophages were consistently 
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observed in cell culture upon action of various oxidative agents such as copper, a 
radical oxidant whose primary target is lipids, and hypochlorite, a non-radical 
oxidant whose primary target is proteins (Hoff and O'Neil, 1991; Hoff et al., 1992; 
Dobrian et al., 1993; Cynshi et al., 1994). In contrast to aggregation, evidence for 
LDL fusion upon oxidation is limited to a report that, after days of LDL incubation 
with 5 μM Cu2+ at 37 oC, extensive LDL oxidation led to complete lipoprotein 
disintegration (Dobrian et al., 1993; Pentikainen et al., 1996), which may or may 
not involve LDL fusion. 
Previous studies by Dr. Jayaraman from our laboratory were aimed at 
quantification of the effects of oxidation on the extent of the heat-induced LDL 
fusion (Jayaraman et al., 2007). Single-donor LDL were isolated from human 
plasma and were modified to various degrees by several radical or non-radical 
oxidants including copper, hypochlorite, and myeloperoxidase that produce 
hypochlorite and contribute to lipoprotein oxidation in vivo. In this system, LDL 
oxidation caused no significant changes in the particle size or morphology at 
ambient temperatures, as observed by non-denaturing polyacrylamide gel 
electrophoresis (PAGE) and negative stain EM. Surprisingly, the extent of 
heat-induced LDL fusion and lipid droplet formation, monitored by circular 
dichroism (CD), turbidity, and EM, gradually decreased upon progressive  
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Figure 1.9  Stability studies showing that heat-induced LDL fusion is 
decreased upon oxidation (adapted from Jayaraman et al., 2007). Intact 
non-modified human LDL (nLDL) and copper oxidized LDL (2 mg/mL protein 
concentration in 10 mM Na phosphate buffer at pH 7.5) were heated at a constant 
rate of 11 K/h, and increase in the particle size due to LDL aggregation, fusion and 
lipid droplet formation was monitored by turbidity at 280 nm as described in 
Chapter 2. LDL samples at different stages of copper-induced oxidation are 
indicated as 1, 2 and 3, with stage 1 being the mildest and stage 3 the most 
advanced. The melting data of intact LDL (black solid line) and LDL oxidized to 
stages 1-3 showed a progressive reduction in the amplitude of turbidity changes 
upon an increase in the degree of oxidation. The trend suggests that oxidation by 
copper hampers heat-induced LDL fusion and lipid droplet formation. A similar 
trend was observed in LDL oxidized by non-radical oxidants (hypochloride, 
myeloperoxidaze). Therefore, LDL oxidation alone hampers LDL fusion and lipid 
droplet formation. 
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oxidation by various agents (Jayaraman et al., 2007) (Figure 1.9). Biochemical 
analysis of LDL at various stages of oxidation suggested that apoB fragmentation 
and cross-linking were partially responsible for this effect.  
To reconcile these observations with numerous in vivo and cell culture studies, 
we note that these studies provided clear evidence for aggregation but not 
necessarily fusion of oxidized LDL. Moreover, different studies used different 
experimental systems that could contain additional factors such as PLA2 that acts 
synergistically with oxidation in vivo. In fact, later studies from our laboratory 
showed that FFA produced by PLA2 or by other means are potent fusion-inducing 
agents in lipoproteins (Jayaraman et al., 2011). This suggests that enhanced in 
vivo lipolysis of oxidized PC by PLA2-family enzymes generates FFA whose 
accumulation greatly enhances LDL fusion.  
In summary, oxidation produces numerous chemical modifications in the 
protein and lipid moieties, which often occur in parallel. Some of these 
modifications enhance LDL remodeling by other factors. For example, oxidized 
PC are avidly hydrolyzed by PLA2, followed by removal of most lipolytic products 
by albumin. This leads to complex structural changes that can deplete LDL 
surface of polar lipids, increase solvent exposure of the apolar groups on LDL 
surface, and thereby promote aggregation, fusion and ultimate disintegration of 
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LDL (Jurgens et al., 1987; Meyer et al., 1996; Ettelaie et al., 1997). 
 
1.6.3  LDL glycation  
Glycation, which covalently links a sugar molecule to a protein or lipid moiety, 
is a ubiquitous LDL modification that contributes to atherogenesis. In contrast to 
glycosylation that occurs at specific sites, is subject to tight enzymatic control, and 
is often functionally important, glycation does not involve enzymatic action, is not 
well-regulated, and often results in impaired macromolecular function. In vivo LDL 
glycation is often linked to oxidation, and the combined effects, termed 
glycoxidation, are deleterious to LDL function (Younis et al., 2008; Soran and 
Durrington, 2011).  
LDL glycation in vivo occurs both in diabetic and in non-diabetic patients 
(Younis et al., 2009), and principally affects lysines that are abundant in apoB. 
Typically, in LDL isolated from human plasma, 2-17% of all lysines are glycated 
(Steinbrecher and Witztum, 1984). As expected, LDL isolated from plasma of 
diabetic patients contain higher proportion of glycated lysine as compared to 
non-diabetic controls (Schleicher et al., 1981). This increased lysine glycation in 
apoB potentially contributes to the link between diabetes and cardiovascular 
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disease. Interestingly, small dense LDL, which are proposed to form a particularly 
pro-atherogenic subclass, are preferentially glycated in vitro and in vivo as 
compared to larger particles (Younis et al., 2009; Younis et al., 2010). This 
difference in glycation, which may result from different apoB conformations on the 
large and small particles (McNamara et al., 1996), potentially contributes to the 
enhanced pathogenic properties of small dense LDL. 
LDL glycation is linked to several pro-atherogenic events, including increased 
LDL binding to proteoglycans, increased susceptibility to oxidation, and impaired 
binding to LDLR (Tabas, 1999). The latter is probably due to the modifications in 
the Lys-rich LDLR binding sites of apoB. As a result, LDL glycation promotes LDL 
clearance by macrophage scavenger receptors, leading to foam cell formation 
(Tabas, 1999; Younis et al., 2008). In addition, LDL glycation reportedly promotes 
LDL aggregation in vitro (Pentikainen et al., 1996). Although the molecular 
mechanism responsible for aggregation of glycated LDL is unknown, we 
speculate that changes in the surface charge distribution on apoB upon Lys 
glycation probably contribute to this effect.  
 
1.6.4  Prolonged storage of LDL 
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Storage, or LDL “aging” in vitro, involves various hydrolytic and oxidative 
modifications to the protein and lipid moieties, which promote LDL aggregation 
and fusion. These changes can be decelerated, but not completely abolished, by 
storing LDL at 4 oC in the dark under anaerobic conditions in the presence of 
ethylenediaminetetraacetic acid (EDTA), which is the standard practice in our 
laboratory. An even safer way of LDL storage is upon flash-freezing with 10% 
sucrose as a cryo-protectant to prevent LDL fusion and rupture at low 
temperatures (see details in Appendix 1). Spontaneous changes that occur during 
LDL storage include lipid peroxidation and apoB fragmentation that is attributed, 
in part, to its weak autoproteolytic activity. These deleterious changes can 
increase LDL susceptibility to other hydrolytic modifications. For example, minimal 
lipolytic activity of secretory PLA2 was observed when freshly isolated plasma LDL 
were used as substrates; however, lipolytic activity increased up to 25-fold upon 
LDL storage at 6 oC for 8 weeks or at 37 oC for 15 hours, which was probably due 
to PC oxidation (Eckey et al., 1997). In another study, plasma incubation at 37 oC 
produced a subpopulation of LDL that were prone to aggregation, fusion and lipid 
droplet formation as detected by dynamic light scattering and atomic force 
microscopy (De Spirito et al., 2006). Kinetic analysis suggested that particle 
aggregation in these experiments was driven by interactions among a limited 
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number of specific surface sites on LDL (De Spirito et al., 2006). This mechanism 
differed from massive aggregation and fusion observed upon other LDL 
modifications such as copper-induced oxidation. Our own studies using 
non-denaturing PAGE, size-exclusion chromatography (SEC), and negative stain 
EM showed that during storage of lipoproteins isolated from human plasma, a 
sub-population of LDL was converted into enlarged particles whose size (~40 nm) 
was consistent with LDL dimerization. In addition, we observed gradual formation 
of larger particles (~100 nm) resulting from LDL fusion and coalescence into lipid 
droplets and their aggregates. These findings are described in Chapter 4 of this 
dissertation. 
 
1.6.5  Other biochemical modifications of LDL  
LDL can be chemically modified in numerous ways in vitro, some of which 
result in aggregation and fusion that invariably enhance LDL uptake by 
macrophages and foam cell formation in cell culture studies (Tertov et al., 1989). 
Such chemical modifications include acetylation and maleylation (Goldstein et al., 
1979), acetoacetylation (Mahley et al., 1979), carbamylation, malondialdehyde or 
glutaraldehyde treatment (Fogelman et al., 1980; Shechter et al., 1981), 
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desialylation (Orekhov et al., 1989), and treatment with certain flavonoids (Rankin 
et al., 1993). Similar effects of these diverse modifications on lipoprotein 
morphology suggest that LDL aggregation and fusion provide a general structural 
response to a broad range of biochemical perturbations. 
 
1.7 Proteins, Lipids, Small Molecules and Polymers That Promote or 
Prevent LDL Aggregation and Fusion  
Aggregation and fusion of lipoproteins are initiated by their surface contacts. 
Since LDL surface is comprised of a phospholipid monolayer and apoB, reagents 
that promote (e.g. FFA and polyethylene glycol) (Jayaraman et al., 2004) or 
prevent (e.g. amphipathic molecules) fusion of phospholipid bilayers are expected 
to have similar effects on LDL fusion. In addition, changes in apoB conformation 
and in the core lipid composition can also contribute to LDL fusion. Below I 
discuss some agents, natural or engineered, that have been observed to promote 
or prevent LDL fusion. The latter are of particular interest, as they may help 
develop novel therapeutics aimed to inhibit LDL fusion in vivo. 
 
1.7.1 Ceramide  
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Ceramide is the product of sphingomyelin hydrolysis by sphingomyelinase, an 
enzyme that promotes LDL aggregation and fusion in vivo (Pentikainen et al., 
1996; Oorni et al., 1998) (Figure 1.7E). LDL from atherosclerotic lesions contain 
10-50 times more ceramide than plasma LDL from healthy donors (Schissel et al., 
1996b; Oorni et al., 2000). Furthermore, in lesional tissues, aggregated LDL 
contain ceramide, whereas native non-aggregated LDL do not (Schissel et al., 
1996b). These observations suggest that ceramide is directly involved in LDL 
aggregation and fusion in vivo and probably contributes to the development of 
atherosclerosis. Quantitative studies support this notion and show that increasing 
ceramide concentration increases the size of LDL aggregates (Walters and Wrenn, 
2008). The physical basis for the ceramide-induced LDL aggregation and fusion 
appears straightforward, as conversion of polar PC into apolar ceramide 
molecules shifts the balance between the polar surface and the apolar core of 
LDL and promotes solvent exposure of the apolar surface moieties. In summary, 
ceramide is a potent inducer of LDL fusion in vivo and in vitro. 
 
1.7.2 Free fatty acids  
FFA are produced in vivo by PLA2-family enzymes that hydrolyze PC, by 
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lipoprotein lipase that hydrolyses TG, and by hepatic lipase that hydrolyses both 
TG and PC. Elevated levels of plasma FFA are observed in inflammation (where 
excess FFA are produced upon clearance of lipid membranes from the dying cells) 
and in metabolic syndrome and diabetes (that are characterized by 
hypertriglyceridemia) (Chisolm and Steinberg, 2000; de Winther and Hofker, 2000; 
Zhang et al., 2006); all these conditions are associated with increased risk of 
cardiovascular disease (Chernomordik, 1996). Notably, FFA are potent promoters 
of cell membrane fusion as they perturb molecular packing in phospholipid 
monolayers (Kantor and Prestegard, 1978). This prompted Dr. Jayaraman from 
our laboratory to test whether incorporation of additional FFA into the PC 
monolayer on the lipoprotein surface promotes lipoprotein fusion. The results 
clearly showed that heat-induced aggregation, fusion and lipid droplet formation 
are greatly enhanced upon FFA incorporation into LDL or other lipoproteins; this 
effect could be achieved either via the enzymatic action of PLA2 or hepatic lipase 
on PC, or via lipoprotein enrichment with exogenous oleic acid (Jayaraman et al., 
2011). Importantly, FFA removal by albumin reversed the effect and hampered 
lipoprotein fusion, indicating that FFA play a direct role in LDL fusion (Figure 1.10). 
Jayaraman et al. concluded that, similar to lipid bilayer fusion, lipoprotein fusion is 
greatly enhanced upon increasing FFA in the surface monolayer. In vivo, such  
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Figure 1.10  Free fatty acids promote LDL fusion (adapted from Jayaraman et 
al., 2011). Curve 0: native LDL. Curve 1: LDL hydrolyzed by PLA2. Curve 1·HSA: 
LDL hydrolyzed by PLA2 and then treated by human serum albumin to remove 
FFA. All LDL samples (2 mg/ml protein in 10 mM Na phosphate buffer at pH 7.5) 
were heated at a rate of 11 K/h. The melting data were recorded at 280 nm by CD 
to monitor repacking of apolar lipids (A) and by turbidity to monitor increase in the 
particle size upon rupture and coalescence into lipid droplets. The heating data of 
native LDL and of LDL that have been hydrolyzed and treated with albumin (0 and 
1·HSA) were similar, suggesting formation of similar-size particles. In contrast, 
hydrolyzed LDL without albumin treatment showed much larger increase in the 
amplitude of near-UV CD and turbidity, suggesting formation of larger lipid 
droplets. Such enlarged lipid droplets were detected by negative-stain EM 
(Jayaraman et al., 2005). The data indicate that the effect of PLA2 in promoting 
LDL fusion is mainly due to FFA, since removal of FFA by albumin hampers LDL 
rupture and reduces the droplet size. 
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increase in lipoprotein-associated FFA can result from impaired action of albumin 
in the acidic environment of deep atherosclerotic plaques, as well as from 
elevated plasma FFA in inflammation, metabolic syndrome and diabetes 
(Chernomordik, 1996; Chisolm and Steinberg, 2000; de Winther and Hofker, 2000; 
Zhang et al., 2006; Lahdesmaki et al., 2009). Consequently, the ability of FFA to 
promote LDL fusion may contribute to the well-established association of these 
diseases with atherosclerosis (Chernomordik, 1996).  
 
1.7.3  Albumin  
Albumin is the most abundant protein in human plasma that acts as a carrier 
of FFA, lyso-PC and other endogenous hydrophobic molecules as well as drugs. 
Khoo et al. showed that albumin reduced LDL aggregation upon vortexing (Khoo 
et al., 1990). Talbot et al. showed that at physiological concentrations, albumin 
reduced flow-induced LDL aggregation (Talbot et al., 2003b). Notably, 
heat-denatured and fatty acid stripped albumin was particularly effective in 
protecting LDL from aggregation. This protective effect was attenuated upon 
progressive oxidation of LDL (Talbot et al., 2003a). In the studies of the 
heat-induced lipoprotein fusion and lipid droplet formation, only FFA-free albumin 
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showed a protective effect that could be fully attributed to FFA removal from LDL 
(Jayaraman et al., 2011). Taken together, these results suggest that albumin can 
serve as an important modulator of lipoprotein fusion in vivo, and that albumin’s 
ability to protect LDL from fusion depends, at least in part, on its ability to 
effectively remove FFA from LDL.  
 
1.7.4 Exchangeable apolipoproteins  
In contrast to the non-exchangeable apoB that is permanently associated with 
its parent particle, exchangeable apolipoproteins can transfer among lipoproteins 
via their water-soluble globular form. These proteins are relatively small (6-32 kDa) 
as compared to apoB (~550 kDa) and are comprised almost exclusively of 
amphipathic α-helices whose large apolar faces are optimized for lipid surface 
binding (Segrest et al., 1992). Apolipoprotein A-I (apoA-I, 28 kDa), the major HDL 
protein, is one such example. In contrast to LDL and apoB, plasma levels of HDL 
(a. k. a. “Good Cholesterol”) and apoA-I correlate inversely with the risk of 
atherosclerosis (Gordon et al., 1977; Boden, 2000). This cardioprotective effects 
of HDL are thought to result from their role in removing excess cell cholesterol via 
the reverse cholesterol transport, as well as their anti-oxidant, anti-thrombolytic 
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and anti-inflammatory effects (Fielding and Fielding, 1995; von Eckardstein et al., 
2001). In addition, apoA-I helps prevent LDL aggregation in vitro and, potentially, 
in vivo. Studies of isolated lipoproteins have shown that LDL aggregation induced 
by vortexing or by PLC lipolysis is inhibited in the presence of HDL or apoA-I 
(Khoo et al., 1990). This inhibitory effect persists in high salt, pointing to the 
importance of hydrophobic interactions between apoA-I and LDL (Khoo et al., 
1990). The authors proposed that amphipathic α-helices in apoA-I can bind to the 
exposed hydrophobic moieties on LDL surface and thereby block the 
intermolecular interactions leading to LDL aggregation and fusion. My studies 
showed that apoA-I and HDL help protect LDL from heat-induced fusion via a 
similar mechanism (Chapter 5). 
This protective effect is not limited to apoA-I but extends to other 
exchangeable apolipoproteins. One example is apolipoprotein E (apoE, 32 kDa) 
that circulates on VLDL and HDL and is important for metabolism of the 
triacylglycerol-rich lipoproteins in plasma and for lipid transport in the brain 
(Mahley, 1988). Similar to apoA-I, apoE can inhibit LDL aggregation and fusion 
upon lipolysis (Khoo et al., 1990). Similarly, PLC-treated LDL did not aggregate in 
the presence of apolipophorin, an exchangeable apolipoprotein of insect origin 
(Liu et al., 1993). In sum, LDL aggregation and fusion upon various biochemical 
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(hydrolytic) or physical (thermal, mechanical) perturbations can be inhibited by the 
exchangeable apolipoproteins in vitro and, possibly, in vivo. This effect may 
contribute to the cardioprotective action of apoA-I, apoE, and related proteins.  
 
1.7.5 Estradiol 
Epidemiological studies show that pre-menopausal women are protected from 
cardiovascular disease, which is attributed to estrogens (Castelli, 1984; Grodstein 
and Stampfer, 1995). The anti-atherogenic action of estrogens is thought to result 
from their antioxidant effects on LDL (Huber et al., 1990; Sack et al., 1994; 
Shwaery et al., 1997). Specifically, Parasassi and colleagues reported that 
17-β-estradiol (Figure 1.11) binds to apoB on LDL, rendering the particle more 
compact and more resistant to copper-induced oxidative modifications (Brunelli et 
al., 2000). The authors hypothesized that, by inhibiting LDL oxidation, estradiol 
can also inhibit LDL fusion. They tested this idea by determining the effects of 
17-β-estradiol on electronegative LDL, a pro-atherogenic subclass that was 
proposed to trigger aggregation of total LDL. The authors reported that 
estradiol-stabilized LDL were resistant to aggregation in the presence of 
electronegative LDL, and proposed that estradiol binding to specific sites on apoB  
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Figure 1.11  Chemical structures lipids and other molecules mentioned in this 
dissertation.  
 
17-β-estradiolBile acid
Pluronic copolymer
Glycerol  Monoacylglycerol Diacylglycerol Triacylglycerol
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was responsible for this effect (Brunelli et al., 2000). 
 
1.7.6 Amphipathic polymers 
The endogenous inhibitors of LDL aggregation and fusion, such as apoA-I, 
apoE and estradiol, are amphipathic molecules whose protective effects 
apparently result from their ability to bind to the solvent-exposed hydrophobic 
moieties on LDL surface. Similarly, other amphipathic molecules that bind to LDL 
surface are likely to block LDL aggregation and fusion. Such molecules may 
potentially provide new therapeutic agents for atherosclerosis.  
To this end, Pluronic block copolymers were tested for their ability to prevent 
LDL aggregation and fusion (Melnichenko et al., 2012). These polymers are 
nanomaterials consisting of hydrophilic poly-(ethylene oxide) and hydrophobic 
poly-(propylene oxide) blocks arranged in A-B-A tri-block structure (Figure 1.11). 
These polymers can incorporate into cell membranes and translocate in the cells 
where they affect various cellular functions (Batrakova and Kabanov, 2008). A 
series of Pluronic copolymers was tested for their ability to inhibit LDL fusion 
(Melnichenko et al., 2012). LDL aggregation, which was induced by incubation at 
37 oC with constant stirring, was greatly diminished in a manner that was 
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proportional to the hydrophobicity of the copolymer. This further supports the 
central role of hydrophobic interactions in LDL aggregation and fusion. 
 
1.8  Physical Perturbations That Cause LDL Aggregation And Fusion  
LDL aggregation and fusion can also result from physical perturbations, 
including mechanical or thermal stress, chemical denaturants such as guanidine 
hydrochloride that interacts with the protein moiety, solutes such as polyethylene 
glycol (PEG) that promotes fusion of lipid membranes and lipoproteins 
(Jayaraman et al., 2004; Lentz, 2007), reduction in pH, increase in solvent ionic 
strength, divalent metal ions, LDL crowding, etc. (see details in Chapter 5). Some 
of these factors and their effects on LDL fusion in vitro, in silico and, potentially, in 
vivo are outlined below. 
 
1.8.1 Mechanical stress 
In 1988, the pioneering studies by Steinberg and colleagues showed that 
even brief 30 sec vortexing of LDL solutions at room temperature caused 
irreversible aggregation, as indicated by increased turbidity and sedimentation 
coefficients (Khoo et al., 1988). These aggregated LDL were avidly ingested and 
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degraded by macrophages, converting them into cholesterol ester-rich foam cells. 
Later studies using fluid stress model confirmed time-dependent LDL aggregation, 
which was monitored by light attenuation and sedimentation (Talbot et al., 2003a; 
Talbot et al., 2003b). Notably, LDL aggregation was partially inhibited in total 
plasma, apparently due to the protective effects of other apolipoproteins that are 
also expected to inhibit LDL aggregation in circulation (described in 1.7.4).  
 
1.8.2 Thermal and chemical denaturation  
Protein unfolding upon heating or addition of denaturants such as guanidine 
hydrochloride (Gdn HCl) is a method of choice for measuring structural stability of 
globular proteins, water-soluble apolipoproteins and lipoproteins in solution. 
Studies from our laboratory during the last decade showed that thermal or 
chemical denaturation of all major lipoprotein classes, including LDL, involves 
irreversible lipoprotein aggregation, fusion and coalescence into lipid droplets 
(Mehta et al., 2003; Jayaraman et al., 2005a; Guha et al., 2007). This is not 
surprising since even partial protein denaturation should disrupt lipid-protein 
interactions, leading to dissociation of a portion of the protein from the lipoprotein 
surface. This is expected to increase solvent exposure of the hydrophobic “sticky  
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Figure 1.12  LDL fusion is a thermodynamically irreversible kinetically 
controlled process (adapted from Jayaraman et al., 2005). (A) Differential 
scanning calorimetry data of intact and heated single-donor human LDL. The data 
are shifted along the Y-axis to avoid overlap. The LDL sample (3.7 mg/ml protein 
in 10 mM Na phosphate buffer, pH 7.5) was heated at a rate of 90 K/h. Curves I 
and II are the first and second scans recorded upon sample heating from 5 to 
115 °C. Curves 1-4 were recorded from an identical LDL sample upon heating 
from 5 °C to incrementally increasing temperatures, followed by 1 h incubation at 
5 °C: 1, 40 °C; 2, 85 °C; 3, 106 °C; 4, 115 °C. The data indicate that the second 
peak (LDL fusion) and the third peak (LDL rupture) are irreversible. This 
conclusion was confirmed by negative-stain EM. (B) Turbidity melting data of 
intact LDL showed the effects of scan rate. The LDL sample (3.3 mg/ml protein in 
10 mM Na phosphate buffer, pH 7.5) was heated and cooled at a rate of 80 K/h. 
Decreasing the heating rate from 80 (black) to 10 K/h (grey) leads to a shift of 
-8 °C in the apparent melting temperature. Such scan rate dependence is a 
hallmark of a slow kinetically-controlled transition (Gursky et al. 2002; 
Sanchez-Ruiz. 2010). 
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patches” that promote lipoprotein aggregation and fusion.  
In my dissertation (Chapter 4 and 5) and in other studies from our laboratory, 
thermal-induced LDL aggregation, fusion and lipid droplet formation have been 
detected by negative-stain EM, non-denaturing PAGE, size-exclusion 
chromatography, turbidity, CD spectroscopy, and calorimetric methods 
(Jayaraman et al., 2005a; Lu et al., 2012). These studies showed that, similar to 
membrane fusion, LDL fusion is thermodynamically irreversible and is subject to 
kinetic control (Jayaraman et al., 2005a) (Figure 1.12). Kinetic analysis of LDL 
fusion revealed sigmoidal time course of the reaction and its high activation 
energy (Chapter 3). Such a high value of Ea reflects the steep temperature 
dependence of the reaction rate, which limits the range of temperatures at which 
one can accurately measure this reaction rate (Chapter 3). In addition, the rate of 
LDL fusion also depends strongly on solvent composition, pH, LDL concentration 
(Chapter 5), and other factors described below. Combined effects of these factors 
limit the range of experimental conditions allowing quantitative kinetic analysis of 
LDL fusion. Nevertheless, in vitro kinetic analysis of LDL fusion provides a useful 
quantitative tool to determine how individual factors, alone or in combination, 
influence the rate of this pathogenic reaction. This analysis is described in detail in 
Chapter 3. 
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1.8.3 Solvent ionic conditions  
In atherosclerotic lesions, the extracellular pH varies from near-neutral to 
acidic, reaching as low as pH 5.5 in deep hypoxic areas (Naghavi et al., 2002; 
Oorni and Kovanen, 2006). LDL fusion at acidic pH can be augmented via two 
independent mechanisms. First, many hydrolytic and oxidative enzymes that 
modify LDL in the arterial intima have optimal activity at acidic pH (Schissel et al., 
1996a; Shamir et al., 1996; Dollery and Libby, 2006; Oorni and Kovanen, 2006). 
Second, my studies revealed that reduction in pH from near-neutral to acidic 
greatly enhances LDL fusion in vitro (Chapter 5) and, probably, in vivo. This strong 
pH effect indicates the importance of electrostatic interactions in LDL fusion. In 
addition to pH, salt ions also importantly influence LDL fusion. Our in vitro studies 
showed that increasing NaCl concentration from 0 to 150 mM greatly accelerates 
heat-induced LDL fusion, probably due to electrostatic screening of repulsive 
interactions between the particles or their specific sites (Chapter 5). Moreover, 
LDL spontaneously fuse and form lipid droplets at room temperature upon 
addition of low millimolar concentrations of divalent metal ions such as Ca2+ or 
Mg2+, which is likely due to divalent metal binding by acidic groups in apoB 
(unpublished data by Dr. Jayaraman). This effect probably underlies a fast 
laboratory method in which Mg-induced precipitation of total plasma LDL is used 
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to estimate the fraction of small dense LDL that are diagnostic markers of 
atherosclerosis (Hirano et al., 2003; Ai et al., 2010). Since small LDL are more 
resistant to fusion than their larger counterparts, we proposed that small dense 
LDL remain in solution at Mg2+ concentrations that cause fusion and coalescence 
of larger LDL into lipid droplets (see details in Chapter 5).  
 
1.8.4 Lipoprotein crowding 
Elevated concentration of plasma LDL is the strongest causative risk factor of 
atherosclerosis (Manninen et al., 1992; Wilson et al., 1998). The higher the 
concentration of LDL in plasma, the higher the pro-atherogenic LDL uptake by 
arterial macrophages. In addition, LDL crowding at elevated concentrations may 
contribute to atherogenesis via two independent mechanisms. First, in the “lattice 
model” proposed for LDL binding to LDLR, steric hindrance produced by the 
receptor-bound LDL decreases the binding of additional LDL particles to the 
adjacent receptors (Chappell et al., 1991). Second, our experimental studies of 
isolated plasma LDL revealed that increasing LDL concentration within a 
physiologically-relevant range greatly accelerates heat-induced fusion and lipid 
droplet formation (Chapter 5). Kinetic analysis of the reaction rate as a function of 
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LDL concentration indicated a high-order reaction (Chapter 5). This suggests that 
LDL crowding in the arterial subendothelium, together with the steric effects of the 
receptor-bound LDL, potentially contribute to atherogenesis. 
 
1.8.5 LDL thermal denaturation as an experimental model for LDL remodeling 
and fusion 
In our laboratory, we use thermal or chemical denaturation approach to study 
lipoprotein remodeling in vitro (Mehta et al., 2003; Jayaraman et al., 2005a; 
Benjwal et al., 2006; Jayaraman et al., 2006; Guha et al., 2007). Thermal stability 
of LDL has been addressed in several earlier studies (Tall et al., 1977a; Tall et al., 
1977b; Prassl et al., 1996), including calorimetric studies from our department 
(Walsh and Atkinson, 1990). Studies from our laboratory have shown that thermal 
stability of LDL and other lipoproteins is modulated by kinetic barriers that arise 
from lipoprotein remodeling such as fusion, rupture, and apolipoprotein 
dissociation (Mehta et al., 2003; Jayaraman et al., 2005a; Guha et al., 2007). The 
specifics of this heat-induced remodeling are different for HDL, LDL and VLDL. 
Studies by Dr. Jayaraman from our laboratory revealed that thermal 
denaturation of LDL involves two irreversible transitions as analyzed by 
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differential scanning calorimetry (DSC) and negative-stain EM upon sample 
heating at a constant rate (Jayaraman et al., 2005a). Heating to about 85 °C 
induces LDL remodeling into both smaller and larger particles. The smaller 
particles have similar size to small, dense LDL, while the larger particles are 
apparent products of LDL fusion (Jayaraman et al., 2005a). Further heating to 
about 115 °C leads to additional LDL fusion, rupture and coalescence into large 
lipid droplets whose size and morphology resemble lipid droplets found in 
atherosclerotioc plaques (Guyton and Klemp, 1994). These thermal transitions in 
native LDL were proposed to mimic in vivo LDL transformations, such as LDL 
fusion in the arterial wall in early atherosclerosis (Jayaraman et al., 2005a). 
Therefore, thermal denaturation provides a convenient model for assessing 
factors that promote or prevent LDL fusion, rupture and lipid droplet formation in 
vivo. I am also using this model throughout my thesis work. 
 
1.9  Detection of LDL Aggregation, Fusion and Lipid Droplet Formation  
Conversion of intact LDL (~22 nm) into lipid droplets (100-400 nm) is a 
complex process whose individual steps are difficult to discern experimentally, in 
part, due to particle heterogeneity. Some of these steps include: i) LDL 
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aggregation that may involve conformational changes in the protein and lipid but 
little or no changes in the particle size; ii) LDL fusion that produces enlarged 
lipoprotein-like particles that can undergo additional rounds of aggregation and 
fusion; iii) lipoprotein disintegration (rupture) and release of the apolar core lipids 
that coalesce into lipid droplets, often forming large aggregates (Figure 1.1). 
Dissecting this complex process is necessary to elucidate its underlying molecular 
basis and key determinants, and to establish therapeutic targets to block its 
specific steps. Experimental techniques that are used to determine lipoprotein 
size and morphology, differentiate between the aggregated and fused LDL and 
lipid droplets, assess changes in the particle size distribution, and monitor these 
changes in real time are outlined below. 
 
1.9.1 Methods to distinguish between lipoprotein aggregation and fusion 
Transmission electron microscopy (EM) is a method of choice to visualize 
particle morphology and distinguish between the fused and aggregated 
lipoproteins and lipid droplets. For example, Guyton and colleagues used 
negative-stain EM to detect aggregated and fused LDL in human atherosclerotic 
lesions and to compare their size and morphology to those of similar particles 
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formed upon LDL vortexing or aging in vitro (Guyton et al., 1990) (Figure 1.5). In 
this dissertation, I also used negative-stain EM to analyze LDL sub-fractions 
isolated by SEC from total LDL upon various perturbations, which enabled us to 
identify LDL dimerization as a novel early step in aggregation and fusion (Chapter 
4, Figure 1.15). Atomic force microscopy has been used to assess LDL 
aggregation and fusion as an alternative to EM (De Spirito et al., 2006). Although 
the resolution of the lipoprotein images attainable by negative-stain EM is superior 
to those obtained by atomic force microscopy, a potential drawback of 
negative-stain preparation is that it can induce lipoprotein aggregation on the 
grids. This artifact can be eliminated by optimizing the staining technique (Zhang 
et al., 2011). Still, negative-stain EM and atomic force microscopy are 
low-resolution techniques that can only resolve relatively large (>1 nm) structural 
features.  
Cryo-EM, which was used to determine LDL structure at up to 16 Å resolution 
(Kumar et al., 2011; Liu and Atkinson, 2011a), can potentially provide a more 
detailed view of the aggregated and fused LDL (Figure 1.13). The application of 
this technique to lipoproteins is restricted, in part, by sample heterogeneity. 
Furthermore, a general drawback of EM applications to heterogeneous samples 
is that the field views do not always represent the broader particle population. This   
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Figure 1.13   A model of LDL structure determined by cryo-EM at 22 Å 
resolution (adapted from Liu et al., 2011). (A) Linear representation of apoB 
domains with the positions of mAbs used in the mapping of apoB in cryo-EM 
studies. (B) The mAb positions with respect to the high-density protein regions on 
the surface of LDL. The locations of mAbs are color-coded similar to panel A. The 
results indicate that the N- and C-terminal regions of apoB are located in close 
proximity on LDL surface (C).  
 
C
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necessitates the use of complementary techniques for accurate analysis of the 
particle size distribution in aggregated and fused LDL, which are described below. 
In addition to EM, proton NMR has been used by Kovanen’s group to 
differentiate between LDL aggregation and fusion (Ala-Korpela et al., 1998). The 
method is based upon observation that 1H NMR resonances from the CH2 groups 
in lipoprotein lipids shift to higher frequencies upon increasing particle size; this 
effect apparently results from anisotropy in the magnetic susceptibility of the 
oriented molecules in the phospholipid monolayer of the lipoprotein surface 
(Lounila et al. 1994). Even though the interpretation of the data obtained by this 
indirect method involves approximations that may not strictly apply to lipoproteins, 
the method holds potential promise, as the results obtained in the studies of LDL 
aggregation and fusion using 1H NMR and EM were in good agreement (Lounila 
et al., 1994). 
Kovanen’s team developed another interesting approach to analyze fusion of 
LDL in solution or bound to proteoglycans (Pentikainen et al., 1997). Cholesteryl 
esters labeled with fluorescent donor (Pyrene) or acceptor (BODIPY) were 
incorporated into LDL core, and LDL fusion kinetics was monitored by 
fluorescence energy transfer (Pentikainen et al., 1997). The advantage of the 
method is that it can differentiate between LDL aggregation and fusion and is 
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applicable to lipoproteins both in fluid and in immobilized phase that mimics LDL 
binding to arterial matrix proteoglycans. The disadvantage is the necessity to label 
core lipids.  
A promising label-free approach to directly visualize lipid assemblies is 
infrared imaging techniques based on coherent anti-Stokes Raman scattering 
developed by Dr. Sunney Xie and colleagues (Fu et al., 2012). This novel 
approach utilizes strong infrared band from CH2 groups in lipid acyl chains, which 
eliminates the need for labeling. The method has been successfully applied for 
real-time imaging of cell organelles and lipid droplets (Fu et al., 2012). However, 
the diffraction limit in this and other infrared-based imaging techniques restricts 
their resolution to 100 nm. Therefore, optical advances will be needed before this 
novel technique can be used for imaging of lipoproteins (which range in size from 
about 10 nm to 100 nm) and their morphologic transitions. 
 
1.9.2 Methods to determine the size distribution in lipoproteins in solution 
Size-exclusion chromatography (SEC) and non-denaturing PAGE are the 
methods of choice to determine particle size distribution in lipoproteins in solution. 
Although these methods cannot differentiate between the aggregated and fused  
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Figure 1.14  Representative size-exclusion chromatography of LDL and the 
products of their thermal denaturation. LDL samples (0.5 mg/ml protein in 10 mM 
Na phosphate buffer at pH 7.5) were heated at 85 oC for 3 min. The particle size 
distribution of intact (black) and heated LDL (grey) was analyzed by SEC using 
Superose 6 10/300 GL column. The SEC profile of intact LDL showed a single 
peak centered at 12 ml, corresponding to the size of a native LDL (d~22 nm). The 
SEC profile of heated LDL showed two major peaks centered at 8 ml and 12 ml. 
The peak at 8 ml corresponds to large LDL aggregates and lipid droplets (d >100 
nm). 
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particles and are not suitable to discern large aggregated lipid droplets, they are 
extremely useful to monitor changes in the particle size during lipoprotein 
aggregation and fusion (Chapter 4, Figure 1.14). In addition to providing an 
excellent analytical tool, SEC also provides a non-invasive preparative tool for 
isolating lipoproteins by size. The lipoproteins and their sub-fractions isolated by 
SEC can then be analyzed by other methods such as EM (Chapter 2).  
As an alternative to SEC, preparative ultracentrifugation is the method of 
choice to isolate lipoproteins by size and density, while analytical 
ultracentrifugation is useful to determine particle size distribution. This method is 
more invasive than SEC and should be used with caution, as prolonged 
ultracentrifugation can mechanically perturb and remodel lipoproteins. For 
example, in my work, total LDL were isolated from human plasma by 
ultracentrifugation, followed by an additional round of ultracentrifugation to isolate 
large and small LDL. This additional round led to particle size increase in a subset 
of LDL, which was apparently due to LDL dimerization upon mechanical 
perturbation (Chapter 4). 
Since the size range of aggregated and fused LDL and lipid droplets (100-400 
nm) is commensurate with the wavelengths of UV-visible light, methods utilizing 
UV–visible light scattering are useful to monitor LDL aggregation and fusion. 
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Dynamic light scattering is one of such methods that has been used to monitor 
lipoprotein size (De Spirito et al., 2006). In principle, measurements of dynamic 
light scattering can provide particle size distribution, especially in dilute solutions 
of spherical particles. In practice, the results are exquisitely sensitive to trace 
amounts of large particles such as dust, have limited accuracy in size analysis of 
non-uniformly shaped particles such as lipoprotein aggregates, and cannot 
differentiate between the aggregated and fused lipoproteins. Still, dynamic light 
scattering remains useful for monitoring changes in lipoprotein size. 
 
1.9.3 Monitoring lipoprotein aggregation, fusion and lipid droplet formation in 
real time 
Static light scattering or turbidity measurements (i. e. attenuation in light 
intensity due to scattering) in UV-visible range are useful to monitor real-time 
changes in the lipoprotein size upon aggregation, fusion and lipid droplet 
formation (Khoo et al., 1990; Benjwal et al., 2006). Our laboratory has developed 
a method to record turbidity and right-angle light scattering in CD experiments 
(Benjwal et al., 2006) to monitor the time course of lipoprotein aggregation, fusion 
and lipid droplet formation. The results are used for quantitative kinetic analysis to 
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determine the Arrhenius activation energy or access the reaction order. Although 
such measurements alone cannot differentiate between lipoprotein aggregation, 
fusion and lipid droplet formation, they can be combined with other methods such 
as SEC or EM to dissect these steps (Figure 1.15).  
Together with light scattering or turbidity, we also monitor near-UV CD that 
reports on lipoprotein rupture and release of core lipids that coalesce into droplets. 
Earlier studies from our laboratory demonstrated that re-packing of apolar lipids in 
this transition leads to a large negative induced CD peak centered circa 320 nm 
(Figure 1.16, see details in Chapter 2). Thus, this near-UV CD signal provides a 
convenient way to selectively monitor lipoprotein coalescence into lipid droplets. 
 
1.10 LDL Stability is Determined by Kinetic Barriers 
In our laboratory, we use a combination of spectroscopy, SEC and EM to 
study the process of LDL aggregation, fusion and lipid rupture (described in detail 
in Chapter 2). Earlier stability studies from our laboratory showed that, in contrast 
to unfolding of lipid-free apolipoproteins, which is a fast thermodynamically 
reversible reaction (Gursky and Atkinson, 1996), denaturation of major 
lipoproteins, including HDL, LDL and VLDL, is a slow thermodynamically   
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Figure 1.15  Integrated approach for the analysis of morphologic LDL 
transitions. Single-donor human LDL (0.5 mg/ml apoB in 20 mM Na phosphate, 
pH 7.5) were incubated at 85 oC, and the time course of the increase in the 
particle size was monitored by turbidity (A). Aliquots taken at various stages, from 
0 (intact LDL) to 6 (fully denatured), were analyzed by native PAGE (A), 
size-exclusion chromatography (B) and negative stain electron microscopy (C). 
SEC showed three peaks: I - intact-size LDL (~22 nm); II - enlarged lipoproteins 
(~40 nm); III – much larger particles (>100 nm). Native PAGE resolved bands 
corresponding to peaks I and II, and EM of isolated peak II suggested LDL 
dimerization (A). Negative-stain EM showed progressive increase in the number 
of fused (violet arrows, stage 2) and ruptured LDL (orange arrows, stages 5, 6) 
and their aggregates. Similar changes in particle size and morphology were 
observed upon lipolysis, sample aging, prolonged ultracentrifugation, or chemical 
denaturation of LDL (Johs et al., 2006; Bancells et al., 2011). 
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irreversible reaction and is subject to kinetic control (Gursky et al., 2002; Mehta et 
al., 2003; Jayaraman et al., 2005). The experimental evidence for the 
thermodynamic irreversibility of lipoprotein denaturation is: 1) hysteresis in the 
heating and cooling data, 2) the scan rate effects on the apparent melting 
temperature Tm that decreases at a slower heating rate, and 3) slow unfolding rate 
of lipoproteins, which occurs on a time scale of seconds to hours, as compared to 
nano- to millisecond time scale of unfolding of small helical proteins in solution 
(Gursky et al., 2002; Mehta et al., 2003; Jayaraman et al., 2005). Taken together, 
these observations indicate that lipoprotein stability is subject to kinetic control. 
In contrast to thermodynamic stability of lipid-free apolipoproteins (which is 
determined by the free energy difference between the unfolded (U) and folded (F) 
states, ΔG=GU-GF), the kinetic stability of lipoprotein is defined by the free energy 
difference between the high-energy transition state and the folded state, 
ΔG*=G*-GF, whereby G* designates the high-energy transition state (Figure 1.17). 
Enthalpic contribution to the kinetic stability (ΔG*= ΔH*- TΔS*) is ΔH*≈Ea. Ea is the 
activation energy of the reaction, which reflects the enthalpic contribution from the 
packing interactions transiently disrupted during lipoprotein denaturation. The 
value of Ea for LDL denaturation was determined, for the first time, in my thesis 
work (Chapter 3). 
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Figure 1.16  Near-UV CD provides a convenient way to monitor the formation 
of LDL-derived lipid droplets upon heating (adapted from Jayaraman et al., 2005). 
LDL (3.7 mg/ml protein in 10 mM Na phosphate buffer at pH 7.5) were 
equilibrated at 20, 60, and 90 °C for 10 min, and then analyzed by near-UV CD 
spectroscopy. The spectrum of LDL samples heated to 60 °C was similar to that of 
intact LDL (20 °C). In contrast, heating to 90 °C led to a large induced negative 
CD peak centered at 320 nm (red arrow), which reflects the repacking of lipids 
upon LDL rupture and lipid droplet formation (see Chapter 2 for details). This 
signal is utilized in our studies to monitor in real time LDL coalescence into lipid 
droplets. 
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Earlier studies from our laboratory have quantitatively characterized the 
kinetics of thermal denaturation in HDL and VLDL and determined their activation 
energy Ea (Mehta et al., 2003; Guha et al., 2007). In HDL, the time course of the 
cooperative unfolding of the secondary structure in apoA-I was monitored by 
far-UV CD (Fang et al., 2003). In VLDL, time-dependent changes in the particle 
size that resulted from lipoprotein fusion, rupture and coalescence into lipid 
droplets were monitored by turbidity measured as dynode voltage in CD 
experiments (Guha et al., 2007). However, no good-quality kinetic data suitable 
for quantitative stability studies have been obtained for LDL. The reason for it is 
two-fold. First, in contrast to apoA-I in HDL, apoB in LDL does not undergo a 
cooperative secondary structural unfolding upon heating (Jayaraman et al., 
2005a); therefore, far-UV CD is not suitable to monitor the time course of LDL 
denaturation. Second, in contrast to relatively large VLDL (d=30-80 nm), LDL are 
smaller (d=19-25 nm) and hence, changes in turbidity upon LDL heating are much 
smaller compared to VLDL. This leads to reduced signal-to-noise ratio in the 
kinetic data recorded by turbidity during LDL denaturation as compared to similar 
kinetic data of VLDL. 
 
68 
Figure 1.17  Free energy diagram illustrating kinetic stabilization of lipoproteins. 
Thermal and chemical denaturation studies of lipoproteins in our laboratory have 
established the kinetic origin of stabilization of all major lipoprotein classes, 
including HDL, LDL and VLDL (Gursky et al., 2002; Mehta et al., 2003; Jayaraman 
et al., 2005). The morphological changes of lipoproteins (i.e. fusion, rupture and 
lipid droplet formation) are associated with high kinetic barriers. We propose that 
similar kinetic barriers modulate lipoproteins remodeling during metabolism. 
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In my PhD studies, I optimized the experimental conditions and obtained, for 
the first time, good-quality kinetic data reporting on LDL denaturation. This 
allowed us to carry out the first quantitative kinetic analysis of LDL thermal stability 
(Chapter 3) and to assess the effects of several important factors, such as LDL 
particle size, LDL concentration, and solvent ionic conditions, on LDL fusion 
(Chapter 5). By using a combination of various biochemical and biophysical 
techniques, I also studied the structural changes during early stages of LDL 
aggregation and fusion, and revealed a novel intermediate step in this process 
(Chapter 4). We expect that studies such as these will ultimately guide therapies 
to block LDL fusion at early stages and lead to cardioprotection. In addition, I have 
established the freezing procedure for prolonged safe storage of LDL, which 
benefits the experiments in our laboratory, and briefly explored the behavior of 
lipoproteins on the lipid-water surface (Appendix 2).  
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CHAPTER 2   MATERIALS AND METHODS 
In this dissertation, I used human plasma LDL and their subclasses that were 
isolated according to the procedures described in part 2.1 of this chapter. The 
methods that I used to analyze structure and stability aspects of these particles 
and their aggregation and fusion are outlined in parts 2.2 and 2.3. 
 
2.1  Sample Preparation 
2.1.1  Density gradient ultracentrifugation 
Density gradient ultracentrifugation is a technique to separate 
macromolecules based on their densities (mass/volume). In my studies, KBr 
density gradient centrifugation was used to isolate lipoproteins (performed by 
Chery England and Michael Gigliotti in our department) and LDL subclasses 
(performed in our laboratory). KBr density gradient was created by gently 
overlaying lower concentrations of KBr onto higher concentrations in a centrifuge 
tube, as described in detail in parts 2.1.2 and 2.1.3. The lipoprotein sample was 
placed on top of the gradient and centrifuged. During centrifugation, lipoproteins 
traveled through the density gradient until they reached the equilibrium point at 
which their density matched that of the surrounding KBr. Lipoprotein fractions of 
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Figure 2.1  Illustration of density gradient centrifugation used in the 
separation of lipoproteins from human plasma. The density range of the major 
lipoprotein classes is shown (Schumaker and Puppione. 1986). 
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desired density were collected after centrifugation and subjected to further 
analysis (Figure 2.1). 
 
2.1.2 Isolation of human plasma LDL 
Plasma of healthy volunteer donors was obtained with their written informed 
consent upon approval by the Institutional Review Board and was provided for our 
studies. Single-donor LDL were isolated from plasma in the density range 
1.019-1.063 g/ml (Schumaker and Puppione, 1986).  Briefly, KBr was added at 
different lipoprotein cutoff densities during sequential ultracentrifugation using a 
Beckman Ti50.2 rotor at 50,000 rpm at 11 oC. When equilibrium was reached, one 
lipoprotein class could be separated at the top of the gradient by gently removing 
the top layer without disturbing the density gradient. The isolated LDL migrated as 
a single band on agarose gel (Figure 2.2). LDL were then dialyzed extensively 
against standard buffer (20 mM Na phosphate, pH 7.5), and stored in the dark at 4 
oC. Unless otherwise stated, LDL in standard buffer were used for further studies. 
LDL stock solutions were used within four weeks during which no protein 
degradation was detected by sodium dodecyl sulfide polyacrylamide gel 
electrophoresis (SDS-PAGE).  The protein concentration in LDL was measured  
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Figure 2.2  Agarose gel electrophoresis of isolated VLDL, HDL and LDL. 
Single-donor human plasma was separated into different lipoprotein classes by 
density gradient centrifugation. Samples containing each lipoprotein class were 
analyzed by agarose gel electrophoresis, and the gels were stained by the lipid 
stain Fat Red 7B. 
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by a modified colorimetric Lowry assay (Markwell et al., 1978). Typical protein 
concentration in LDL stock solution was 3-7 mg/ml. 
 
2.1.3 Isolation of LDL subclasses on the basis of particle size and density 
LDL subclasses were isolated from the total plasma LDL by KBr density 
gradient ultracentrifugation in the following density ranges: 1.025-1.034 g/ml for 
LDL1 (large buoyant), 1.034-1.044 g/ml for LDL2 (mid-range), and 1.044-1.060 
g/ml for LDL3 (small dense) (Krauss, 2010). The density of total LDL was first 
adjusted to 1.020 g/ml by adding solid KBr and then transferred into SW55 
centrifuge tubes. Each tube was overlaid with 1.060 g/ml KBr solution to reach a 
total volume of 4.5 ml. A blank tube was overlaid in a similar way, except that 
1.020 g/ml KBr was used instead of LDL. The six tubes were centrifuged at 
50,000 rpm, 11°C for 20-25 hours until the density gradients of KBr solution 
reached equilibrium. Aliquots of 200 or 500 μl were taken carefully from the top of 
each tube. The same fractionation was done on the blank tube for determination 
of density using a refractometer.  
 
2.2  Circular Dichroism Spectroscopy and Turbidity Measurements 
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In my structural and stability studies of LDL, I used CD and turbidity 
measurements in the melting and in kinetic experiments, to monitor in real-time 
the changes in particle size and protein conformation. 
 
2.2.1 Far-UV circular dichroism 
CD spectroscopy is used extensively in the far-UV spectral region (190-250 
nm) to study the secondary structure of proteins, since α-helix, β-sheet and 
random coil have unique CD spectral signatures: α-helix exhibits strong positive 
peak at 193 nm and negative peaks at 208 and 222 nm, β-sheet exhibits positive 
signal near 197 nm and negative signal near 218 nm, and random coil shows a 
prominent negative signal at 203 nm (Figure 2.3). Therefore, the characteristic 
shapes and magnitudes of far-UV CD spectra can be used to estimate the 
secondary structural content of proteins in solution (Gao et al., 2012).  
For the structural analysis of lipoproteins, the assessment is complicated by 
sample heterogeneity, by light scattering effects caused by the large particle size 
of lipoproteins (Mao and Wallace, 1984), and by the contribution from lipids. All 
these effects lead to systematic errors in protein secondary structure estimation, 
which are difficult to correct. In addition, far-UV CD is particularly useful for  
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Figure 2.3  Characteristic far-UV circular dichroism spectra of α-helix, β-sheet 
and random coil (adapted from http://www.ap-lab.com). Different secondary 
structures of proteins show characteristic shapes and magnitudes in far-UV CD 
spectra. These spectral signatures can be used to determine protein secondary 
structure content in solution. 
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studying proteins that contain mostly α-helical structures. Since LDL contains only 
apoB, which contains both α-helix and β-sheet structures, its secondary structure 
estimate is less straightforward as compared with that for highly-helical 
apolipoproteins such as apoA-I. In fact, secondary structure estimate for apoB 
requires deconvolution of far-UV CD spectra, which is not very reliable for 
lipid-surface binding proteins, and the estimation is further complicated by 
spectral distortion resulting from the large size of LDL(Mao and Wallace, 1984). 
Therefore, we limit our far-UV CD studies of LDL to qualitative assessment of 
secondary structural changes in apoB induced by changes in environmental 
conditions (temperature, salt, pH, etc.). 
In my thesis work, I recorded far-UV CD spectra of LDL samples at various 
stages of thermal denaturation. The purpose of this was to detect possible 
secondary structural changes in apoB during thermal denaturation of LDL. Since 
LDL aggregation, fusion and rupture upon heating are strongly 
concentration-dependent (Chapter 5), LDL heat denaturation was performed at a 
relatively high sample concentration (~0.5 mg/ml), which was higher than the 
optimal concentration for far-UV CD data collection (<0.1 mg/ml). This high 
concentration resulted in high UV absorption, and hence, high noise level that 
limited CD data collection. To reduce the noise level, far-UV CD spectra were 
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recorded using LDL samples taken out at various stages of heat denaturation, 
immediately cooled on ice, and diluted to 100 μg/ml protein concentration. These 
samples were placed in a 1 mm cell, and the spectra were recorded with 1 nm 
increment, 1 nm bandwidth and 30 sec averaging time per data point. 
 
2.2.2  Near-UV circular dichroism 
The CD spectrum of a protein in the near-UV spectral region (250-350 nm) is 
sensitive to the asymmetry in the packing of aromatic residues, which depends 
upon the tertiary structure of a protein. The CD signal strength in near-UV, which 
contains contributions mainly from the aromatic residues, is much weaker than 
that in the far-UV region, which contains contributions from all peptide bonds. 
Therefore, the protein concentration used in near-UV CD experiments (1-10 
mg/ml) is usually higher than that in far-UV (0.01-0.1 mg/ml). The major aromatic 
residues contributing to the near-UV CD of proteins are: i) Phe at 250-265 nm, ii) 
Tyr at 270-290 nm, and iii) Trp at 285-295 nm, which is the strongest contributor 
(Woody, 1986; Woody and Dunker, 1986). Importantly, the contribution from 
aromatic residues or any other protein groups are negligible at λ > 310 nm.  
Near-UV CD spectra of intact LDL showed little signal from the aromatic 
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residues (Figure 2.4). Interestingly, lipoprotein coalescence into lipid droplets 
upon heating resulted in a large induced negative CD peak that was centered at 
320 nm and extended into visible range up to 400 nm. This peak was observed 
upon thermal denaturation of VLDL, LDL, and of HDL in high salt solutions (Figure 
2.4 and 2.5) (Jayaraman et al., 2006). The amplitude of this near-UV CD peak 
increased with increasing size of the lipoprotein and of the lipid droplets formed 
upon heating in the order: VLDL>LDL>HDL. The unusually long wavelength of 
this CD peak at 320 nm suggests that it originates from the lipids rather than 
proteins, since it is beyond the CD range from aromatic residues. Jayaraman et al. 
concluded that this peak is a result of the altered packing of the core lipids, 
particularly TG, CE and/or carotenoids, which are the only LDL components that 
could exhibit such induced CD near 320 nm (Chen and Kane, 1974; Sklar et al., 
1981; Yeagle et al., 1982). In fact, formation of this heat-induced CD peak 
correlates directly with DSC and EM data showing lipoprotein rupture and 
formation of lipid droplets. Therefore, the induced negative CD peak at 320 nm 
reflects the re-packing of core lipids upon their release from the lipoprotein core 
and coalescence into large lipid droplets. 
In my studies, I took advantage of this induced CD to monitor rupture of LDL 
in thermal denaturation experiments. I recorded near-UV CD spectra of intact and  
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Figure 2.4  Near-UV CD spectra of intact and ruptured human HDL and the 
major HDL protein, apoA-I. The spectra were recorded from HDL (2.5 mg/ml 
protein, 0.5 M NaCl in 10 mM Na phosphate pH 7.5) that were intact (purple) or 
heated and cooled in a DSC experiment from 25 to 115 oC (brown). CD spectrum 
of lipid-free intact human apoA-I in the same buffer at 25 oC, is shown for 
comparison (black). Spectral contributions from aromatic residues are indicated. 
Arrow shows the near-UV CD peak that is induced upon release of the apolar 
lipids from the lipoprotein core and their coalescence into large lipid droplets 
(adapted from Gao et al., 2012). 
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Figure 2.5  Negative near-UV CD peak is induced upon LDL or VLDL rupture 
and coalescence into lipid droplets (adapted from Guha et al., 2007). (A) LDL 
samples were equilibrated for 10 min at 20, 60, and 90 °C, respectively, and were 
analyzed by near-UV CD spectroscopy.  Irreversible LDL rupture, which occurred 
upon heating to 90 oC, was accompanied by formation of a large negative CD 
peak. (adopted from Jayaraman S. et al., 2005 Biochemistry.) (B) CD spectra of 
intact VLDL and of VLDL that have been heated and cooled from 25-98 °C at a 
rate of 80 °C/h. Such heating causes irreversible rupture of VLDL which is 
accompanied by the formation of a large negative near-UV CD peak.  
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thermally-denatured LDL to confirm the presence of a negative peak centered at 
320 nm upon heating. LDL samples of 0.5 mg/mL protein concentration were 
placed in a 5 mm cell. The near-UV spectra were recorded from 250 to 350 nm 
with 1 nm increment, 1 nm bandwidth and 10 sec averaging time per data point. 
 
2.2.3  Turbidity measurements 
Thermal denaturation of LDL involves particle aggregation, fusion and rupture, 
which result in large changes in the particle size. Turbidity is a way to monitor 
such changes in lipoprotein samples. The sizes of LDL (~22 nm) and the products 
of LDL heat denaturation, such as lipid droplets and their aggregates (> 100 nm) 
are commensurate with the wavelength of UV light (~102 nm), leading to 
significant light scattering effects in CD experiments. Such effects are not only a 
limitation for far-UV CD data analysis, but they also can be used as a tool to 
monitor changes in particle size during LDL heat denaturation. Turbidity can be 
recorded simultaneously with the CD signal in the same experiment, to accurately 
correlate changes in particle size and LDL coalescence into lipid droplets. Also, 
right-angle light scattering can be recorded in these experiments by using a 
fluorescent accessory available in one of our CD instruments. 
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In my CD experiments, turbidity was recorded at a constant wavelength by 
using dynode voltage. Dynode voltage is the high voltage (102-103 V) applied to 
the photomultiplier of the UV detector to compensate for the intensity reduction of 
the incident light. Dynode voltage increases nearly linearly with the reduction in 
the light intensity. The reduction may result from light scattering and/or absorption 
while passing through the sample. No significant changes in UV absorption are 
expected to occur upon lipoprotein heating, since the chemical composition and 
hence, the UV extinction coefficient does not significantly change. Therefore, any 
heat-induced changes in dynode voltage during lipoprotein heat denaturation 
must result from changes in light scattering, which reflects changes in particle size 
(Gursky et al., 2002; Benjwal et al., 2006). Consequently, any significant changes 
in dynode voltage originate from the changes in the particle size, which is a result 
of particle aggregation, fusion and lipid droplet formation. Since light scattering 
depends non-linearly on the particle size (approximately as 6), the signal is 
dominated by the large particles. 
In the melting and T-jump experiments, turbidity was recorded together with 
CD at 320 nm. This allowed me to simultaneously monitor the increase in the 
particle size due to aggregation, fusion and lipid droplet formation (by turbidity), 
and repacking of apolar lipids upon their release from LDL core and formation of 
84 
droplets (by CD). In my studies, turbidity measurements were used to explore the 
structural changes during LDL thermal denaturation and to investigate the effects 
of particle size, protein concentration and pH on LDL fusion and rupture. 
 
2.2.4  Melting experiments  
In melting experiments, CD signal at a characteristic wavelength (e.g. 222 nm 
for α-helix or ~217 nm for β-sheet) is recorded continuously as the sample 
temperature increases at a constant rate. Melting data are generally used to 
determine the melting temperature, Tm, of a macromolecule, which is used as a 
measure of its thermal stability. Further, for thermodynamically reversible 
(equilibrium) transitions, the melting data are used to determine effective, or van’t 
Hoff enthalpy of the transition, ΔHv, which provides a measure of inter-atomic 
interactions that are disrupted upon unfolding of a cooperative unit within a 
macromolecule. In thermodynamically reversible transitions, the shape of the 
melting curve as well as the transition midpoint, Tm, are independent of the 
heating rate, and the heating and cooling data largely superimpose. Importantly, 
these conditions do not apply to lipoproteins.  
Earlier studies from our laboratory showed that thermal denaturation of LDL 
85 
upon heating to 98 oC involves irreversible changes in the particle morphology 
and protein conformation. Moreover, LDL melting data, Θ(T), showed hysteresis 
and a strong heating rate dependence, with Tm shifting to lower temperatures at 
slower heating rates. This behavior is a hallmark of slow kinetically controlled 
transitions with high activation energy (Gursky et al., 2002; Sanchez-Ruiz, 2010).  
For such a transition, van’t Hoff analysis of the melting data cannot be used to 
determine ΔHv. Instead, we use Arrhenius analysis of the kinetic data to 
determine Arrhenius activation energy (enthalpy) of the transition, Ea≈ΔHv, as 
described in part 2.4 below. Furthermore, for thermodynamically irreversible 
transitions, the melting temperature Tm is not an accurate measure of the absolute 
marcromolecular stability, as Tm decreases with a decreasing heating rate (and 
hence, it is called apparent melting temperature, Tm,app). Nevertheless, Tm,app can 
still be used to establish a relative rank order of macromolecular stability for 
similar systems, such as mutant forms of the same protein, or variants of the 
same lipoprotein. To do so, it is essential that all experimental conditions, 
including heating rate, are identical in different experiments.  
Finally, heat-induced LDL aggregation, fusion and rupture are strongly 
concentration dependent, as first shown by Dr. Jayaraman (Jayaraman et al., 
2005a) and described in greater detail in Chapter 5. Therefore, it is essential to 
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use exactly the same LDL concentration in the stability studies of various LDL 
species.   
In my thesis work, I used melting data recorded in CD experiments to 
qualitatively compare the stability of LDL samples differing in particle size, protein 
concentration, salt, and pH. These experiments were performed under otherwise 
identical experimental conditions. In the melting experiments, LDL samples were 
heated at a constant rate of 80 oC/h; the CD and turbidity data, Θ(T) and V(T), 
were recorded simultaneously as a function of temperature at λ = 320 nm to 
monitor changes in the particle sizes (by turbidity), and in LDL rupture and 
coalescence in to lipid droplets (by CD) (Figure 2.6). Under standard conditions, 
LDL samples of 0.5 mg/mL protein concentration were placed in 5 mm cell, and 
the data were recorded during sample heating and subsequent cooling from 5 to 
98 oC. 
 
2.2.5  Kinetic temperature-jump experiments  
In temperature-jump (T-jump) experiments, CD and turbidity data, Θ(t) and 
V(t), were recorded simultaneously as a function of time to monitor the time 
course of LDL aggregation, fusion and rupture. LDL heat denaturation was  
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Figure 2.6  Representative melting data of LDL. CD and turbidity data were 
recorded simultaneously at 320 nm while human LDL sample (0.5 mg/ml protein 
in 20 mM Na phosphate, pH 7.5) was heated from 25 oC to 98 oC and cooled at a 
rate of 11 K/h. LDL rupture and coalescence into lipid droplets leads to a large 
increase in negative CD signal at 320 nm (A). LDL fusion and rupture also leads 
to a large increase in turbidity which results from an increase in the particle size 
(B). 
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triggered by a rapid temperature increase at t=0, and the time course of the 
transition was monitored at λ = 320 nm. Under standard conditions, LDL samples 
of 0.5 mg/mL protein concentration were placed in 5 mm cell, and the transition 
was triggered by increasing temperature rapidly from 4 oC to 85 oC. The time 
course was monitored with 10 s increments for up to 21 h (Figure 2.7).  
In my studies, I first used T-jumps to quantitatively measure the thermal 
stability of LDL. I also used T-jumps to analyze the reaction order of LDL fusion by 
measuring the rate of denaturation at different LDL concentrations. I also used 
T-jumps to detect the effects of certain plasma factors, such as apoA-I and HDL, 
on LDL stability.  
  
2.3  Quantitative Kinetic Analysis of LDL Thermal Stability 
For Arrhenius analysis, the turbidity data, V(t), recorded in T-jumps at each 
final temperature were approximated by a sigmoidal function:  
      V(t) = V0+ (V0-V1) / {1 + exp[(t – t½) / k]} 
  Here, V0 is the initial turbidity of intact LDL, V1 is the asymptotic value 
corresponding to denatured LDL, t½ is the reaction midpoint corresponding to 50% 
change in turbidity, and k is the rate constant (Figure 2.8). The results were  
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Figure 2.7  Representative temperature-jump data of LDL. An LDL sample 
(0.5 mg/ml in 20 mM Na phosphate pH 7.5) was heated rapidly at t=0 from room 
temperature to 85 oC, and turbidity at 320 nm was recorded as a function of time, 
to monitor the increase in the particle size due to LDL aggregation, fusion and 
rupture. The reaction time course is sigmoidal, which is unique to LDL. 
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analyzed by using an Arrhenius model as described previously (Gursky et al., 
2002). The Arrhenius plots, k(T) versus 1/T, where T is temperature in Kelvin, 
were approximated by linear functions whose slopes were used to determine the 
Arrhenius activation energy (enthalpy), Ea, of LDL denaturation. The value of Ea 
reflects the number and character of packing interactions per cooperative unit 
which are transiently disrupted during lipoprotein heat denaturation. Previous 
studies from our laboratory concluded that a cooperative unit in model HDL 
probably contains one protein molecule and adjacent lipids ((Guha et al., 2008) 
and references therein). Cooperative unit in LDL heat-denaturation remains to be 
determined. Based on the value of Ea≈100 kcal/mol measured in my studies 
(described in Chapter 3), we hypothesize that the cooperative unit involves a 
portion of apoB and adjacent lipids.  
ORIGIN software was used for the data analysis and graphic representation. 
 
2.4  Negative-Stain Electron Microscopy  
To visualize particle morphology at various stages of thermal denaturation, 
LDL samples (20-100 μg/mL protein concentration in 20 mM Na phosphate buffer, 
pH 7.5) subjected to various thermal treatments were analyzed by negative  
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Figure 2.8  Arrhenius analysis of LDL heat denaturation. (A) T-jump kinetic 
data. LDL samples under identical conditions (0.5 mg/ml protein in 20 mM Na 
phosphate pH 7.5) were subjected to T-jumps from room temperature (25 oC) to 
final constant temperatures ranging from 75 oC to 95 oC. Each curve was 
approximated by a sigmoidal function, V(t) = V0+ (V0-V1) / {1 + exp[(t – t½) / k]}, to 
obtain the reaction rate k and midpoint t1/2. (B) Arrhenius plots show the values of 
ln k, obtained from the data in (A), plotted against 1/T. The plots were fitted by 
linear functions (solid lines) whose slope corresponds to the activation energy, Ea. 
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staining EM.  
To prepare the grids for EM, carbon Formvar-coated 300 mesh copper grids 
were glow-discharged before use. Four μL aliquots of LDL sample were applied 
onto a grid and incubated for 10 sec. Excess solution was gently blotted by a filter 
paper for 4 sec. The grid was immediately stained with 1% w/v sodium 
phosphotungstate at pH 7.4, 22 oC. After 10 sec, excess staining solution was 
blotted and the grid was air-dried for 3 min. Samples were visualized under 
low-dose conditions using a CM12 transmission electron microscope (Philips 
Electron Optics). Digital images were collected at 56,250 magnifications with a 
Teitz 1K CCD camera (Gauting, Germany). Particle size analysis was carried out 
by PHOTOSHOP computer graphics with EXCEL program using ~100 particles. 
The negative EM studies of LDL were performed under the guidance of Mr. 
Donald Gantz. 
 
2.5  Cryo-Electron Microscopy  
To avoid possible artifacts caused by negative staining, cryo-electron 
microscopy (cryo-EM) was used to visualize intact LDL and an isolated product of 
their thermal denaturation, which appeared as LDL dimer by negative-stain EM 
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(Chapter 4). Cryo-preservation was performed following the protocols established 
in our department (Liu and Atkinson, 2011b; Liu and Atkinson, 2011a; Liu et al., 
2011). Briefly, Quantifoil® Cu-400 mesh holey carbon grids were glow-discharged 
before use. Aliquots of 3-4 μl LDL samples (0.2-1.0 mg/mL protein concentration 
in 20 mM Na phosphate buffer, pH 7.5) were applied on the grids. The grids were 
incubated at 22˚C with 100% humidity. The grids were then double-sided blotted 
for 1-4 s and plunged into liquid ethane using the Vitrobot® plunging system. The 
frozen grids were transferred in liquid nitrogen for storage until cryo imaging [40]. 
Cryo-preserved samples were visualized at 120 kV under low-dose conditions by 
using a CM12 transmission electron microscope. Digital images were collected at 
56,250 magnification with a Teitz CCD camera. The cryoEM studies of LDL were 
performed with great help of Mr. Donald Gantz and Dr. Jing Wang. 
 
2.6  Gel Electrophoresis: Non-Denaturing and SDS-PAGE  
  Non-denaturing PAGE (NDGE) was performed using 4% polyacrylamide 
homogeneous system to examine irreversible changes in the particle size upon 
lipoprotein aggregation and fusion. SDS-PAGE was performed using 4% 
polyacrylamide homogeneous system to assess apoB aggregation and/or 
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proteolysis. LDL samples containing approximately 5-10 μg protein were loaded 
on the gels. Native- and SDS-PAGE were run on a Hoefer SE260 (Bio-Rad) 
mini-vertical apparatus at 150-200 V for 1.5–2 h, and were stained with Denville 
Blue protein stain.  
 
2.7  Western Blotting 
To detect possible conformational changes in apoB during thermal 
denaturation of LDL, immunoblotting was performed following NDGE. Proteins on 
the gel were transferred to a polyvinylidene fluoride (PVDF) membrane on ice or 
in the cold room. The conditions for transfer were 1-1.5 h at 100 V or for 24 h at 30 
V. The PVDF membrane was then incubated in blocking buffer (5% (w/v) non-fat 
milk proteins in buffer consisting of 10 mM Tris HCl, pH 7.5, 150 mM NaCl, 0.05% 
w/v Tween-20) and incubated with monoclonal antibodies (mAbs) to apoB100. 
Membranes were washed and then probed by horseradish 
peroxydase-conjugated secondary antibodies. ApoB was visualized after 
incubation of membranes with enhanced chemiluminescent system (Perkin 
Elmer).  
We explored nine mAbs to apoB100 N- and C-terminal domains that are  
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Figure 2.9  Domain architecture of apoB and epitope map of monoclonal 
antibodies used in this dissertation. Lower panel: apoB was proposed to contain 
five domains with alternating α-helical and β-sheet regions designated as βα1, β1, 
α2, β2, and α3 (Segrest et al., 2001). Residue numbers delineating individual 
domains are indicated. Upper panel: the epitope map of the monoclonal 
antibodies used in this dissertation. 
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expected to undergo structural changes during LDL fusion. These mAbs and their 
epitopes include: Mb19 (71), Mb24 (405-539), 1D1 (474-539), Mb11 (1022-1031), 
Mb47 (3429–3453 and 3507–3523), 5E11 (3441-3569), 4F6 (3569-3925), Mb43 
(4027–4081), and Bsol7 (4517–4536). (Figure 2.9). All mAbs were a kind gift by Dr. 
David Atkinson, except for 1D1 that was purchased from the University of Ottawa 
Heart Institute. Immunoblotting studies were carried out under the guidance of Dr. 
Haya Herscovitz. 
 
2.8  Size-Exclusion Chromatography 
Size-exclusion chromatography (SEC) was used as an analytical tool to 
assess particle size distribution at various stages of LDL thermal denaturation, 
and as a preparative tool to isolate lipoprotein fractions differing in particle size 
(Figure 2.10). LDL samples (0.5 mg/ml protein in 20 mM Na phosphate buffer, pH 
7.5) that have been subjected to various thermal treatments were filtered using a 
0.2 μm filter and applied to a Superose 6 10/300 GL column in an AKTA-FPLC 
system (GE Healthcare). The samples (100-500 μl injection volumes) were eluted 
with 20 mM Na phosphate buffer, pH 7.5 at a flow rate of 0.5 ml/min. Elution of 
lipoproteins was monitored by absorbance at 280 nm. Fractions of 0.5 ml each  
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Figure 2.10  Size-exclusion chromatography used as a preparative tool to 
isolate LDL fractions differing in the particle size. An LDL sample (0.5 mg/ml in 20 
mM Na phosphate pH 7.5) was incubated at 85 oC for 1 min, cooled to 25 oC, and 
then applied to Superose 6 10/300 GL column. Three peaks were eluted and 
collected in different fractions. The isolated peaks were used for stability studies 
as described in Chapter 4. 
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were collected and used for other analyses. 
 
2.9  Ion-Exchange Chromatography  
   Ion-exchange chromatography (IEC) was used to isolate native LDL (LDL+) 
and electronegative LDL (LDL-) on the basis of their charge (Figure 2.11). Total 
LDL (0.5-2 mg/ml protein in 10 mM Na phosphate buffer, pH 7.5) were filtered 
using a 0.2 um filter and applied to a Hi-Load 26/10 Q-Sepharose column in the 
AKTA-FPLC system. The separation was performed using buffer A (10 mM Na 
phosphate buffer, pH 7.5) and buffer B (10 mM Na phosphate buffer, 1 M NaCl, 
pH 7.5). LDL+ were eluted as a single peak at 0.24 M NaCl, and LDL- were eluted 
as a single peak at 0.5 M NaCl. Elution of lipoproteins was monitored by 
absorbance at 280 nm. Fractions of 0.5 ml each were collected for future studies.  
 
2.10  Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) is a thermoanalytical technique used 
to measure the heat capacity of a sample as a function of temperature. 
Experimentally, DSC measures the amount of heat that has to be supplied to or 
withdrawn from the sample to maintain zero temperature difference between the  
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Figure 2.11  Ion-exchange chromatography used to isolate electronegative 
LDL. (A) LDL sample (0.5 mg/ml in 20 mM Na phosphate pH 7.5) was applied to a 
Hi-load 26/10 Q-Sepharose column and eluted step-wise with increasing 
concentrations of NaCl (indicated on the green line). Electronegative LDL (LDL-) 
were eluted at a higher concentration of salt. This method was used to isolate 
LDL- from native LDL (LDL+). 
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sample cell (filled with macromolecular solution in buffer) and the reference cell 
(filled with buffer) during heating or cooling. Heat effects can result from molecular 
re-packing (such as protein unfolding, lipid phase transitions, or lipoprotein fusion 
and rupture) upon sample heating at a constant rate (usually 90 oC/h).  
DSC records the differential energy input (ΔQ/Δt, mcal/sec) between the 
sample and reference cells as a function of temperature during heating. Because 
the heating rate is constant, ΔT/Δt = const, ΔQ/ΔT can be derived from ΔQ/Δt. 
Since the DSC experiments are performed at a constant pressure, the differential 
heat capacity of the two cells, ΔCp=(ΔQ/ΔT)p, can be determined. Since the 
sample cell is loaded with the macromolecules in buffer, the reference cell 
contains the same buffer solution, and the two cells are identical, the differential 
heat capacity, ΔCp(T)= Cp(T)sample-Cp(T)buffer, is the heat capacity of the 
macromolecules alone. 
One advantage of DSC is that the measurements can be extended beyond 
100 oC (to about 115 oC) by applying pressure to the aqueous sample and thereby 
increasing its boiling point. Another advantage of DSC is high accuracy with which 
it can measure the transition temperature, Tm, which corresponds to the peak 
position in the heat capacity data, Cp(T). In contrast, CD and turbidity experiments 
can only measure Tm indirectly by taking the first derivative of the melting data. 
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However, DSC also has its limitations. First, DSC requires high sample 
concentrations (>1 mg/ml protein), which is 50-100 times higher than those 
typically used in far-UV CD or fluorescence spectroscopic experiments. However, 
in my LDL stability studies, I had to use high sample concentrations anyway, since 
LDL aggregation and fusion are strongly concentration-dependent. Hence, the 
LDL concentrations I used in DSC and CD studies were comparable. Another 
limitation of DSC is that, due to its high thermal inertia, DSC is suitable for melting 
but not for kinetic T-jump experiments. 
In my stability studies, I used DSC to compare the apparent temperatures of 
LDL fusion / rupture at different sample concentrations or in different buffers. I 
took advantage of the fact that in DSC the samples can be heated above 100 oC, 
as compared to the maximal temperature of 98 oC available in spectroscopic 
experiments. In my experiments, excess heat capacity from degassed LDL 
samples of 0.5-4.0 mg/mL protein concentration was measured by using an 
upgraded Microcal MC-2 differential scanning microcalorimeter. The Cp(T) data, 
which were recorded during sample heating from 5-115 oC at a rate of 90 oC/h, 
were corrected for buffer baseline and normalized to protein concentration. 
ORIGIN software (Microcal) was used for the data collection, analysis and display. 
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2.11  Drop Tensiometry 
  The drop tensiometer used in my studies is a special instrument designed by 
Hoffman La Roche for Dr. Small’s laboratory in our department (Small et al., 2009; 
Mitsche et al., 2010). The instrument consists of a stirred cuvette and a 
computer-automated syringe that can deliver a bubble of gas or oil into the 
aqueous phase in the cuvette (Figure 2.12) (Mitsche et al., 2010). There is a 
delivery-removal system of the cuvette that allows for the complete exchange of 
solution. The drop shape is continuously projected on a camera, and the image 
analyzed by the computer can give a continuous measure of drop volume, surface 
area, and surface tension. The method was previously used by Dr. Small and his 
laboratory to study amphipathic α-helix and β-strand consensus peptides derived 
from human apolipoproteins (Wang et al., 2003; Wang and Small, 2004; Wang et 
al., 2005; Wang et al., 2006). The results showed that both α-helical and β-strand 
peptides bind rapidly to the triolein / water interface, but α-helices were pushed off 
by moderately high surface pressures whereas there was no evidence that 
β-strands were pushed off. Tensiometric studies of full-length apoA-I and apoB 
revealed that apoA-I showed similar features to α-helical peptides, while apoB 
acted as a combination of α-helices and β-strands (Wang et al., 2006). In this 
thesis work, our goal was to analyze the time course of lipoprotein interactions  
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Figure 2.12  Schematic illustration of the drop tensiometer (adopted from 
Mitsche et al., 2010). (A) A drop of oil or air is made at the tip of U-shape syringe 
②. The volume of the bubble can be changed by the syringe, which is connected 
to a computer. The drop is submerged in a tank filled with 2 mM Na phosphate 
buffer pH 7.4 ③ . The shape of the bubble is monitored in real-time by a 
Charge-Coupled Device (CCD) camera, which also reports the surface tension. 
(B) The buffer in the tank can be changed by the cooperation of two tubes and a 
stirrer ①. One tube is attached to a reservoir of buffer ④, and another tube is 
attached to a vacuum pump ⑤. 
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and possible fusion with the lipid droplet surface, as well as the specific steps 
involved, such as protein or lipoprotein adhesion to and fusion with the surface of 
the lipid droplet or apolipoprotein displacement from it. 
  To investigate the specific steps that take place at the lipid droplet interface 
during lipoprotein fusion, VLDL, LDL or HDL were added to the cuvette that 
contained triolein drop in 2 mM Na phosphate buffer at pH 7.4. The surface area 
and tension of triolein/water interface were monitored simultaneously by Windrop 
tensiometer. When the surface tension reached a plateau, the excess lipoproteins 
in aqueous phase were washed out by buffer exchange. Triolein drop was then 
alternately compressed and expanded and the surface response was monitored. 
These studies were performed together with Dr. Libo Wang, who is an expert in 
drop tensiometry. 
 
2.12  Competitive Enzyme-Linked Immunosorbent Assay 
  Enzyme-linked immunosorbent assay (ELISA) is an immuno assay which 
uses antibodies to detect and quantify the presence of a specific antigen. 
Competitive ELISA works through competitive binding of different antigens to the 
same antibody and measures the difference in the binding affinity of these 
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antigens, which reflects differences in exposure of their specific epitopes and/or 
the conformational changes in these epitopes (Figure 2.13). 
In our experiments, plastic wells were coated overnight with 100 μl of LDL (50 
μg/ml in 0.1 M NaHCO3 buffer, pH 9.6) on a shaker in the cold room. The wells 
were washed 3 times with PBST (1×phosphate-buffered saline containing 0.05% 
Tween 20). Next, each well was saturated with nonspecific protein by incubation 
for 1 h at room temperature with 200 μl of 3% bovine serum albumin (BSA) in 
PBST. Different dilutions of either the intact or heated LDL (0.25-2 μg/ml in 2% 
BSA/PBST) were added to the wells according to the experimental design, and 
then primary mAbs (diluted in 2% BSA/PBS) were added to each well. The wells 
were then incubated overnight in the cold room and washed 3 times with PBST. 
Horseradish peroxidase-conjugated secondary antibodies were diluted in 0.02% 
BSA/PBST before use. Two hundred microliters of diluted secondary antibody 
solution was added to each well and incubated for 1 h. The wells were finally 
washed with PBST 5 times. Next, a 100 μl of substrate (3,3’,5,5’ 
tetramethylbenzidine liquid substrate, Sigma) was added and incubated for 30 
min. Afterwards, 100 μl  of 2 N HCl was added to stop the reaction, and the 
absorbance at 450 nm was determined using a plate reader. 
The competitive immunoassay allowed us to clearly identify the apoB  
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Figure 2.13  Diagram showing a step-by-step procedure for performing 
competitive ELISA (adapted from www.testkappa.com). 1). A 96-well plate is 
coated with intact LDL. 2)  Different dilutions of competing antigens (i.e. intact or 
heated LDL ) are added to the wells. 3) Anti-apoB mAbs are added to each well at 
their optimal dilutions. 4) The solutions are incubated overnight allowing for 
binding of different LDL species to the mAb to reach equilibrium. 5) 
Enzyme-conjugated secondary antibodies are added and incubated for binding. 6) 
Substrate is added to start the reaction and incubate for 30 min. HCl is added to 
stop the reaction. 7) The absorbance is measured by a plate reader to quantify 
the binding. 
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epitopes that undergo structural changes at early stages of LDL aggregation and 
fusion. These epitopes will be mapped on the low-resolution (16Å) LDL structure 
to see if they can form a continuous “sticky patch” on the particle surface. These 
experiments were performed under the expert guidance of Dr. Haya Herscovitz, 
which I greatly appreciate. 
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CHAPTER 3  KINETIC ANALYSIS OF LDL THERMAL STABILITY 
3.1  Background and Challenges In LDL Stability Studies 
Previous studies by Dr. Jayaraman from our laboratory showed that in vitro 
thermal denaturation of LDL mimics in vivo LDL aggregation, fusion and rupture, i. 
e. release of neutral lipids from LDL core and their coalescence into droplets 
(Jayaraman et al., 2005a). In fact, the products of the heat-induced LDL fusion are 
similar in size and morphology to LDL-derived extracellular deposits in early 
atherosclerotic lesions (Guyton and Klemp, 1994) (Figure 1.5). These LDL 
transitions are clearly irreversible, as aggregated and fused LDL do not 
spontaneously reassemble upon cooling into intact particles. Therefore, 
equilibrium thermodynamic analysis is not applicable to LDL denaturation. As 
outlined in Chapter 2, thermal denaturation studies from our laboratory revealed 
that stability of LDL and other lipoproteins is determined by kinetic barriers, and 
suggested that similar barriers modulate lipoprotein remodeling and fusion in vivo 
(Gursky et al., 2002; Mehta et al., 2003; Jayaraman et al., 2005a; Jayaraman et 
al., 2006; Guha et al., 2007).  
To measure these barriers and to relate them to lipoprotein remodeling during 
metabolism under normal or pathological conditions, such as normal HDL fusion 
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during reverse cholesterol transport or pathological LDL fusion in the arterial wall, 
our laboratory developed a quantitative kinetic approach described in Chapter 2. 
In this approach, we used denaturant- or temperature-jumps to trigger lipoprotein 
denaturation. The denaturation time course was monitored by using far- or 
near-UV CD or turbidity. This approach was successfully used to measure the 
Arrhenius activation energy of denaturation of model and human plasma HDL and 
their subclasses, and of human plasma VLDL (Mehta et al., 2003; Jayaraman et 
al., 2006; Guha et al., 2007).  
When I started working on this project, good-quality kinetic data suitable for 
quantitative stability studies have not been obtained for LDL. The reason for it is 
two-fold. First, in contrast to apoA-I in HDL, apoB in LDL does not undergo a 
cooperative unfolding upon heating (Jayaraman et al., 2005a); therefore, far-UV 
CD is not suitable to monitor the time course of LDL denaturation. Second, in 
contrast to relatively large particle size in VLDL (d=30-80 nm), LDL are smaller 
(d=19-25 nm) and hence, changes in turbidity upon LDL heating are much smaller 
as compared to VLDL. This leads to reduced signal-to-noise ratio in the kinetic 
data recorded by turbidity during LDL denaturation as compared to similar kinetic 
data of VLDL. The application of the quantitative kinetic approach is further 
complicated by the relatively narrow range of experimental conditions that are 
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amenable to such an analysis of LDL. In fact, our steady-state AVIV CD 
instruments can reliably measure reaction times ranging from 2 min to 10 h. Most 
experimental conditions (lipoprotein concentration, salt, pH, temperature, etc.) 
that were suitable for kinetic stability studies of HDL and VLDL did not work for 
LDL, as they yielded reaction times that were either too fast or too slow to be 
accurately measured in CD experiments. Therefore, I had to find experimental 
conditions under which the characteristic time t1/2 of LDL denaturation falls into the 
range from 2 to 6000 min. 
My goal was to optimize the experimental conditions and obtain good-quality 
kinetic data reporting on LDL denaturation. This goal has been accomplished in 
my thesis work. The results allowed us to perform the first quantitative kinetic 
analysis of LDL stability and to characterize the early stages in LDL fusion.  
 
3.2  Standard Condition For LDL Kinetic Analysis Using 
Temperature-Jumps 
To establish experimental conditions allowing kinetic data collection in a 
temperature range broad enough for an accurate Arrhenius analysis, we explored 
a range of LDL concentrations (0.1-1.5 mg/ml protein), salt concentrations (0-150 
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mM NaCl or Na phosphate), pH (6.0-8.0), and temperatures (20-98 oC). 
Single-donor LDL were isolated by density ultracentrifugation as described in 
Chapter 2 and were used in kinetic T-jump experiments. Under most conditions, 
the time scale of LDL fusion was either too fast (<2 min) or too slow (>10 h) to be 
accurately measured by steady-state CD spectroscopy. Representative data are 
shown in Figure 3.1. LDL samples varying in apoB concentration (0.2 or 0.5 mg/ml) 
or buffer conditions (5 or 10 mM Na phosphate, pH 6.2 or 7.5) were rapidly heated 
to the desired temperature (70 oC or 80 oC), and increase in the particle size due 
to fusion, rupture, and coalescence into lipid droplets was monitored by turbidity 
at 320 nm as a function of time. The results strongly suggest that the rate of LDL 
fusion and/or rupture increases upon increasing LDL concentration from 0.2 to 0.5 
mg/ml protein (Figure 3.1A), increasing buffer salt from 5 to 10 mM Na phosphate 
(Figure 3.1B), increasing temperature from 70 to 80 oC (Figure 3.1C), and 
decreasing the pH from 7.5 to 6.2 (Figure 3.1D). The effects of each of these 
parameters on the kinetics of LDL denaturation were explored and are described 
in detail in Chapter 5.  
The existence of such effects suggests that experimental conditions of LDL 
T-jumps need to be carefully examined. A series of trials and errors eventually 
lead to the establishment of a “standard condition” which works well for T-jump  
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Figure 3.1  Temperature-jump turbidity data recorded for LDL under various 
experimental conditions. The time course of LDL denaturation, which was 
triggered in a T-jump from 4 oC to a higher constant temperature, was monitored 
by turbidity at 320 nm at different LDL protein concentrations (A), Na phosphate 
concentrations (B), final temperatures (C) and pH (D). In each panel, one 
parameter was changed at a time as indicated at the bottom right. For example, in 
panel A, only LDL protein (apoB) concentration was different in the two 
experiments. Note: the reduction in turbidity and increased noise in the data at 
advanced stages of thermal denaturation (e.g. A, B and D, red) are due to lipid 
phase separation, protein precipitation and sample loss upon massive LDL 
rupture and coalescence into large lipid droplets. 
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experiments using most batches of human LDL. This standard condition is LDL 
solutions of 0.5 mg/ml protein concentration in 20 mM Na phosphate buffer, pH 
7.5. Samples from different donors may need subtle adjustment around this 
standard condition.  
 
3.3  Sigmoidal Time Couse Of LDL Denaturation 
LDL stability under standard condition was assessed in T-jump experiments. A 
surprising observation in these experiments was the lag phase. As shown in 
Figure 3.1, all T-jump data showed a lag phase (e.g. approximately 5 minutes in 
Figure 3.1A and B) before the onset of the particle fusion and rupture as 
monitored by turbidity. During this lag phase, no significant changes in turbidity 
were observed, suggesting the absence of large changes in the particle size. The 
length of the lag phase decreased upon increasing the final temperature (Figure 
3.1C) and decreased pH (Figure 3.1D), but appeared relatively independent of the 
protein concentration in LDL samples (Figure 3.1A) or of the salt concentration 
(Figure 3.1B). A similar lag phase was observed in different LDL batches from 
various donors, suggesting that this is a general property of human LDL. 
Remarkably, such a lag phase is unique to LDL denaturation and was not 
114 
observed in any other plasma or reconstituted lipoproteins whose denaturation 
was well-described by exponential decay functions (Mehta et al., 2003; 
Jayaraman et al., 2005b; Guha et al., 2007) (Figure 3.2 and 3.3). In contrast, the 
time course of LDL denaturation is sigmoidal (Figure 3.4). We used sigmoidal 
function to fit of the LDL T-jump data to determine the reaction rate k and midpoint 
t1/2, as described in Chapter 2 and illustrated in Figure 2.8. 
A possible explanation for such a unique sigmoidal time course of LDL 
denaturation is that, in contrast to the small exchangeable apolipoproteins that 
undergo rapid dissociation from HDL or VLDL (Mehta et al., 2003; Guha et al., 
2007), apoB is a large amphipathic protein that remains anchored to the surface 
during LDL remodeling and fusion. Therefore, we hypothesize that the lag phase 
is due to slow conformational changes in apoB on LDL surface which precede 
LDL fusion or rupture. The nature of these structural changes in LDL at early 
stages of aggregation and fusion is not entirely clear and will be addressed in 
Chapter 3. 
 
3.4  Quantitative Kinetic Analysis Of LDL Thermal Stability 
Thermal stability of LDL was determined by Arrhenius analysis of the  
115 
Figure 3.2  Quantitative kinetic analysis of HDL stability (adapted from 
Jayaraman et al., 2006). The time course of HDL protein unfolding was triggered 
by rapidly heating the samples in T-jumps to 80-95 °C as indicated on the curve 
(left). The unfolding of the protein secondary structure was monitored by 
recording changes in far-UV CD. At each temperature, the T-jump data were 
approximated by a multi-exponential decay function. Arrhenius analysis of the CD 
data (described in detail in Chapter 2) suggests two kinetic phases, fast and slow 
(right). The activation enegry of each kinetic phase, Ea, are shown (right). The 
inset in the left panel zooms in on the initial portion of the data showing the fast 
unfolding phase.  
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Figure 3.3  Quantitative kinetic analysis of VLDL stability (adapted from Guha, 
et al., 2007). The time course of VLDL thermal denaturation was trigger by rapidly 
heating the samples to 78-95 °C as indicated on the curve (A). The changes in the 
particle size were monitored by turbidity in CD experiments. The data at each 
temperature were approximated by a multi-exponential decay function. Arrhenius 
analysis of the turbidity data suggests two kinetic phases, fast and slow (B), with 
similar activation energy, Ea ≈ 53 kcal/mol. 
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heat denaturation. Figure 3.4 shows the first kinetic analysis of LDL stability. 
Thermal denaturation of freshly-isolated LDL was triggered in T-jumps from 25 oC 
to a series of higher constant temperatures ranging from 75 to 85 oC (Figure 3.4A), 
and was monitored by turbidity (dynode voltage, V) as described in Chapter 2. At 
each temperature, the turbidity data V(t) were approximated by a sigmoidal 
function to determine the reaction midpoint t½ and the rate constant k. The 
calculated values of t½ and k were used to obtain Arrhenius plot, ln k(T) versus 1/T, 
as well as the plot of lnt½(T) versus 1/T (Figure 3.4B). The slopes of these plots 
were similar within the error of their experimental determination, indicating similar 
temperature dependence of the lag phase (that contributes to t½) and the 
transition phase of LDL denaturation (that influences both k and t½). The activation 
energy determined from the slope of the Arrhenius plot was Ea=1008 kcal/mol. 
The uncertainty in this value incorporates the fitting errors and the deviations 
among the data sets recorded from different batches of normal single-donor 
human LDL.  
 
3.5  Unique Features of LDL Denaturation Kinetics and the Role of ApoB 
Comparison of the thermal denaturation kinetics of human LDL (Figure 3.4)  
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Figure 3.4  Kinetic analysis of thermal stability of human LDL. (A) 
Single-donor LDL (0.5 mg/ml protein in 20 mM Na phosphate, pH 7.5) were 
subjected to temperature jumps from 4 °C to higher temperatures ranging from 75 
to 85 oC as indicated. The time course of LDL thermal denaturation was monitored 
by turbidity at 320 nm. Inset shows zoomed-in portions of the data recorded 
during the first 60 min of LDL incubation at 80, 82 or 85 oC. Each data set was 
approximated by a sigmoidal function to determine the rate constant k and the 
transition midpoint t1/2. (B) Arrhenius analysis of the turbidity data. The plots ln k(T) 
vs. 1/T (black) and ln t1/2 vs. 1/T (grey) have similar slopes, indicating similar 
temperature dependence of the lag phase (that contributes to t½) and the 
transition phase of LDL denaturation (that influences both k and t½). Both slopes 
correspond to an Arrhenius activation energy of Ea=100±8 kcal/mol. 
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with the earlier thermal stability studies of HDL and VLDL in our laboratory 
revealed several unique features. First, the thermal or chemical denaturation of 
HDL and VLDL followed hyperbolic time course without a lag phase (Figure 3.2 
and 3.3) (Mehta et al., 2003; Jayaraman et al., 2006; Guha et al., 2007), in 
contrast to the sigmoidal time course with a lag phase observed in LDL (Figure 
3.4A). Second, the highest activation energy observed in HDL and VLDL 
denaturation was circa 50-53 kcal/mol (Jayaraman et al., 2005a; Guha et al., 
2007), as compared with Ea=1008 kcal/mol determined for LDL (Figure 3.2B). 
We propose that these differences result, at least in part, from the distinct protein 
composition in LDL (that contain almost exclusively the non-exchangeable apoB), 
HDL (that contain only exchangeable proteins, mainly apoA-I), and VLDL (that 
contain comparable amounts of exchangeable and non-exchangeable proteins).  
Although the role of other LDL constituents cannot be excluded, we 
hypothesize that the unique kinetic properties of LDL aggregation, fusion and 
rupture reflect mainly the large size and high hydrophobicity of apoB whose single 
copy comprises over 95% of total LDL protein. Earlier studies of recombinant HDL 
in our laboratory showed that the activation energy of lipoprotein denaturation, 
which reflects transient disruption of the protein and lipid packing interactions, 
depends upon the apolipoprotein and lipid composition and increases from about 
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22 to 50 kcal/mol with increasing protein size from 6.6 to 28 kDa (Guha et al., 
2008; Sneck et al., 2012). We speculate that the relatively high activation energy 
of LDL denaturation (Figure 3.4B) probably reflects transient disruption of protein 
and lipid packing interactions involving relatively large parts of apoB.  
Accumulated evidence suggests that LDL fusion results from major 
perturbations of the protein and/or lipid on the amphipathic lipoprotein surface 
(Chapter 1). This may include extensive lipolysis of phospholipids, hydrolysis of 
apoB with release of proteolytic fragments, and chemical or thermal denaturation 
(see details in Chapter 1 and references therein). Some of these perturbations 
have been proposed to involve conformational changes in apoB, particularly in its 
N- and C-terminal domains (Bancells et al., 2011; Gao et al., 2012). The 
enormous size of apoB prompts us to hypothesize that its structure is kinetically 
trapped by both protein-lipid and protein-protein interactions. The latter is 
supported by several lines of evidence, including the preservation of substantial 
secondary structure in apoB upon thermal denaturation of LDL indicated by 
far-UV CD spectra (Chapter 4, Figure 4.1) and preservation of immunoreactivity 
and the overall domain structure of apoB upon LDL delipidation by non-ionic 
detergents (Melnik and Melnik, 1988; Johs et al., 2006). The presence of multiple 
kinetic traps in the conformational landscape of apoB suggests that multiple 
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incremental structural changes in this large hydrophobic protein may be needed 
to initiate LDL fusion. These incremental changes probably accumulate during the 
lag phase in our T-jump experiments. The activation energy for these structural 
changes is provided by particle collisions (addressed below). 
Exchangeable apolipoproteins are much smaller and less hydrophobic than 
apoB and hence, they dissociate from the lipoprotein surface relatively easily; 
such dissociation is tightly coupled to lipoprotein fusion (Gursky et al., 2002; 
Jayaraman et al., 2005a; Guha et al., 2007; Sneck et al., 2012). This suggests 
that only one or a small number of lipoprotein collisions at high temperatures can 
cause dissociation of an exchangeable protein and lipoprotein fusion. This helps 
explain the absence of the lag phase observed in HDL and VLDL heat 
denaturation (Jayaraman et al., 2005a; Guha et al., 2007). Furthermore, earlier 
studies of VLDL heat denaturation revealed two-phase kinetics, with 
exchangeable proteins dissociating in the faster phase, followed by partial 
dissociation of apoB in the slower phase (Guha et al., 2007). Taken together with 
the current work, these results suggest that the lag phase in VLDL denaturation is 
masked by the faster kinetic phase; this helps explain the overall hyperbolic 
kinetics of VLDL denaturation despite the presence of apoB on its surface.  
In summary, we propose that sigmoidal kinetics with a lag phase observed in 
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the heat-induced fusion of LDL (Figures 3.1 and 3.4) is due, at least in part, to the 
large size and the non-exchangeable character of apoB and the absence of 
substantial amounts of exchangeable apolipoproteins on LDL surface. Sigmoidal 
kinetics with a lag phase is generally associated with a slightly unfavorable energy 
of nucleation (Kodaka, 2004). We hypothesize that this nucleation may involve 
small structural changes in apoB that accumulate during the lag phase, priming 
LDL for fusion. These changes may alter the exposure of certain apoB epitopes 
that can form “sticky patches” leading to LDL pairing. Experiments aimed at 
locating these epitopes are described in Chapter 4 and in the future studies 
(Chapter 6).  
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CHAPTER 4 STRUCTURAL STUDIES OF LDL FUSION 
4.1  Background and Challenges 
A variety of approached have been utilized to study the structure of LDL, 
including small-angle scattering and x-ray crystallography (Prassl et al., 1996; 
Ritter et al., 1997; Lunin et al., 2001; Johs et al., 2006), electron microscopy (Spin 
and Atkinson, 1995; van Antwerpen et al., 1999; Gantz et al., 2000; Ren et al., 
2010), nuclear magnetic resonance spectroscopy (Lund-Katz et al., 1988; 
Ala-Korpela et al., 1998; Cushley and Okon, 2002), circular dichroism 
spectroscopy (Jayaraman et al., 2005a; Jiang et al., 2005) and computational 
methods (Segrest et al., 1994; Segrest et al., 1999; Jiang et al., 2005; Jiang et al., 
2008). However, structural analysis of LDL has been limited to low resolution (16 
Å) by the large size and hydrophobicity of apoB and by LDL heterogeneity (Kumar 
et al., 2011; Liu and Atkinson, 2011b). 
It is well established that LDL is a spheroid macromolecular assembly with an 
apolar core surrounded by an amphipathic shell. Based on the X-ray and neutron 
scattering, and on the differential scanning calorimetry studies, the LDL core 
undergoes a reversible structural transition near body temperature (Prassl et al., 
2008; Liu et al., 2011). The core CE are arranged in an ordered liquid-crystalline 
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phase below the transition temperature, and in an isotropic state above the phase 
transition temperature (Atkinson et al., 1977; Deckelbaum et al., 1977; Laggner et 
al., 1984). The phase transition in the lipid core influences the overall shape and 
structure of LDL. As revealed by cryo-EM, LDL particles undergo subtle changes 
from discoidal shape below the transition temperature to spheroidal shape above 
this temperature (Liu et al., 2011). Such changes in LDL shape may involve 
conformational changes in apoB and its interactions with core lipids.   
ApoB is proposed to have five putative domains: βα1, β1, α2, β2, and α3, as 
described in Chapter 1 (Figure 1.1B). The first domain, βα1 (approximately 
residues 1-1000), possesses an intrinsic lipid-remodeling activity and is thought to 
be essential for the initial assembly of apoB-containing particles (Herscovitz et al., 
1991; Carraway et al., 2000; Herscovitz et al., 2001; Jiang et al., 2007). This 
domain shares sequence homology with two other lipid binding proteins: lamprey 
lipovitellin and human microsomal triacylglycerol transfer protein (MTP) (Segrest 
et al., 1999). The crystal structure of lipovitellin has been determined 25 years ago 
(Raag et al., 1988), providing a useful homology model for the studies of the βα1 
domain of apoB. Notably, several 3D models revealed a knob-shaped protrusion 
on the outer shell (Spin and Atkinson, 1995; Liu and Atkinson, 2011a). The recent 
16 Å 3D model proposed by Kovanen and colleagues showed that the N-terminal 
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260 amino acids of apoB fit into this protrusion (Kumar et al., 2011).  
The goal of my study was to use the available LDL models and low-resolution 
methods to identify parts of LDL structure that undergo conformational changes at 
various stages of LDL aggregation, fusion and rupture. Targeting these structural 
changes may potentially help block these pathogenic reactions.  
 
4.2  Approach to Study the Structural Changes During Thermal 
Denaturation of LDL  
Although the detailed structural basis for LDL fusion is unclear, it is thought to 
result from accumulation of packing defects on LDL surface which form upon 
mechanical, thermal, chemical or enzymatic perturbations (Chapter 1). The latter 
include lipolysis of polar lipids, such as phosphatidylcholine or sphingomyelin, and 
proteolysis of apoB followed by dissociation of its proteolytic fragments (Chapter 
1). 
  To determine what structural changes are involved in heat-induced LDL 
aggregation, fusion and rupture, I used an  integrated approach  that combined 
density gradient centrifugation, SEC, SDS PAGE and non-denaturing PAGE 
(NDGE), turbidity and CD spectroscopy, negative-stain EM, and monoclonal 
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antibody  (mAb) binding  to apoB.  I recorded far-UV CD spectra of LDL 
samples at different stages of the lag and the transition phase, to explore the 
secondary structural changes in apoB and changes in the particle size, respetively. 
I used NDGE to detect the changes in particle size at various stages of LDL 
denaturation. I also used negative-stain EM to visualize the particle morphology. 
Moreover, with the help of Dr. Herscovitz, I used monoclonal antibodies that bind 
to various regions of apoB (e.g. the N-terminus, the C-terminus, or the receptor 
binding site) to detect possible conformational changes in apoB at different stages 
of LDL heat denaturation (Bancells et al., 2011). 
 
4.2.1  Possible changes in secondary structure 
To identify structural changes at specific stages of LDL heat denaturation, an 
LDL sample under standard conditions was subjected to a T-jump to 85 oC. 
Aliquots were taken at various times and were analyzed by far-UV CD (Figure 4.1), 
NDGE (Figure 4.2), and negative-stain EM (Figure 4.3) to determine secondary 
structure, particle size, and particle morphology, respectively.  
During the lag phase, i. e. prior to significant changes in turbidity, no changes 
in far-UV CD were observed, indicating that there were no large secondary 
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structural changes in apoB (0–2, Figure 4.1). In the transition phase 
corresponding to an increase in turbidity and hence, increase in the particle size, 
far-UV CD spectra showed a progressive reduction in intensity below 208 nm 
(4–7, Figure 4.1B). This could potentially result from two effects: i) increased light 
scattering upon increasing the particle size, which disproportionately reduces CD 
intensity at short wavelengths and thereby distorts far-UV CD spectra of large 
particles (Wallace and Teeters, 1987), and/or ii) partial unfolding of the secondary 
structure in apoB upon heating (30, 36). Notably, the CD spectra in Figure 4.1B 
showed little changes at 208-250 nm, indicating that, consistent with previous 
studies from our laboratory (Jayaraman et al., 2005a), apoB retained most of its 
secondary structure after prolonged incubation of LDL at high temperatures.  
 
4.2.2  Changes in the particle size by non-denaturing gel electrophoresis 
NDGE revealed incremental changes in the particle size during incubation at 
85 oC (Figure 4.2A). At stage 1, the particle size distribution appeared unchanged 
(lanes 0 and 1), with the sole band I similar to that observed in intact LDL  
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Figure 4.1  Far-UV CD spectra of total LDL at various stages of thermal 
denaturation. LDL (0.5 mg/ml protein in 20 mM Na phosphate, pH 7.5) were 
subjected to a T-jump from 4 oC to 85 oC, and LDL heat denaturation was 
monitored by turbidity (A). Aliquots of 40 l taken at various time points are 
numbered from 0 (intact LDL) to 8 (fully denatured LDL). Each aliquot was diluted 
to 0.1 mg/ml protein and placed in a 1 mm path length cell to record a far-UV CD 
spectrum (B). The CD spectra of aliquots 0 (black dots), 1 (black line) and 2 (grey 
dots) fully overlapped. The major spectral changes observed at later stages of 
heat denaturation (numbered) are shown by arrow (green, dash).  
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Figure 4.2  Non-denaturing and SDS-PAGE of total plasma LDL at various 
stages of thermal denaturation. Ten μl aliquots of an LDL sample were taken 
during a T-jump to 85 oC as shown in Figure 4.1A and were analyzed by 4% 
NDGE and SDS-PAGE. The lane numbers 0-8 correspond to denaturation stages 
in Figure 4.1A. St - molecular size standard. Data for intact human VLDL (particle 
diameter 40-100 nm) are shown for comparison. Three major bands observed in 
the heat-denatured LDL, marked Band I, II, and III, correspond to the particle size 
of ~22 nm, ~40 nm, and > 80 nm, respectively. 
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(average diameter <d>=22 nm). At stages 2-5, two additional bands were 
observed: a sharp band II corresponding to hydrodynamic size circa 40 nm, and a 
diffuse band III encompassing a broad range of sizes larger than 80 nm (Figure 
4.2A, lanes 2-5). At stages 6 and beyond, i. e. near the transition midpoint t½ 
measured by turbidity (Figure 3.2A), few if any lipoproteins entered the gel (Figure 
4.2A, lanes 6-8). This is consistent with earlier EM observation of LDL 
aggregation, fusion, rupture and release of apolar core lipids that coalesce into 
lipid droplets at advanced stages of denaturation (Jayaraman et al., 2005a).       
  Notably, SDS-PAGE showed that heat denaturation of LDL does not cause 
significant apoB fragmentation but induces gradual formation of apoB aggregates 
during the transition phase (Figure 4.2B), in good agreement with our NDGE and 
EM results (Figure 4.2 and 4.3). 
 
4.2.3  Changes in the particle morphology by negative-stain electron 
microscopy 
Figure 4.3 shows negative-stain EM of total LDL at various stages of thermal 
denaturation. Electron micrographs of total LDL that were intact (0) or were taken 
at stages 1 or 2 of the lag phase (Figure 4.3, panel 2) were indistinguishable. At 
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stage 3 corresponding to the beginning of the transition phase, the particles 
became heterogeneous in size, with a significant population of enlarged 
lipoprotein-like particles (d~40 nm) that were apparent products of LDL fusion 
(Figure 4.3, panel 3, red arrows). This trend continued upon progression of 
denaturation when smaller and larger particles with progressively increasing radii 
as well as their aggregates were observed (Figure 4.3, panels 6-8). In addition, 
thin electrolucent strands whose size and morphology were consistent with 
dissociated apoB were detected at advanced stages of heat denaturation in this 
(Figure 4.3, panels 7, 8, long white arrows) and earlier LDL studies (Jayaraman et 
al., 2005a).  
In summary, NDGE and negative-stain EM of total LDL agreed with the 
turbidity data and showed changes in the particle size upon thermal denaturation. 
These changes include formation of smaller and larger particles and their 
aggregates, in good agreement with our earlier studies of LDL (Jayaraman et al., 
2005a). A novel result was a sharp band observed by NDGE at denaturation 
stages 2-5, which corresponded to particle size circa 40 nm (Figure 4.2, band II).  
 
4.3  Early Stages Of LDL Thermal Denaturation: Aggregation And Fusion 
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Figure 4.3  Electron micrographs of negatively-stained total plasma LDL at 
various stages of thermal denaturation. Aliquots were taken at different times of 
incubation at 85 oC as described in Figure 4.1. Panel numbers correspond to the 
denaturation stages in Figure 4.1. Each aliquot was cooled to 22 oC, diluted to the 
concentration of 50 g/ml protein, and then the aliquots were visualized by 
negative-stain EM. Intact LDL (not shown) and LDL that had been incubated at 85 
oC for 4 min (2) or fewer were indistinguishable by EM; other micrographs show 
LDL that have been incubated at 85 oC for 6 min (3), 12 min (6), 17 min (7), or 24 
min (8). Short red arrows point to fused LDL, and long magenta arrows to 
electrolucent strands whose morphology is consistent with dissociated apoB. 
 
  
          
2 3
50 nm
6 7 8
133 
Next, we focused on the early stages of LDL thermal denaturation which 
occur during the lag phase. Our goal was to identify structural changes in the 
protein and lipid that prime LDL for fusion. 
 
4.3.1  Size-exclusion chromatography studies of the lag phase 
   SEC was used to isolate and characterize LDL at early stages of thermal 
denaturation. LDL under standard conditions were subjected to a T-jump to 85 oC, 
and aliquots were taken during the first 11 min of incubation (Figure 4.4A, stages 
2-5), i. e. before the transition reached its midpoint measured by turbidity, t½=17 
min. As expected, SEC profile of intact LDL showed a single peak with elution 
volume circa 12 ml (peak I) corresponding to NDGE band I (Figure 4.4B, lane 0). 
SEC profile of LDL denatured to stage 2 (end of the lag phase) showed two 
additional peaks: peak II centered near 9.5 ml and peak III near 8 ml 
corresponding to the void volume (Figure 4.4B, line 2). At stage 3 (early transition 
phase), peak III increased in intensity, peak II showed little change, and peak I 
decreased (Figure 4.4B, line 3). This increase in peak III at the expense of peak I 
continued until peak III became the sole feature in the SEC profile at relatively 
advanced stages of LDL heat denaturation (Figure 4.4A, stage 4 and 5 and  
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Figure 4.4  Morphological analysis of LDL at early stages of heat denaturation. 
(A) LDL sample under standard conditions was subjected to a T-jump from 4 oC to 
85 oC, and LDL fusion was monitored by turbidity at 320 nm. Aliquots were taken 
at different times during incubation at 85 oC, from stage 2 (200 sec) to stage 5 
(500 sec) prior to the denaturation midpoint (t½=17 min for this sample); 0 stands 
for intact LDL. (B) SEC of selected aliquots (0, 2, 3, 4, 5) eluted with 20 mM Na 
phosphate, pH 7.5. The three major peaks in the SEC profile are marked I, II, III. 
The results agree with the earlier analysis of LDL by SEC showing increased 
particle size upon heat denaturation (43). (C) Non-denaturing PAGE of LDL 
sample at denaturation stage 2. T stands for the total plasma LDL; 0 stands for 
intact LDL; SEC fractions encompassing peaks I, II and III are numbered. 
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beyond, Figure 4.4B, line 4 and 5).  
  Next, LDL were denatured to stage 2 and peak fractions I, II and III were 
isolated by SEC and analyzed by NDGE (Figure 4.4C). The results were 
consistent with NDGE of total LDL (Figure 4.2B) and clearly showed that: i) SEC 
peak I and NDGE band I encompassed intact-size LDL (d~22 nm); ii) SEC peak II 
corresponded to the sharp NDGE band II (hydrodynamic size ~40 nm); iii) SEC 
peak III corresponded to the broad NDGE band III encompassing particle sizes 
from about 80 to over 100 nm.  
 
4.3.2  Negative-stain EM studies of Peak II suggest LDL pairing 
   Negative-stain EM of peak fractions I–III isolated by SEC from LDL denatured 
to stage 2 showed that peak I contained intact-size LDL, while peak III contained 
clusters of aggregated and fused particles and lipid droplets (Figure 4.4C) similar 
to those observed by EM of total LDL at advanced stages of thermal denaturation 
(Figure 4.3, panels 6-8). Notably, EM of peak II fraction showed mainly intact-size 
LDL (Figure 4.5B) even though NDGE detected only larger-size particles (Figure 
4.5A, lane II), suggesting that peak II contained low-order LDL aggregates. This 
idea was supported by EM analysis of peak II fraction taken at various dilutions  
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Figure 4.5  Negative-stain electron micrographs of Peak II. LDL heated to 
stage 2 were separated into size fractions by SEC, and fractions corresponding to 
Peak II were collected. The particle size was analyzed by NDGE (A). The sample 
was diluted to protein concentration of 100 g/ml (B) or 20 g/ml (C) prior to 
deposition on the grid for negative-stain EM studies. Arrows show enlarged (fused) 
particles, and ovals show intact-size LDL tethered in pairs. (D) shows a zoomed-in 
pair of LDL and their connecting strand (C). 
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(Figure 4.5B and C). At a relatively high sample concentration (100 μg/ml protein), 
EM of peak II fraction showed mainly clusters of intact-size LDL, along with a 
small population of fused particles with diameters d~40 nm (arrows, Figure 4.5B). 
To minimize lipoprotein clustering, the sample was diluted to 20 μg/ml protein prior 
to deposition on the EM grid. The EM results showed mainly intact-size LDL most 
of which appeared in pairs tethered via the connecting strands (ovals in Figure 
4.5C). Occasional fused particles such as those seen in Figure 4.5B (arrows, 
Figure 4.5B) were detected. Notably, electron micrographs of intact LDL under 
similar conditions showed mainly single particles, suggesting that LDL pairing at 
stage 2 resulted, at least in part, from thermal modifications rather than from 
artifacts of the negative stain. Taken together, NDGE, SEC and EM data in 
Figures 4.4 and 4.5 suggest that peak II is probably comprised of fused or 
aggregated LDL particles.  
 
4.3.3  Chemical denaturation and aging lead to formation of Peak II 
   A similar sharp band II (or Peak II in SEC profile) was detected by NDGE in 
LDL subjected to other perturbations, such as chemical denaturation or hydrolysis 
upon prolonged storage at 4 oC (Figure 4.6). This suggests that band II represents  
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Figure 4.6  LDL storage or chemical denaturation lead to formation of Peak II. 
NDGE shows LDL disintegration and formation of a distinct band II with 
hydrodynamic diameter circa 40 nm (shown by arrows) upon storage at 4 oC for 
5-10 months (lanes 1-4) or upon incubation with chemical denaturant at 37 oC for 
10-60 min (lanes 1’–4’). Intact human LDL (lane 0) and VLDL are shown for 
comparison. These samples, as well as LDL stored for months at 4 oC (lanes 1-4), 
are in standard buffer (20 mM Na phosphate, pH 7.5) containing 0.25 mM Na 
EDTA. Other samples are in standard buffer. Sample conditions are as follows:  
Lane 0: 4.2 mg/ml apoB, intact LDL;  
Lane 1: 2.6 mg/ml apoB after incubation at 4 oC for 5 months;  
Lane 2: 3.4 mg/ml apoB, after incubation at 4 oC for 7 months;   
Lane 3: 7.0 mg/ml apoB, after incubation at 4 oC for 9 months;  
Lane 4: 4.2 mg/ml apoB, after incubation at 4 oC for 10 months;  
Lanes 1’-4’: LDL samples (3.5 mg/ml apoB) after incubation in 5.5 M 
guanidinum hydrochloride (Gdn HCl) for 10 min (1’), 20 min (2’), 30 min (3’), 
or 60 min (4’) at 37 oC. 
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a common early stage in LDL denaturation by various physical or chemical 
perturbations. The position of band II on NDGE suggests that it is probably 
comprised of a small number of aggregated and/or fused LDL whose identity is 
beginning to be addressed in the next section. 
 
4.4  Possible Origins Of Peak II 
Peak II has been reported for the first time in our work (Lu et al., 2012). Our 
next step was to explore the origin of Peak II. We hypothesized that better 
understanding of Peak II formation may help to control the pathogenic pathway of 
LDL aggregation and fusion. To this end, we tested whether formation of Peak II 
results from disulfide bonding of LDL particles, whether or not this peak is 
observed in a particular LDL subclass, and whether conformational changes in 
apoB are involved in its formation. 
 
4.4.1 Formation of Peak II is not due to disulfide bonding 
ApoB has 25 cysteines, and 16 of them form eight intra-molecular disulfide 
bonds (Burch and Herscovitz, 2000). Specifically, seven of these eight disulfide 
bonds are clustered in the N-terminal 21% of apoB, and are thought to be 
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important for the initial assembly and secretion of apoB-containing particles (Tran 
et al., 1998; Burch and Herscovitz, 2000). Rearrangement of these disulfide 
bonds and/or creation of additional bonds by free cysteines may potentially 
contribute to LDL pairing. To test this possibility, dithiothreitol (DTT) was added to 
intact and heated LDL (0.5 mg/ml in 20 mM Na phosphate pH 7.5) at the final 
concentration of 5 mM. The solutions were then incubated at 37 oC for 15 min, 
followed by particle size analysis by NDGE (Figure 4.7). If disulfide bond 
formation in heated LDL causes the formation of Peak II, then DTT will reduce 
these bonds and produce LDL monomer. Hence, Peak II will diminish or even 
disappear on the gel. However, our result showed that Peak II did not diminish in 
the presence of DTT, indicating that Peak II formation is not due to disulfide 
bonding. 
 
4.4.2 Formation of Peak II is not limited to a particular particle size 
Our SEC and NDGE data showed that, regardless of the LDL perturbation 
(thermal or chemical denaturation or aging), the fraction of particles forming Peak 
II typically does not exceed ~10% of the total LDL (Figure 4.2A). This suggests 
that Peak II might be formed by a particular LDL subclass, such as LDL particles  
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Figure 4.7  Peak II is not diminished in the presence of dithiothreitol. An LDL 
sample (0.5 mg/ml protein in 20 mM Na phosphate, pH 7.5) was heated to 85 oC 
for ~2 min to produce Peak II. Dithiothreitol (DTT) was added to the heated 
sample at a final concentration of 5 mM, mixed well, and incubated at 37 oC in the 
water bath for 15 min. Twenty laliquote of this mixture was analyzed by 4% 
NDGE; heated LDL without DTT were used as a control. Peak II was present in 
both samples, indicating that DTT did not prevent its formation.  
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of a particular size and/or charge.  
Human plasma LDL are comprised of subclasses differing in the particle 
diameter (20-24 nm), charge, biochemical composition, apoB conformation, and 
metabolic properties (McNamara et al., 1996; Kwiterovich, 2002; Bancells et al., 
2010; Krauss, 2010). Among these subclasses, small dense LDL are thought to 
be particularly pro-atherogenic due to their reduced affinity for LDL receptor, 
increased affinity for arterial proteoglycans, and increased susceptibility to 
pro-atherogenic modifications such as oxidation (Kwiterovich, 2002; Ai et al., 2010; 
Krauss, 2010).  
To test whether Peak II is derived from LDL of a particular size, such as small, 
dense LDL, we used density gradient centrifugation to separate fresh LDL into 
fractions of different densities. Briefly, total LDL solution (protein concentration ~4 
mg/ml) was adjusted to 1.020 g/ml with solid KBr and transferred into SW55 
centrifuge tubes. Each tube was overlaid with 1.060 g/ml KBr and centrifuged to 
equilibrium at 50,000 rpm at 11°C for 20-25 hours. Next, LDL fractions with 
different densities were collected. Our initial plan was to heat each fraction 
individually to test whether only certain fractions formed Peak II upon thermal 
denaturation. To our surprise, fresh sample of total plasma LDL containing little or 
no Peak II became heterogeneous upon an additional round of density gradient 
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ultracentrifugation, and a new band was observed on NDGE with the particle size 
similar to that of Peak II (Figure 4.8A). Therefore, it appears that prolonged 
density centrifugation leads to remodeling of LDL and formation of Peak II.  
In another experiment, total LDL with pre-formed Peak II (in this case, aged 
LDL that was stored at 4 oC for >3 months) was separated into size/density 
fractions by density gradient centrifugation. Peak II was observed in fractions with 
a wide range of density (Figure 4.8B). This result suggests that, once formed, 
Peak II is associated with particles of different density or size. Therefore, Peak II 
formation is not limited to a particular size or density of LDL.  
 
4.4.3 Formation of Peak II is not associated with electronegative LDL 
  A subclass of LDL, electronegative LDL (LDL-) shows enhanced 
pro-atherogenic properties that have been linked to their increased propensity to 
aggregate and fuse (Sanchez-Quesada et al., 2004; Gaubatz et al., 2007; 
Bancells et al., 2010; Bancells et al., 2011). In healthy humans, LDL- comprise 
less than 5% of the total LDL population (Sanchez-Quesada et al., 2002). We 
hypothesized that Peak II may possibly be derived from LDL- and tested this 
hypothesis by using ion-exchange chromatography and NDGE. First, LDL- was  
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Figure 4.8  Peak II is associated with LDL subclasses of various density or 
size. (A) Fresh total LDL (3.0 mg/ml protein in 10 mM Na phosphate, pH 7.5, 
theoretical density range 1.019-1.063 g/L) were separated into fractions by 
density gradient ultracentrifugation. Ten laliquotes from each density fraction 
were taken and analyzed by 4% NDGE. The gels were stained with Denville Blue 
protein stain. Left lane corresponds to fresh total LDL sample prior to density 
gradient centrifugation, and other lanes correspond to density fractions after 
separation, with increasing density (decreasing size) from left to right. After 
separation by density, all fractions developed an additional band with particle size 
corresponding to Peak II. (B) Aged LDL (3.6 mg /ml protein in 10 mM Na 
phosphate, pH 7.5) were separated into density fractions and analyzed as 
described in (A). The results showed that Peak II was already present in the aged 
total LDL sample prior to density gradient centrifugation, and that this pre-formed 
Peak II was associated with all fractions (Courtesy of Dr. Shobini Jayaraman). 
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separated from normal LDL (LDL+) by ion-exchange chromatography using 
different concentrations of salt. LDL+ were eluted at 0.23 M NaCl, while LDL- were 
eluted at 0.5 M NaCl (Figure 4.9A). After separation, fractions corresponding to 
LDL+ or LDL- were collected and heated to the stage when Peak II is usually 
formed. Then the heated and the intact samples of LDL+ and LDL- were analyzed 
by NDGE (Figure 4.9B). Contrary to our expectation, LDL+ formed Peak II upon 
heating, although it was inconclusive from the NDGE data whether LDL- formed it 
or not due to limited amount of LDL- sample (Figure 4.9B). We concluded that 
Peak II can be formed by normal LDL, and not necessarily by LDL-. Therefore, it 
appears that Peak II is a common early intermediate of LDL denaturation that is 
not limited to LDL particles of a particular density, size or charge. 
  An interesting finding in our ion-exchange chromatography studies was that 
heating increased the net negative charge on LDL. When we first heated LDL up 
to the lag phase, and then analyzed the composition of LDL+/LDL-, we found that 
the population of LDL- was increased upon heating, rising from less than 5% in 
unheated LDL to about 40% in heated LDL (Figure 4.10). The underlining basis 
for this observation is unclear and will be explored in future studies. 
 
4.4.4 Lipolysis does not account for Peak II formation 
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Figure 4.9  Formation of Peak II is not associated with electronegative LDL. 
(A) An LDL sample (100 L, 1.72 mg/ml protein in 10 mM Tris HCl, pH 7.4) was 
separated by ion-exchange chromatography into electronegative LDL (LDL–) and 
normal LDL (LDL+). LDL+ was eluted at 0.23 M of NaCl, and LDL– was eluted at 
0.5 M of NaCl. LDL– comprise ~5% of total LDL. (B) Separated LDL– and LDL+ 
were heated at 85 oC for ~3 min, and aliquots were taken from intact and heated 
LDL– and LDL+. The samples were analyzed by 4% NDGE. Total LDL prior to 
separation and heating were used as a control. 
 
 
4% Native PAGE
Intact   Heated   
Peak II
Intact size
10 20 30 40 50
0
20
40
60
80
100
 
0.0
0.2
0.4
0.6
0.8
1.0
 
LDL-
LDL+
 LDLmonoQ100ul001:10_UV
 LDLmonoQ100ul001:10_Cond
 LDLmonoQ100ul001:10_Conc
  0
 20
 40
 60
 80
mAU
0.0 10.0 20.0 30.0 40.0 50.0 ml
Elution volume, ml
A
b
s
. a
t 
2
8
0
n
m [N
a
C
l], M
A B
147 
Figure 4.10  Heating increases the net negative charge of LDL. (A) An LDL 
sample (100 L, 1.72 mg/ml protein in 10 mM Tris HCl, pH 7.4) separated by 
ion-exchange chromatography (IEC) into electronegative LDL (LDL–) and normal 
LDL (LDL+). Similar to Figure 4.9A, LDL– comprise no more than 5% of total LDL. 
(B) The same intact LDL sample was first incubated at 85 oC for 2 min, and then 
analyzed by IEC. The population of LDL+ was reduced (~60%) as compared with 
that in intact LDL (~95%). Meanwhile, the population of more negatively-charged 
LDL increased. Note: these negatively charged LDL are heated fractions and 
hence, are not equivalent to intact LDL–. 
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We hypothesized that lipolysis can possibly occur in the early stages of LDL 
denaturation and account for Peak II formation. To test this possibility, I performed 
thin-layer chromatography (TLC) to analyze the lipid composition in intact and 
heated LDL. As shown in Figure 4.11A, no significant changes were observed in 
CE, TG, PC or sphingomyelin content in heated as compared to intact LDL. Since 
some lipases (e.g. PLA2) are metal-dependent, I also used EDTA to chelate metal 
ions and thereby block such lipolysis. The NDGE of LDL heated with or without 
EDTA showed comparable presence of Peak II, meaning that metal-dependent 
lipolysis did not occur during heating (Figure 4.11B). We conclude that 
spontaneous lipolysis of LDL lipids upon heating does not account for Peak II 
formation.  
 
4.4.5 Conformational changes in apoB revealed by Western blotting 
Another possible structural change during the lag phase of LDL denaturation 
is the conformational changes in apoB. Such changes may influence 
protein-protein interactions and contribute to LDL pairing. In an attempt to identify 
apoB regions involved in LDL aggregation and fusion, we tested whether binding 
of mAbs to specific epitopes of apoB was affected by the heat-induced changes in  
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Figure 4.11  Peak II formation does not result from lipolysis of LDL.  (A) 
Analysis of the lipids in intact and heated LDL by thin-layer chromatography (TLC). 
An LDL sample (0.5 mg/ml protein in 20 mM Na phosphate, pH 7.5) was heated at 
85 oC for 2 min (end of lag phase) or 8 min (fully denatured). Aliquots of heated 
and intact LDL samples (~100 l) were analyzed by TLC to determine their lipid 
composition. Ht1 - LDL heated for 2 min, Ht2 - LDL heated for 8 min. (B) Addition 
of EDTA during heating does not block the formation of Peak II. Three identical 
LDL samples (0.5 mg/ml protein in 10 mM Na phosphate, pH 7.5) were mixed with 
0, 1, or 10 mM of EDTA, followed by rapid heating and incubation at 85 oC for 3 
min. Samples were cooled and aliquots were taken from each solution and 
analyzed by 4% NDGE. Intact LDL sample is shown as a control.  
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LDL morphology at early stages of thermal denaturation. The mAbs used in this 
work targeted apoB epitopes from the N- and C-terminal domains (Figure 4.12A). 
These  mAbs  and their epitopes  include: Mb19  (apoB  residue 71), Mb24 
(405-539), 1D1 (474–539), Mb11 (1022–1031),  Mb47  (3429–3453,  
3507–3523), 5E11 (3441–3569), 4F6 (3569–3925), Mb43 (4027–4081), and Bsol7 
(4517–4536). N- and C-terminal domains targeted by these mAbs are located in 
proximity to each other on LDL surface and are expected to undergo structural 
changes upon LDL aggregation and/or changes in the particle size (Johs et al., 
2006; Prassl and Laggner, 2009; Bancells et al., 2011; Kumar et al., 2011; Liu and 
Atkinson, 2011b) (Figure 1.13C).  
To prepare the samples for Western blotting, LDL were first subjected to a 
T-jump to 85 oC, and an aliquot was taken at the end of the lag phase (stage 2, 
Figure 4.4A). This aliquot together with intact LDL sample was analyzed by NDGE 
and Western blotting. Representative results are shown in Figure 4.13A. Most 
mAbs clearly showed binding to the LDL species comprising bands I and II, 
except for MB24 and MB11 that showed minimal binding to band II.  
To further explore the binding of these and other antibodies to the dimeric / 
fused LDL comprising Peak II, Peak II was isolated by SEC and concentrated to 
~0.1 mg/ml. The binding of mAbs to peak II was analyzed by immunoblotting. 
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Figure 4.12   Monoclonal antibodies used in this dissertation and their epitopes 
in apoB. (A) Top: Schematic representation of the pentapartide structure of apoB, 
with alternating -helical and -strand structures. The residue numbers 
delineating individual domains are indicated. (See details in Figure 1.1B.) Bottom: 
The epitope map of the mAbs used in my work. (B) The names of these mAbs and 
their epitopes.  
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Figure 4.13  Western blot analysis of LDL at an early stage of thermal 
denaturation. (A) An LDL sample (0.5 mg/ml protein in 10 mM Na phosphate, pH 
7.5) was incubated for 5 min at 85 oC, and was analyzed by NDGE (left, stained 
by Denville Blue) followed by immunoblotting (right) using mAbs that bind to 
epitopes from the N- or the C-terminal thirds of apoB. The bands corresponding to 
Peak I, II and III in SEC are indicated. The results show mAbs binding to bands I 
and II. The binding of Mb24 and Mb11 (grey) were relatively weak, and were 
further analyzed as shown in B. (B) Peak II fraction isolated by SEC was 
subjected to NDGE and immunoblotting using selected mAbs. Blots for peak I 
(intact LDL) are shown for comparison. The epitopes of the mAbs used here are 
listed in Figure 4.12. 
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Representative results are shown in Figure 4.13B. These and other results show 
that all mAbs explored bound to the early intermediate of LDL aggregation / fusion 
(Peak II), although different mAbs had apparently different affinities for this Peak II. 
Specifically, Mb24, Bsol7, and Mb11 had significantly lower affinities compared to 
other mAbs. This result looked promising, suggesting that conformational 
changes and/or altered exposure in specific regions of apoB, particularly its 
N-terminal domain, are involved in early stages of LDL aggregation. To better 
characterize this effect, quantitative affinity studies using a wide array of 
antibodies are needed to identify apoB epitopes that undergo structural changes 
prior or during LDL aggregation and fusion. We began such studies by using 
ELISA with selected mAbs to the N- and C-terminal domains of apoB. 
 
4.4.6 Quantitative assay of mAb binding to LDL using competitive ELISA 
To perform a quantitative assay of mAb binding to LDL, we used competitive 
ELISA. The details of this technique are described in Chapter 2. Briefly, intact LDL 
was added to 96-well plates to coat the surface and then LDL were added to 
compete for the binding of mAb to LDL adsorbed onto the surface of the wells. If 
certain domains of apoB have a different conformation and/or exposure in the 
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heated LDL, their binding to specific mAbs would be altered, and hence could be 
detected by ELISA. For each mAb, I first used intact LDL as the “competing 
antigen” to obtain a standard curve. The optimal dilution for a particular mAb was 
determined from the standard curve. Once the optimal conditions for the mAb 
were established, heated LDL was used as the competing atigen. To-date, I have 
carried out competitive ELISA for three mAbs, Mb11 (1022–1031), Mb24 
(405-539), and Bsol7 (4517–4536). The results are shown in Figure 4.14. For Mb11 
and Bsol7, intact and heated LDL showed little if any difference in their binding 
affinity. Notably, in the experiment with Mb24, heated LDL showed statistically 
significant increase in absorbance compared to intact LDL, indicating that the 
Mb24 epitope in apoB (residues 405-539) is less exposed and/or alters its 
conformation in heated than in intact LDL.  
In summary, our competitive ELISA studies of intact and heated LDL showed 
that: i) apoB undergoes conformational changes prior to heat-induced LDL fusion; 
ii) residues 405-539 are involved in these conformational changes, and these 
residues are less exposed and/or have a different conformation in mildly heated 
LDL, possibly due to dimerization; iii) these conformational changes probably 
contribute to the enhanced negative charge on LDL during heating (Figure 4.10). 
In future studies, additional mAbs to various apoB epitopes will be tested to   
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Figure 4.14  Competitive ELISA of intact and heated LDL. 96-well plates were 
coated with 100 l of LDL solution (50 g/ml protein in 0.1 M NaHCO3, pH 9.6). 
Intact (0.5 mg/ml protein in 10 mM Na phosphate, pH 7.5) or heated LDL (85 oC, 3 
min) were added to the wells at the concentration of 0, 0.5, 1, 1.5, 2, or 4 μg/ml. 
The absorbance measured at 450 nm for each well was plotted as a function of 
concentration of the competing agent. (See Chapter 2, part 2.13 for details.) Each 
experiment was performed in triplicate; the error bar for each data point is shown. 
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elucidate the complex conformational changes in apoB that prime LDL for fusion. 
 
4.4.7 Mapping Mb24 epitope on the lipovitellin-based homology model of apoB 
N-domain 
Residues 405-539 that comprise the Mb24 epitope are located in the -helical 
part of the N-terminal 1 domain. This region forms an autonomically folded 
domain of apoB that is critical for its lipidation (Segrest et al., 1994). The helical 
part of this domain forms part of the lipid binding pocket in apoB (Segrest et al., 
1994; Wang et al., 2010). Our Western blot and ELISA studies suggest that these 
residues undergo conformational changes at early stages of the heat-induced 
LDL aggregation and fusion. This observation is consistent with the previous 
tensiometry studies by Dr. Small and colleagues reporting that amphipathic 
-helices in apolipoproteins dissociate more readily from the lipid surface as 
compared to amphipathic -sheets (Wang et al., 2006). 
Although the molecular structure of apoB is not available, the atomic structure 
of lipovitellin, which is homologous to N-terminal 20.5% of apoB, has been 
determined by X-ray crystallography (Raag et al., 1988). The structure of 
lipovitellin provides a useful model for studying the N-terminal 1 domain of 
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apoB. In the lipovitellin-based homology model of the 1 domain derived by Dr. 
McKnight and colleagues, the Mb24 epitope (residues 405-539) are located in the 
helices 8-13 from the -helical region (Jiang et al., 2005; Jiang et al., 2006). This 
region forms a semi-circular double layer comprised of 17 -helices (Figure 4.15). 
The even numbered helices are exposed to solvent, while the odd-numbered 
helices are largely buried and either form part of the lipid binding pocket (helices 2, 
6 and 8) or interact with the C-sheet (helices 12, 14 and 16) (Figure 4.15). Helix 6 
(residues 379-392), which is particularly hydrophobic, is located near the 
N-terminal part of the Mb24 epitope (residues 405-539). 
Interestingly, Western blot analysis showed conformational changes in the 
Mb24 epitope (residues 405-539), but did not show any significant conformational 
changes in the epitope of 1D1 (474-539), which overlaps the C-terminal part of 
the Mb24 epitope. This preliminary result will be tested in our future ELISA studies 
of 1D1 binding to LDL at early stages of aggregation. If confirmed, this will indicate 
that the conformational changes in apoB at early stages of LDL aggregation 
involve the first ~70 residues of the Mb24 epitope, 405-474 and perhaps, their 
adjacent helices located N-terminally to this epitope, such as helices 6 and 7. 
Previous studies by the teams of Howlett and Parassasi suggested that LDL 
aggregation upon oxidation, or in the presence of electronegative LDL involves  
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Figure 4.15  A homology model of apoB6.4-13 (the region from the N-terminal 
6.4% to 13% of apoB) derived from the X-ray crystal structure of lipovitellin 
(adapted from Wang et al., 2010). The region contains 17 amphipathic -helices 
(bottom panel). The helical wheel diagram of the 17 -helices is shown in the top 
panel. Green-hydrophobic, gray-neutral, blue-positively charged, red-negatively 
charged residues. The hydrophobic surface created by helices 4, 6, and 8 is 
predicted to form a lipid binding pocket. The positively charged surface formed by 
helices 10, 12, and 14 may stabilize the negatively charged face of the C-sheet 
domain. Helix 6 is the most hydrophobic of all these -helixes. Helices 8-13 
comprise the epitope of Mb24. 
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formation of cross--sheet amyloid-like structures by apoB on LDL (Stewart et al., 
2005; Parasassi et al., 2008). To our knowledge, no convincing evidence for 
amyloid formation by apoB was provided in these or any other studies, including 
work from our laboratory (Jayaraman et al., 2007). Nevertheless, it cannot be 
excluded that irreversible aggregation of LDL is mediated via the intermolecular 
cross--sheet formation by apoB molecules. 
To explore which regions of apoB have intrinsic propensity for -aggregation, 
we used 12 sequence-based prediction algorithms that are designed to predict 
amyloid “hot spots”, or short residue segments with high propensity for 
-aggregation that initiate protein misfolding into amyloid (Trovato et al., 2007; 
Tsolis et al., 2013). The amyloidogenic profile obtained for apoB residues 1-1000 
by one such prediction algorithm, PASTA (Trovato et al., 2007), is shown in Figure 
4.16A. In this profile, residue segment 379-392, LLIDVVTYLVALI, encompassing 
helix 6 is predicted very strongly to form parallel in-register -sheet that can 
initiate -aggregation. This prediction is not surprising, since hydrophobicity is one 
of the major criteria used in PASTA, and helix 6 is the most hydrophobic part of 
the 1 domain. 
In addition to PASTA, we used consensus software AmylPred2 that combines 
11 amyloid prediction algorithms using various criteria such as charge distribution  
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Figure 4.16  Prediction of amyloidogenic segments in the N-terminal domain of 
human apoB. (A) Amyloidogenic profile of human apoB residues 1-1000 predicted 
by PASTA (Trovato et al., 2007). Relative amyloidogenic potential is plotted as a 
function of residue number. The inset is a 10-fold zoom-in of the Y-axis to clearly 
show the smaller peaks. (B) Prediction of amyloidogenic segments in residues 
300-400 of apoB by AmylPred2 and PASTA (Tsolis et al., 2013; Trovato et al., 
2007). The 12 different algorithms used are listed. Segments with high 
amyloidogenic potential are in red. Boxed regions indicate the segments that are 
predicted to have high amyloid propensity by six or more algorithms. Residues in 
the red box (379-382) correspond to helix 6, the most hydrophobic helix in the 
N-terminal 1 domain. These residues correspond to the strongest peak in the 
PASTA file (A). 
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and hydrophobicity, average packing density, dual -helical and -sheet 
propensity, hidden conformation switches from -helix to -sheet, 
correspondence to known amyloidogenic patterns, -sheet contiguity, etc. 
(Fernandez-Escamilla et al., 2004; Lopez de la Paz and Serrano, 2004; 
Galzitskaya et al., 2006; Conchillo-Sole et al., 2007; Hamodrakas et al., 2007; 
Zhang et al., 2007; Zibaee et al., 2007; Kim et al., 2009; Tian et al., 2009; 
Maurer-Stroh et al., 2010; O'Donnell et al., 2011; Tsolis et al., 2013). Since 
amyloid hot spot prediction by any individual method is not always reliable, 
multiple methods are used to improve the prediction reliability. A prediction by a 
consensus of more than five from a total of 11 algorithms used in AmylPred 2 has 
~85% specificity, and this specificity increases with increasing number of hits 
(Tsolis et al., 2013).  
Amino acid sequence analysis of apoB residues 1-1000 by using AmylPred2 
shows multiple amyloid hot spots predicted by a consensus of five or more 
methods. The number and length of such hot spots predicted for apoB domains 
exceed those predicted for typical globular proteins or exchangeable 
apolipoproteins (unpublished data from the Gursky laboratory). This is consistent 
with the highly hydrophobic non-exchangeable character of apoB that is protected 
from misfolding by its strong association with the lipid. Notably, the segment 
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containing residues 379-392 (helix 6) is among the strongest hits by all 11 
algorithms for the 1 domain (Figure 4.16B).  
In sum, helix 6 is predicted very strongly to form amyloid “hot spot” by all 12 
algorithms explored in AmylPred2 and PASTA. The specificity of such a prediction 
is probably well over 90%. We propose that the reason that helix 6 does not 
normally misfold to form amyloid despite a high amyloid- forming propensity, is 
that this helix is protected by extensive protein-protein and protein-lipid 
interactions in the native structure of LDL. However, it is possible that these native 
interactions are disrupted at early stages of LDL disintegration upon 
conformational changes in the adjacent segments from the Mb24 epitope.  
Taken together, our preliminary data prompt us to speculate that 
conformational changes involving Mb24 epitope, which were suggested by our 
Western blot and ELISA analyses of mildly-heated LDL (Figures 4.13 and 4.14), 
may extend beyond this epitope to the nearby helix 6 that forms part of the lipid 
binding pocket. If the segment containing helix 6 dissociates from the lipid, it has 
high propensity to misfold into a -sheet and thereby initiate -aggregation of LDL 
(Figure 4.15). Our future studies will test this hypothesis. In these studies, we will 
verify that residues 379-392 (helix 6) have high propensity to form amyloid by 
analyzing synthetic peptides encompassing these residues for their ability to form 
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amyloid fibrils in vitro. 
 
4.4.8 Summary and future studies 
We have demonstrated that conformational changes in apoB occur during the 
lag phase of LDL fusion. These changes alter the exposure of certain apoB 
epitopes that can form “sticky patches” leading to LDL pairing, as observed by 
negative-stain EM. These regions involve residues 405-539 (or approximately 
9-12% of apoB), which are located in the N-terminal 1 domain of apoB, and 
possibly other regions.  
Once these additional regions have been identified in the future using ELISA, 
they will be mapped on the low-resolution structural model of apoB on LDL, to test 
if these regions form a sticky patch on the particle surface. We speculate that 
targeting conformational changes in apoB that prime LDL for fusion may 
ultimately provide a strategy for blocking this pathological reaction before it 
occurs.  
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CHAPTER 5  FACTORS AFFECTING STRUCTURAL STABILITY OF LDL 
We hypothesize that LDL stability, remodeling and fusion in vivo and in vitro 
depend upon internal factors (such as LDL lipid composition and apoB 
conformation) and are modulated by external factors (such as other plasma 
lipoproteins and proteins) and environmental conditions (such as solvent ionic 
conditions, temperature, and the presence of small molecules). In this chapter, I 
assessed the effects of some of these factors on the structural stability of LDL. 
The role of LDL aggregation and fusion in atherosclerosis and the effects of 
various LDL perturbations (thermal, mechanical, hydrolytic, acidic pH, binding by 
proteoglycanes, etc.) are well-documented in studies by many teams, including 
Kovanen, Oorni, Camejo and Hurt-Camejo, and their colleagues (Khoo et al., 
1988; Tertov et al., 1989; Hurt-Camejo et al., 1992; Pentikainen et al., 1996; 
Camejo et al., 1998; Oorni et al., 2000). Here, we use our kinetic approach 
described in Chapter 3 to demonstrate, for the first time, that thermal denaturation 
accelerates upon increasing LDL concentration, increasing particle diameter, and 
decreasing pH. Thus, our kinetic approach provides a tool for quantitative analysis 
of kinetic LDL stability under various conditions.  
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5.1  Concentration Dependence of LDL Fusion 
Elevated concentration of plasma LDL is the strongest causative risk factor of 
atherosclerosis (Manninen et al., 1992; Wilson et al., 1998). The higher the 
concentration of plasma LDL, the higher the uptake of pro-atherogenic LDL by 
arterial macrophages. Since LDL denaturation involves aggregation, fusion and 
coalescence of many particles, it is expected to be a high-order reaction 
(Jayaraman et al., 2005a) and hence, to be concentration dependent. If so, 
increased local LDL concentration in the arterial wall may promote LDL fusion in 
vivo and thereby contribute to the development of atherosclerosis. In addition, 
LDL crowding at elevated concentrations may contribute to atherogenesis. For 
example, in the “lattice model” proposed for LDL binding to LDLR, steric 
hindrance produced by the receptor-bound LDL decreases the binding of 
additional LDL particles to the adjacent receptors (Chappell et al., 1991). 
Therefore, LDL crowding (i.e. increased local LDL concentration) can interfere 
with the non-atherogenic clearance of LDL by LDLR. This implies that LDL 
crowding in the arterial subendothelium, together with the steric effects of the 
receptor-bound LDL, potentially contribute to atherogenesis.  
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5.1.1 LDL denaturation is a high-order reaction  
Earlier melting studies of isolated plasma LDL from our laboratory showed 
that increasing LDL protein concentration from 1.5 to 4.0 mg/ml reduced the 
apparent transition temperature of thermal denaturation, Tm, app, by nearly 20 
oC, 
and thereby promoted LDL fusion and rupture (Jayaraman et al., 2005a) (Figure 
5.1A). I carried out a series of melting experiments using different LDL 
concentrations, from 0.2 to 1.0 mg/ml protein. These conditions are close to the 
physiological concentration of plasma LDL (~0.5 mg/ml protein) (Margolis, 1967; 
Ai et al., 2010). The melting data showed that the transition temperature of LDL 
thermal denaturation is decreased upon increasing LDL concentration (Figure 
5.1B), in agreement with the trend observed in a previous study in our laboratory 
(Jayaraman et al., 2005a).  
Next, we determined the effect of LDL concentration on the denaturation 
kinetics in the range from 0.15 mg/ml to 1.0 mg/ml of LDL protein (Figure 5.2A). 
This range encompasses physiological LDL concentrations in plasma (Margolis, 
1967; Ai et al., 2010). Kinetic analysis of our work showed, for the first time, that 
increasing LDL concentration in this range greatly accelerates fusion. This is 
illustrated in Figure 5.2A showing the denaturation time course monitored by 
turbidity in a T-jump to 85 oC under standard buffer conditions and LDL protein  
167 
 
Figure 5.1  Melting experiments using LDL samples at different 
concentrations. (A) LDL samples containing 1.5-4.0 mg/ml protein in standard 
buffer were heated from 25 oC to 98 oC at a constant rate of 11 k/h, and the 
changes in turbidity were recorded (Jayaraman et al., 2005). (B) LDL samples 
containing 0.2-1.0 mg/ml protein were subjected to similar melting experiments, 
and turbidity was recorded (my own data). The apparent transition temperature of 
LDL denaturation shifted to lower value as the LDL concentration increased, 
indicating that LDL fusion and rupture are enhanced upon increasing LDL 
concentration. 
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Figure 5.2  Temperature-jump data recorded from LDL samples at different 
concentrations. (A) LDL samples containing 0.15-1.0 mg/ml protein in standard 
buffer were subjected to T-jumps from 4 to 85 oC, and the time course of LDL 
denaturation was monitored by turbidity. LDL protein concentrations are indicated. 
Solid lines show data fitting by a sigmoidal function, (V(t) = V0+ (V0-V1) / {1 + 
exp[(t – t½) / k]}. This sigmoidal function was used to determine fusion rate, k, as 
described in Chapter 2. (B) Fusion rates, k, as a function of LDL protein 
concentration. Thin line shows fitting by a second-degree polynomial. The 
non-linear plot suggests that LDL fusion is a high-order reaction. 
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concentrations varying from 0.15 to 1.0 mg/ml. The results reveal that increasing 
LDL concentration from 0.15 to 1.0 mg/ml protein leads to an approximately 
20-fold increase in the rate of thermal denaturation (Figure 5.2A). Thus, our 
previous and current melting experiments are consistent with our kinetic data and 
clearly show that increasing LDL concentration in near-physiologic range 
promotes LDL fusion and lipid droplet formation in vitro. 
To assess the reaction order of LDL fusion, we plotted the denaturation rate 
constant k versus apoB concentration. Although the quality of our kinetic data was 
insufficient to accurately measure the reaction order, the non-linear character of 
this plot suggests that LDL denaturation is higher than a second-order reaction 
(Figure 5.2B). Acceleration of LDL fusion upon increasing LDL concentration 
implies that, under conditions of our experimental conditions, the fusion rate is 
limited by the diffusion-collision rate of LDL. Therefore, increasing LDL 
concentration increases the collision rate and thereby accelerates LDL fusion.  
 
5.1.2 Comparison with other lipoproteins 
The rate constant of LDL denaturation measured in our studies increases 
steeply with increasing lipoprotein concentration in the range explored (0.15-1.0 
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mg/ml protein), suggesting a high-order reaction. In contrast, the rate of the 
heat-induced HDL fusion shows no significant concentration dependence in the 
comparable concentration range (Jayaraman et al., 2006), (Mehta et al., 
2003)suggesting an apparent 1st order reaction. Concentration dependence of 
VLDL heat denaturation appeared intermediate between that of HDL and LDL 
(Guha et al., 2007). Increase in VLDL concentration leads to an increase in the 
amplitude and in the apparent cooperativity of the transition, but has no large 
effect on its onset temperature (Guha et al., 2007). The reason for this difference 
among various lipoprotein classes may be due to different protein compositions. 
The large size and high hydrophobicity of apoB in LDL probably contribute to the 
strong concentration dependence of LDL thermal denaturation. We hypothesize 
that, due to the non-exchangeable character of apoB and its complex energy 
landscape, multiple consecutive LDL collisions are required to produce structural 
changes on LDL surface that prime it for fusion (also discussed in Chapter 3, 
section 3.5). These changes are expected to accumulate faster upon increasing 
the collision rate, which helps explain the strong concentration dependence 
observed in LDL fusion (Figure 5.2).  
In contrast, HDL contains only small exchangeable apolipoproteins that are 
much easier to dissociate from the lipoprotein surface, so only one or several 
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collisions can result in HDL fusion. Therefore, LDL fusion is limited by the rate of 
particle collision, while HDL fusion is not. For VLDL that contain both 
non-exchangeable and exchangeable apolipoproteins, their concentration 
dependence is expected and observed to be intermediate between HDL and 
VLDL.  
 
5.1.3 Physiological relevance 
Notably, LDL concentrations used in our melting and kinetic studies (0.1-1.0 
mg/mL apoB) are comparable to those found in human plasma. In fact, 0.5 mg/ml 
apoB corresponds to approximately 100 mg/dl LDL cholesterol, which is 
borderline between normal and elevated plasma levels (Margolis, 1967), while 
LDL concentration in the arterial wall can be substantially higher. This prompts us 
to propose that the strong concentration dependence of LDL fusion observed in 
vitro (Figure 5.1 and 5.2) is relevant to in vivo conditions. It is well established that 
elevated concentrations of LDL in plasma and, particularly, in the arterial wall are 
highly pro-atherogenic. We hypothesize that lipoprotein fusion can contribute to 
this effect, since increasing LDL concentration in the near-physiologic range 
accelerates LDL fusion in vitro, whereas reducing LDL concentration (e. g. upon 
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administration of lipid-lowering therapies) is expected to decelerate this 
pathogenic reaction in vivo.  
 
5.2  Effects of Particle Size on LDL Thermal Stability 
5.2.1  Background and rationale 
In contrast to HDL and VLDL which contain multiple copies of exchangeable 
apolipoproteins, each LDL particle contains only one copy of the 
non-exchangeable apoB100 as its major protein. Therefore, LDL form a relatively 
homogeneous population. Nevertheless, human plasma LDL form distinct 
subclasses differing in density, size, charge, lipid composition, and apoB 
conformation (Krauss and Burke, 1982; McNamara et al., 1996; Berneis and 
Krauss, 2002). LDL are produced from heterogeneous VLDL precursors (Packard 
and Shepherd, 1997), and different precursors, along with various enzymatic 
modifications, contribute to the formation of discrete LDL subclasses 
(Hurt-Camejo et al., 2000). A direct precursor-product relationship of large VLDL 
with small, dense LDL (or LDL3) was suggested by a stable isotope kinetic study 
(Rutledge et al., 1995). This relationship is consistent with early studies of LDL 
heterogeneity showing that subjects with LDL of increased density have increased 
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levels of serum TG and decreased levels of HDL cholesterol (Swinkels et al., 
1989).  
The current consensus is that small, dense LDL have increased 
pro-atherogenic properties, and elevated level of these particles is a risk factor for 
coronary artery disease (Kwiterovich, 2002). The increased pro-atherogenic 
properties of small, dense LDL may result from their increased affinity for the 
arterial proteoglycans and/or increased propensity to undergo post-translational 
modifications such as oxidation (Kwiterovich, 2002).  
Although the importance of LDL heterogeneity has been known for years, the 
structural details underlying functional differences among LDL subclasses are not 
well understood. Analysis of the chemical composition of LDL subclasses 
revealed that the surface area covered by apoB is different in various subclasses 
(McNamara et al., 1996), suggesting that the altered apoB conformation could be 
the reason why small, dense LDL are particularly vulnerable to oxidation and have 
increased affinity for arterial proteoglycans (Bancells et al., 2011). 
To test whether the apparently increased pro-atherogenic effect of small, 
dense LDL is related to their higher propensity to fuse and coalesce into lipid 
droplets, I studied thermal stability of LDL subclasses differing in particle size, 
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density and composition. 
 
5.2.2 Separation of LDL subclasses by size and density 
Single-donor LDL were isolated from human plasma by density gradient 
centrifugation as described in Chapter 2. Individual LDL subclasses were further 
separated by density gradient ultracentrifugation: LDL1 were isolated at density 
range 1.025-1.034 g/ml, LDL2 at 1.034-1.044 g/ml, and LDL3 (or small, dense LDL) 
at 1.044-1.060 g/ml. The separation was confirmed by negative-stain EM (Figure 
5.3A). Electron micrographs of LDL1, LDL2 and LDL3 showed statistically 
significant differences in particle size distribution, confirming that the separation 
was successful (Figure 5.3B). 
 
5.2.3 Thermal stability studies 
Thermal stability of individual subclasses and of total plasma LDL was 
analyzed in melting experiments by recording turbidity. The results clearly show 
that smaller LDL3 particles undergo fusion and rupture at higher temperatures and 
hence, are more stable than their larger counterparts. Figure 5.4 shows 
representative melting and kinetic data obtained from LDL subclasses under  
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Figure 5.3  Characterization of LDL subclasses isolated from single-donor 
plasma. (A) Representative electron micrographs of LDL1, LDL2 and LDL3 
recorded at 50 μg/ml protein concentration. (B) Particle size distribution in LDL 
subclasses and statistics of the particle size distribution based on the electron 
micrographs shown in (A). EM micrographs of LDL1, LDL2 and LDL3 showed 
statistically significant differences (P-value < 0.05) in the particle size distribution. 
For the sizing, more than 100 particles were selected for each population and the 
diameters were measured. The sizing was performed using Photoshop and Excel 
softwares. 
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Figure 5.4  Effect of the particle size on LDL stability assessed in melting 
experiments. LDL subclasses were isolated from total LDL by density gradient 
centrifugation as described in Chapter 2, from LDL1 (large buoyant) to LDL3 (small 
dense). Relative thermal stability of these subclasses and of total LDL (0.5 mg/ml 
protein in standard buffer) was analyzed in melting experiments. LDL denaturation 
was monitored by near-UV CD (A) and turbidity (B) at 320 nm. A sharp decline in 
the amplitude of turbidity and near-UV CD following lipoprotein rupture reflects 
sample loss upon lipid phase separation at advanced stages of denaturation 
(Jayaraman, et al, 2005; Guha et al., 2007).  
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standard conditions. The melting data were recorded during heating at a rate of 11 
oC/h by turbidity and by near-UV CD. CD signal at 320 nm was used to monitor 
re-packing of apolar core lipids upon lipoprotein rupture and coalescence into lipid 
droplets, as described in Chapter 2. The results reveal that, under otherwise 
identical conditions, larger LDL have lower apparent melting temperature (Figure 
5.4A, B). This trend was confirmed in T-jump experiments showing that the 
denaturation rate of LDL subclasses correlates with the particles size: smaller 
LDL2 fuse more slowly than their larger LDL1 counterparts (Figure 5.5).  
This rank order was reproducible for LDL from different donors. Even though 
the apparent transition temperatures are different for LDL subclasses isolated 
from different batches, the rank order of the particle stability is similar and 
correlates inversely with the particle size, LDL3 > LDL2 > LDL1. Therefore, larger 
LDL are less stable and more prone to heat-induced fusion and rupture than their 
smaller counterparts. 
 
5.2.4 Comparison with other lipoproteins 
The reason why smaller LDL (and smaller lipoproteins in general) tend to be 
more stable than their larger counterparts is unclear. It may result from the higher 
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protein to lipid ratio in smaller particles (and hence, more extensive 
protein-protein as opposed to protein-lipid interactions), higher surface curvature, 
as well as the differences in the protein conformation and lipid composition in 
large and small particles (Bancells et al., 2011). In addition, increased surface 
coverage by apoB, which was reported for small dense LDL (McNamara et al., 
1996), may contribute to their increased stability.  
A similar trend was observed by Dr. Xuan Gao from our laboratory in her 
studies of plasma HDL subclasses: small HDL3 are more stable than their larger 
HDL2 counterparts (Gao et al., 2009). Moreover, our earlier stability studies of the 
major classes of plasma lipoproteins suggest that the rank order of lipoprotein 
stability correlates inversely with the particle size: HDL>LDL>VLDL (Mehta et al., 
2003; Jayaraman et al., 2005a; Guha et al., 2007). The general trend emerging 
from these studies is that smaller lipoproteins tend to be more stable.  
Elastic incoherent neutron scattering studies by Prassel et al. indicated that 
apoB in VLDL has higher mobility than in LDL, suggesting that apoB is in a more 
condensed and rigid state when converted from VLDL to LDL (Mikl et al., 2011). 
One possible explanation for this general trend is that smaller lipoproteins, 
which have higher protein-to-lipid ratio than their larger counterparts, have more 
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extensive lipid surface coverage by the protein that hampers formation of surface 
packing defects. In addition, protein-protein interactions are also likely to be more 
extensive on smaller lipoproteins, further stabilizing these lipoproteins. 
Differences in the protein conformation and lipid composition may also contribute 
to the differences in stability of plasma LDL of different sizes.  
 
5.2.5 LDL subclasses interact with each other during thermal denaturation 
Interestingly, our results reveal that the kinetic data recorded for LDL 
subclasses are not additive. This is illustrated in Figure 5.5B showing the first 
derivatives of the sigmoidal functions, dV(t)/dt, obtained by fitting the T-jump data, 
V(t), recorded by turbidity from total LDL and from the individual LDL subclasses 
(Figure 5.5A). The dV/dt function of total LDL shows a single peak rather than a 
weighted average of individual peaks corresponding to LDL1, LDL2 and LDL3 
(Figure 5.5B). This non-additive behavior indicates interactions among LDL 
subclasses and suggests that they can fuse with each other. Taken together with 
a similar non-additive behavior of human HDL subclasses during heat 
denaturation (Jayaraman et al., 2005b) and with the demonstrated ability of HDL 
or its major protein to inhibit LDL aggregation and fusion (Melnik and Melnik, 1988; 
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Khoo et al., 1990; Gao et al., 2012), this result indicates that different lipoprotein 
classes and subclasses interact with each other during fusion. 
 
5.2.6 Elevated atherogenicity of small dense LDL does not result from their 
enhanced fusion 
The results in Figure 5.4 and 5.5 indicate that the enhanced pro-atherogenic 
property of small, dense LDL cannot be due to their enhanced propensity to fuse 
and form lipid droplets. Therefore, other factors must contribute to the enhanced 
pro-atherogenic properties of small, dense LDL. These factors may include 
reduced affinity of small, dense LDL for the LDL receptor, increased affinity for the 
arterial proteoglycans, and increased susceptibility to post-translational 
modifications such as oxidation (Kwiterovich, 2002).  
Our results suggest that large LDL fuse and precipitate faster since they are 
less stable than small dense LDL. Interestingly, it has been reported that a 
combination of heparin and Mg2+ selectively precipitates large LDL, but leaves 
small, dense LDL (d>1.044 g/ml) in the supernatant (Hirano et al., 2003). This 
simple method can be used clinically to quantify the amount of small, dense LDL 
in plasma samples. Our finding of enhanced thermal stability of small, dense LDL  
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Figure 5.5  Kinetic experiments showing the non-additive behavior of LDL 
subclasses. The stability of LDL subclasses (LDL1, LDL2, and LDL3) and total LDL 
was analyzed in T-jump experiments (A). The T-jump data were approximated by 
sigmoidal functions (solid lines in panel A). The 1st derivatives of these functions, 
dV(t)/dt, are shown in (B). The results reveal that fusion of total LDL cannot be 
represented as a sum of transitions of individual LDL subclasses, indicating that 
LDL from different subclasses interact during fusion. 
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suggests that these particles might be more stable upon perturbations by other 
means such as heparin-Mg2+ precipitation. This helps explain the mechanism 
underlying the separation method. 
Moreover, our results are in good agreement with the report by Hurt-Camejo 
et al. that LDL subfractions which are more electronegative and have lower 
surface-to-core lipid ratio (i. e. larger diameter) are more prone to retention by 
proteolycans and degradation by arterial macrophages (Hurt-Camejo et al., 1990). 
We speculate that lower structural stability of larger LDL contributes to the latter 
effect. 
 
5.2.7 Physiologic implications 
The effects of particle size and LDL concentration on LDL fusion observed in 
vitro may have potential implications for the lipid-lowering therapies. Elevated 
plasma levels of LDL, particularly small, dense LDL, are a major risk factor and a 
likely causative agent of atherosclerosis (Kwiterovich, 2002; Ai et al., 2010; 
Krauss, 2010). Conventional lipid-lowering therapies (including statins, fibrates, 
niacin, and their combinations) not only improve the overall plasma levels of 
lipoproteins but also reduce the proportion of small, dense LDL and thereby 
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increase the median size of LDL (Morgan et al., 2003; Backes and Gibson, 2005; 
Baldassarre et al., 2005; Tribble et al., 2008; Florentin et al., 2010; McCullough et 
al., 2011; Sampson et al., 2012). The results in Figure 5.4 and 5.5 suggest that 
such an increase in size is likely to augment LDL fusion. We speculate that this 
potentially pro-atherogenic effect is counterbalanced by the reduction in LDL 
concentration upon administration of the lipid-lowering therapies, which is 
expected to decelerate LDL fusion, as suggested by our data in Figure 5.1 and 5.2. 
Thus, we hypothesize that i) the lipid-lowering therapies are expected to increase 
LDL propensity to fuse; ii) this potentially pro-atherogenic effect in vivo is probably 
counterbalanced by the reduction in LDL concentration that decelerates LDL 
fusion. This hypothesis will be tested in future studies that will compare structural 
stability of LDL isolated from plasma of hyperlipidemic patients before and after 
treatment with lipid-lowering drugs.  
 
5.3  Electrostatic Effects on LDL Thermal Stability 
5.3.1 Rationale 
Electrostatic interactions contribute to the functionality of LDL in several ways. 
First, site B in apoB100 (residues 3359-3367) is the primary LDL receptor binding 
184 
site (Law and Scott, 1990), which is conserved across different species and has 
strong net positive charge resulting from basic groups (three Arg and two Lys) 
(Law and Scott, 1990). The charge complementarity between this basic patch on 
apoB and the acidic patch in the ligand binding domain of LDLR provides an 
important electrostatic component of LDL-LDLR interaction (North and Blacklow, 
2000; Raffai et al., 2000; Rudenko et al., 2002). Second, electrostatic interactions 
are also involved in LDL binding to PG and other acidic components of the 
extracellular matrix in the arterial wall (Olsson et al., 1997; Boren et al., 1998). In 
fact, site B of apoB100 is thought to be the primary binding site for proteoglycans 
(Boren et al., 1998). Other charged regions of apoB are also proposed to be 
important for heparin binding (Olsson et al., 1997).  
In addition, changes in pH may also contribute to LDL metabolism. It has been 
reported that the extracellular pH varies from near-neutral to acidic, reaching as 
low as pH 5.5 in deep hypoxic areas of atherosclerotic plaques (Naghavi et al., 
2002; Oorni and Kovanen, 2006). LDL fusion at acidic pH can be augmented via 
two independent mechanisms. Many hydrolytic and oxidative enzymes that 
modify LDL in the arterial intima have optimal activity at acidic pH (Schissel et al., 
1996a; Shamir et al., 1996; Dollery and Libby, 2006; Oorni and Kovanen, 2006), 
which is expected to promote LDL fusion (see Chapter 1 for details). In fact, 
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degradation of LDL takes place in the lysosome at pH≈4.8 (Ohkuma and Poole, 
1978; Beglova et al., 2004; Beglova and Blacklow, 2005; Jeon and Blacklow, 
2005), suggesting that changes in pH from neutral to acidic may help to break the 
structural integrity of LDL.  
My results showed that electrostatic interactions, which are influenced by pH 
and salt, affect LDL aggregation and fusion (Figure 3.1). Therefore, our working 
hypothesis was that electrostatic interactions are important not only for 
functionality but also for the structural integrity of LDL. To establish a role for 
electrostatic interactions in LDL stability, we analyzed the effects of salt and pH on 
LDL fusion and rupture upon heating. Earlier studies from our laboratory showed 
that electrostatic interactions have a large favorable contribution to the stability of 
human plasma VLDL and HDL. As a result, screening of these interactions by salt 
ions destabilized these lipoproteins (Jayaraman et al., 2006; Guha and Gursky, 
2011). My work addressed the role of electrostatic interactions in LDL stability. 
 
5.3.2 Effects of pH on LDL stability 
The effects of pH on LDL thermal stability were tested at pH 6.0-8.0 using 
standard concentrations of buffer and LDL (0.5 mg/ml apoB) in the melting and  
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Figure 5.6  Mildly acidic conditions destabilize LDL in melting experiments. 
Total plasma LDL (0.5 mg/ml protein, 20 mM Na phosphate buffer at pH 6.0-8.0 as 
indicated) were analyzed for thermal stability in melting experiments. LDL were 
heated at a constant rate of 60 oC/h from 25 oC to 98 oC and particle fusion and/or 
rupture was monitored at 320 nm by turbidity (A) and by near-UV CD (B), 
respectively. 
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kinetic experiments. Figure 5.6 shows representative thermal denaturation data 
recorded by turbidity and near-UV CD. The melting data show that reduction in pH 
leads to a progressive decrease in the apparent transition temperature, from ~100 
oC at pH 8.0 to ~75 oC at pH 6.0, indicating LDL destabilization at acidic pH. 
The kinetic data support this result and show much faster LDL fusion at lower 
pH (Figure 5.7A). At pH 6.0, LDL were marginally stable and gradually fused at 22 
oC, which limited the pH range explored in our thermal stability studies. Although 
the lag phase was observed at any pH, the reaction time course often deviated 
from sigmoidal transition at pH 8. To compare the reaction kinetics at pH 6.0–8.0, 
we used the reaction midpoint t½ that correlates inversely with the rate constant k. 
Since t½ corresponds to 50% change in amplitude regardless of the exact time 
course of the reaction, it is well-suited for comparison of sigmoidal and 
non-sigmoidal transitions. Analysis of kinetic data shown in Figure 5.7B suggests 
a nearly 40-fold reduction in t½ upon reduction in pH, from ~90 min at pH 8.0 to 
2.4 min at pH 6.0. The plot of inverse t½ versus pH showed that LDL fusion greatly 
accelerates upon reduction in pH from pH 8 to mildly acidic pH (Figure 5.7B).  
 
5.3.3 Relevance to acidic environment in atherosclerotic lesions 
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Figure 5.7  Kinetic experiments showing the pH-dependence of LDL fusion 
and rupture. LDL samples (0.5 mg/ml protein, 20 mM Na phosphate buffer at pH 
6.0-8.0 as indicated) were subjected to T-jumps to 85 oC (A). Values of inverse t½ 
determined from these T-jump data are plotted as a function of pH (B). The plot 
shows that LDL fusion and rupture greatly accelerate at mildly acidic pH. 
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 Strong pH dependence of LDL fusion reported here (Figure 5.6 and 5.7) is 
consistent with recent studies of LDL hydrolysis by sphingomyelinase or 
phospholipase A2, which reported enhanced LDL aggregation, fusion and 
retention by proteoglycans upon reduction in pH to mildly acidic range (Oorni and 
Kovanen, 2006; Gao et al., 2012; Lahdesmaki et al., 2012). Therefore, LDL 
destabilization and enhanced fusion below pH 7 is a general phenomenon that is 
not limited to high temperatures. In fact, we observed gradual fusion of human 
LDL at pH 6.0, 22 oC. Destabilization of LDL at mildly acidic pH may result, in part, 
from the reduced electrostatic repulsion between the particles upon reduction in 
their net charge below pH 7 (Melnik and Melnik, 1988). This destabilization and 
fusion likely contributes to LDL retention in the mildly acidic anaerobic 
environment of the atherosclerotic plaques and helps explain why LDL 
accumulation during atherogenesis starts in the deep areas of arterial thickening 
that have lowest pH (Nakashima et al., 2008). In addition, destabilization of LDL at 
acidic pH is expected to promote their lysosomal degradation during normal 
catabolism. Although the origin of this destabilization remains unclear, 
destabilization of VLDL but not HDL observed at mildly acidic pH (Guha and 
Gursky, 2011) suggests that this effect is rooted, at least in part, in the pH-induced 
changes in apoB. 
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5.3.4 Effects of salt 
I carried out limited analysis of the effects of salt on LDL stability. Kinetic data 
in Figure 3.1B clearly showed that increase in Na phosphate concentration from 5 
mM to 10 mM at neutral pH destabilized LDL. This conclusion is further supported 
by the melting data in Figure 5.8. Our melting data recorded by near-UV CD 
(Figure 5.8A) and turbidity (Figure 5.8B) showed that increasing Na phosphate 
concentration from 7 to 20 mM progressively shifted LDL fusion and rupture to 
lower temperatures by more than 10 oC, indicating salt-induced destabilization. 
Increasing Na phosphate concentration from 5 mM to 7 mM also led to a 
significant increase in the amplitude and the apparent cooperativity of the 
transition. In the future, we plan to determine the temperature of LDL fusion and 
rupture in a broad range of solvent ionic conditions using various salts at different 
concentrations. We also plan to study the kinetics of LDL denaturation under 
various solvent ionic conditions. The results will help to quantify the effects of 
electrostatic interactions on the structural integrity of LDL and on specific stages 
of LDL denaturation.   
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Figure 5.8  Effects of phosphate buffer concentration on thermal stability of 
LDL. LDL samples (1.0 mg/ml protein, pH7.5, at various concentrations of the Na 
phosphate buffer as indicated) were heated at a constant rate of 11 oC/h, and 
thermal denaturation was monitored at 320 nm by CD (A) and turbidity (B). 
Increasing Na phosphate concentration from 5 to 20 mM shifted LDL fusion and 
rupture to lower temperatures progressively, indicating salt-induced 
destabilization.  
 
  
       
60 70 80 90 100
-30
-25
-20
-15
-10
-5
0
5
 
 
 
heating
Q
3
2
0
, 
m
d
e
g
Temperature, oC
5 mM
7 mM
10 mM
20 mM
60 70 80 90 100
350
400
450
500
550
 
 
heating
Temperature, oC
T
u
rb
id
it
y
 a
t 
3
2
0
 n
m
, 
V
5 mM
7 mM
10 mM
20 mM
192 
5.4  Effects of HDL and apoA-I on LDL transitions 
5.4.1 Experimental stability studies 
Exchangeable apolipoproteins, which are present in plasma either in 
lipid-poor/free form or in complexes with HDL or VLDL, are expected to prevent 
LDL remodeling and fusion by binding to lipid packing defects on LDL surface and 
thereby blocking LDL aggregation and fusion (Brunelli et al., 2000). Since various 
lipoproteins co-exist in plasma, it is possible that LDL interact with HDL or their 
proteins that can transiently dissociate from HDL, and such interaction may affect 
remodeling of both lipoproteins in vivo. 
To test these hypotheses, I studied thermal stability of LDL in the presence of 
HDL, the major HDL protein, apoA-I (243 a. a.), or a minor protein found on HDL 
and VLDL, apoC-I (57 a. a.). Single-donor LDL and HDL were isolated from 
plasma of healthy volunteer donors by KBr density gradient ultracentrifugation in 
the density range from 1.019-1.063 mg/ml for LDL and 1.063- 1.21 mg/ml for HDL 
(Schumaker and Puppione, 1986). LDL and HDL were dialyzed against standard 
buffer (10 mM Na phosphate, pH 7.5) and stored at 4oC. Human apolipoprotein 
C-I (apoC-I) was obtained commercially by solid state synthesis and purified by 
HPLC to 98% purity as previously described (Benjwal et al., 2007). The amino 
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acid sequence was confirmed by mass spectroscopy, and the peptide termini 
were not chemically blocked. Synthetic human apoC-I obtained by this method 
has structural and lipid-binding properties very similar to those of human plasma 
apoC-I (Gursky and Atkinson, 1998). Human apoA-I was isolated and purified 
from plasma HDL as described (Wetterau and Jonas, 1982; Gursky and Atkinson, 
1996b). 
In my CD spectroscopic experiments, LDL samples (0.5 or 1.0 mg/ml apoB 
concentration in standard buffer) were used. Other proteins or lipoproteins were 
added to LDL at final concentrations that were comparable to the apoB 
concentration in LDL. The samples that contained LDL alone or were mixed with 
other proteins or lipoproteins were treated in the same manner. The CD data of 
LDL alone (black line, Figure 5.9) are consistent with our earlier studies and show 
a cooperative transition centered at about 90 oC. In contrast, HDL in low-salt 
near-neutral buffer, such as the standard buffer used here, are highly 
thermostable and do not undergo detectable heat denaturation in the temperature 
range used in CD experiments (5-98 oC) (Jayaraman et al., 2006). As a result, the 
CD and turbidity melting data recorded for HDL showed no structural transitions 
(Jayaraman et al., 2006).  
The melting data of a LDL+HDL mixture (red line, Figure 5.9) are different  
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Figure 5.9  Effects of HDL and apolipoproteins on thermal stability of LDL. In 
melting experiments, the samples of LDL (alone or in mixtures with HDL or 
apolipoprotein A-I or C-I) were heated and cooled at a constant rate of 11 oC/h, 
and heat denaturation was monitored by CD at 280 nm. The protein concentration 
of LDL, HDL, apoA-I, and apoC-I in all samples was 0.5 mg/ml. LDL alone – black, 
LDL+HDL – red, LDL+apoA-I – violet, LDL+apoC-I – grey. The results show that 
HDL and, particularly, apoA-I hamper LDL fusion and rupture, while apoC-I has 
little effect. 
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from either LDL or HDL alone and show a structural transition upon heating above 
80 oC, which probably involves LDL rupture and coalescence into lipid droplets. 
Comparison of the black and red lines suggests that this LDL transition is shifted 
to higher temperatures and is less extensive and less cooperative in the presence 
of HDL. Also, the CD melting data show reduced transition amplitude in the 
LDL+HDL mixture as compared to LDL alone, suggesting that HDL inhibits LDL 
rupture. The melting data of LDL+apoA-I mixture are similar to that of LDL+HDL 
mixture (Figure 5.9), showing reduced transition amplitude as compared to LDL 
alone. Lipid-free apoA-I is even more effective in hampering LDL fusion, rupture 
and lipid droplet formation compared to HDL alone. In near-neutral low-salt 
solution, lipid-free apoA-I unfolds at Tm≈ 60 
oC (Gursky and Atkinson, 1996b); 
therefore,  in the temperature range of LDL denaturation (>80 oC), all apoA-I that 
was not tightly bound to the lipoprotein was essentially unfolded. Nevertheless, 
this unfolded protein prevented LDL fusion. The inhibition of LDL fusion probably 
involves apoA-I binding to LDL surface, which seals the packing defects on this 
surface. Such binding does not necessarily require apoA-I to be folded; in fact, 
some of the fully unfolded apoA-I remains bound to HDL upon heat denaturation 
(Jayaraman et al., 2005b). 
In future studies aimed to understand whether apoA-I binds to the surface of 
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intact or heated LDL and whether the binding induces secondary structural 
changes in apoA-I, we plan to use far-UV spectroscopy to determine the 
secondary structure of apoA-I in the presence of LDL. We also plan to use size 
exclusion chromatography to determine whether apoA-I can bind in significant 
amounts to LDL surface at 22 oC and at high temperature. Furthermore, we plan 
to carry out T-jump experiments by using mixtures of apoA-I and LDL, and thereby 
determine the effects of apoA-I on the lag and the transition phase of LDL 
denaturation. 
Interestingly, in contrast to apoA-I, apoC-I did not seem to significantly affect 
LDL fusion or rupture (grey line, Figure 5.9). The size of apoC-I (57 a. a.) is much 
smaller than that of apoA-I (243 a. a.), which may explain why apoC-I is less 
efficient than apoA-I in preventing LDL fusion and rupture. In fact, earlier studies 
by Dr. Jayaraman from our laboratory have shown that the kinetic stability of 
reconstituted discoidal HDL correlates inversely with the apolipoprotein size 
(Jayaraman et al., 2005b): the smaller the apolipoprotein, the less efficient it is in 
preventing HDL fusion and rupture. To further test these results for LDL, future 
studies may involve recording T-jump data from a mixture of LDL and apoC-I, to 
analyze in detail the effect of apoC-I on LDL stability.  
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5.4.2 Discussion and future directions 
Earlier studies from our laboratory showed that the DSC data recorded for 
HDL subclasses, HDL2 (large) and HDL3 (small), were not additive, suggesting 
that HDL from different subclasses interact with each other during heating and 
fuse to form hybrid particles (Gao, 2010; Gao et al., 2011). Similarly, my own 
studies on LDL subclasses (Chapter 5.2) showed that LDL from different 
subclasses also interact with each other. We hypothesize that HDL and LDL may 
also interact with each other and form hybrid particles during heat denaturation. 
To test this hypothesis, we will record DSC data of HDL, LDL and their mixture, 
and determine whether these data are additive. In the future, we will also analyze 
the biochemical composition and particle morphology in the products of LDL+HDL 
denaturation, to test for formation of hybrid particles. 
We also plan to carry out the CD and turbidity melting experiments in which 
the ratio of HDL to LDL in the mixture will be varied. We will also carry out kinetic 
T-jump experiments by using LDL+HDL mixture to conduct quantitative analysis of 
the effects of HDL on LDL stability. In addition, we plan to carry out DSC 
experiments in which the samples will be heated up to 115 oC at selected 
LDL+HDL conditions in the mixture. This will enable us to accurately measure the 
apparent Tm as a function of LDL to HDL ratio. The results of these studies will 
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help to better understand the mechanism via which HDL can inhibit LDL fusion in 
vitro and, potentially, in vivo. 
 
5.5  Summary of Factors That Affect LDL Fusion 
In this chapter, we summarize the effects of several internal and external 
factors that are expected to influence LDL fusion in vivo. Our results show that the 
following factors can reduce the thermal stability of LDL and thereby promote their 
fusion: increased LDL concentration, larger particle size, lower pH, higher salt 
concentration, and the absence of HDL or apoA-I.  Most of these factors have 
physiological relevance as discussed through the chapter. However, the real 
situation in vivo is far more complicated and additional factors may also be 
important. One example is the core lipid composition of LDL particularly the TG to 
CE ratio. Patients with metabolic syndrome and tupe 2 diabetes have increased 
TG:CE ratio in plasma, which may potentially influence LDL fusion, and thereby 
contribute to high risk of CVD in these patients. Another possible factor is LDL 
charge, which is expected to influence fusion of electronegative LDL, as well as 
their binding to the arterial proteoglycans. In the future, we will try to determine in 
detail how these and other factors affect the structural stability of LDL and the 
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kinetics of LDL fusion in vitro. 
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CHAPTER 6  SUMMARY AND FUTURE STUDIES 
The goal of my PhD research was to better understand the process of LDL 
fusion, an important but under-explored event in atherogenesis. To this end, I 
optimized the experimental conditions to perform the first quantitative kinetic 
analysis of LDL stability. The results revealed sigmoidal time course of LDL fusion 
and an unusually high activation energy, Ea=100 kcal/mol, which is unique among 
lipoproteins, providing important insights into the role of apoB in particle fusion 
(Chapter 3).  
To dissect the molecular mechanisms of LDL fusion, I combined 
size-exclusion chromatography, gel electrophoresis, turbidity, circular dichroism 
spectroscopy, electron microscopy, Western blotting and ELISA. The results of 
this integrated approach suggested that lipoprotein “pairing” is a common early 
step in LDL fusion. Our on-going ELISA studies indicate that LDL pairing is 
accompanied by structural changes in the N-terminal domain of apoB involving 
residues 405-539 (the epitope of Mb24). These changes may result in the 
formation of “sticky patches” on the surface of LDL particles, which then lead to 
LDL pairing (Chapter 4). Interestingly, the smaller epitope of 1D1 (residues 
474-539) did not show significant structural changes at early stages of LDL fusion 
in our Western blotting experiments (Figure 4.13). In the future, we plan to verify 
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this result by performing ELISA with 1D1. If the results obtained by ELISA confirm 
that 1D1 epitope (residues 474-539) does not show structural changes at early 
stages of LDL fusion, this would imply that conformational changes observed by 
ELISA in the Mb24 epitope (residues 405-539) are localized to the N-terminal part 
of this epitope (405-473). This would suggest that apoB segments located before 
residue 405 may also be involved in the early stages of LDL aggregation. Notably, 
these segments encompass helix 6 (residues 379-392), the most hydrophobic 
helix in 1 domain of apoB, which is predicted to have very high propensity to 
form a parallel-sheet or amyloid. Thus, we speculate that if helix 6 undergoes 
conformational changes that increase its solvent exposure at early stages of LDL 
aggregation and fusion, it is very likely to be involved in protein aggregation.  
In the future, we also plan to test additional mAbs to various apoB epitopes to 
elucidate the complex conformational changes in apoB during early stages of 
thermal denaturation. Hopefully, by mapping these regions that undergo 
conformational changes on the structural model of apoB on LDL, we would be 
able to identify all the sticky patches on LDL surface. We expect that targeting 
such structural changes that prime LDL for fusion can provide a useful strategy to 
block this pathogenic reaction before it occurs. 
Next, I applied the quantitative kinetic approach to determine the effects of 
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selected factors that are expected to importantly influence LDL fusion in vivo 
(Chapter 5). The main findings are as follows: First, increasing LDL concentration 
in the range that encompasses physiological conditions (~0.5 mg/ml apoB) rapidly 
accelerates LDL fusion. We propose that this strong concentration dependence of 
LDL fusion, which was not detected in other lipoproteins, is a contributing factor to 
cardiovascular disease. Second, small, dense LDL fuse more slowly than larger 
LDL. This effect explains the simple laboratory test for quantification of small, 
dense LDL by Mg2+ precipitation (Hirano et al., 2003), and suggests that the 
enhanced pro-atherogenic properties of small, dense LDL result from factors 
other than their enhanced propensity to fuse. Third, we showed that a reduction in 
pH from 7.5 to mildly acidic conditions greatly accelerates LDL fusion (Figure 5.8). 
We propose that this effect contributes to LDL fusion and retention in the acidic 
environment of atherosclerotic plaques, as well as to lysosomal degradation of 
LDL. Fourth, we showed that interactions with apoA-I and HDL help hamper LDL 
fusion in vitro. This effect may potentially contribute to the anti-atherogenic 
properties of apoA-I. In sum, my work helped to identify potentially pro- and 
anti-atherogenic factors that can influence LDL fusion in vitro and in vivo.  
Our future studies will quantify the effects of these and other factors on the 
structural stability of LDL in greater detail. For example, we will determine the 
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effects of pH and salt by carrying out kinetic experiments in a broad range of 
solvent ionic conditions. Next, we plan to study the mechanisms underlying the 
effects of apolipoproteins and HDL on LDL fusion. The questions we would like to 
answer are: Do HDL and LDL interact with each other? Does apoA-I bind to LDL 
surface during heating? If yes, does the binding occur during the lag phase? Does 
it involve the changes in the secondary structure of apoA-I? Further, we want to 
follow up some of the interesting observations. For example, we want to 
understand why heating resulted in the increase of electronegative LDL. Finally, 
we want to explore other factors that may influence LDL fusion in vivo such as 
TG:CE ratio, LDL charge, and the presence of estradiol. 
In summary, my PhD research started to dissect the pathogenic pathway of 
LDL fusion and identified key factors that promote or inhibit it. I anticipate that 
future studies in this field will guide the search for novel therapies to block LDL 
fusion at early stages and thereby benefit cardioprotection. 
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APPENDIX 1  EFFECTS OF FREEZING AND STORAGE ON LDL 
STRUCTURAL INTEGRITY 
Since human lipoproteins are isolated from plasma of volunteer donors in 
quantities sufficient for multiple experiments (300 mg apoB per batch on average), 
it is very useful to be able to store lipoproteins for long-time use. If LDL are stored 
at 4 oC for more than four weeks, apoB undergoes oxidative damage and 
proteolytic degradation (Cardin et al., 1984; Ettelaie et al., 1997; Jayaraman et al., 
2008). ApoB degradation can be slowed down by freezing. However, if 
lipoproteins are frozen without a cryoprotectant, their structural integrity can be 
compromised (Rumsey et al., 1992).  
In fact, freezing and thawing of LDL or VLDL results in “milky” samples, 
suggesting massive lipoprotein fusion, rupture and coalescence into lipid droplets. 
This phenomenon is reminiscent of “cold denaturation” of globular proteins that 
are stable in a limited temperature range and undergo unfolding not only upon 
heating but also upon cooling beyond this range (Privalov et al., 1986; Gursky and 
Atkinson, 1996a). Therefore, safe conditions have to be established for long-time 
storage of lipoproteins. Earlier studies suggest that freezing of HDL or LDL at 
-80oC with 10% (w/v) sucrose as a cryoprotectant helps retain their biochemical 
composition and particle morphology (Rumsey et al., 1992). Since we study the 
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structural stability of lipoproteins, it is important to establish storage conditions 
that preserve the structural stability of these particles after freeze-thaw treatment.  
To this end, I used fresh and frozen-thawed samples of human LDL to test 
their thermal stability (by CD and turbidity in the melting experiments), particle 
morphology (by negative staining EM), and apoB degradation (by SDS-PAGE). 
Single-donor lipoproteins used in these studies were either fresh or frozen with 10% 
w/v sucrose as a cryoprotectant, stored at -80oC for four weeks, thawed on ice, 
and dialyzed overnight against the standard buffer (10 mM Na phosphate, pH 7.5) 
prior to use.  
The results in Figure A.1A and A.1B show that freeze-thaw treatment in the 
presence of 10% sucrose did not have any detectable effects on the melting data 
of LDL, indicating that the thermal stability of LDL was not affected by this 
treatment. The electron micrographs in Figure A.1C and A.1D show that the 
morphology of the intact and frozen-thawed LDL was indistinguishable. 
SDS-PAGE detected no obvious degradation or aggregation in frozen-thawed 
LDL (Figure A.1E). Therefore, LDL freezing with 10% sucrose appears safe for 
long-time storage. 
In the future, we plan to carry out DSC and kinetic studies of frozen-thawed  
206 
Figure A.1  Characterization of intact and frozen-thawed LDL in the presence 
of 10% sucrose. Melting data of freshly prepared and frozen-thawed LDL samples 
recorded by CD (A) and turbidity (B) during sample heating and cooling from 25 
oC to 98 oC at a rate of 11 oC/h. LDL protein concentration was 1.0 mg/ml. 
Electron micrographs of freshly prepared (C) and frozen-thawed LDL (D). Freshly 
prepared and frozen-thawed LDL samples were resolved by SDS-PAGE (4%) and 
stained by Denville Blue (E). 
 
  
            
30 40 50 60 70 80 90 100
-30
-25
-20
-15
-10
-5
0
5
  
 
 
heating
Temperature, oC

3
2
0
, m
d
e
g Intact
Frozen
30 40 50 60 70 80 90 100
300
350
400
450
500
550
  
 
heating
Temperature, oC
T
u
rb
id
it
y
 a
t 
3
2
0
 n
m
, 
V
Intact
Frozen
Near-UV CD melting data Turbidity melting data
FrozenIntact
A B
C D E
207 
LDL, which are more sensitive to small changes in lipoprotein stability than the CD 
melting data. To ascertain that LDL stability does not change as a result of 
freeze-thaw treatment, we also plan to establish a safe storage procedure for 
VLDL, which are less stable than LDL and may require different freezing 
conditions. To this end, we will use 10-20% sucrose or other cryoprotectants 
(glycerol, polyethylene glycol, etc.). We will also explore the effect of the 
“universal protein folding agent” trimethylamide-N-oxide (TMAO) (Wang and 
Bolen, 1997) on structural stability of LDL and VLDL, which may potentially help 
their prolonged storage. 
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APPENDIX 2  INTERFACIAL PROPERTIES OF VLDL STUDIED BY DROP 
TENSIOMETRY 
In the initial stage of atherosclerosis, modified LDL are taken up by 
macrophages, whose death leads to the formation of large lipid droplets 
(d=100-400 nm) (Pentikainen et al., 1996; Oorni et al., 2000). During the 
development of atherosclerosis, additional LDL or VLDL are expected to fuse with 
these lipid droplets to contribute to the advancement of atherosclerosis. Therefore, 
fusion of LDL or VLDL with lipid droplets may be important for the development of 
atherosclerotic lesion in vivo. Together with Dr. Libo Wang, we attempted to use 
drop tensiometry to analyze the time course and specific steps involved in 
lipoprotein interactions and possible fusion with lipid droplets. 
Dr. Small’s laboratory has developed protocols to study the interfacial 
behavior of peptides using a modified tensiometer (Small et al., 2009). The 
tensiometer consists of a stirred cuvette and a computer-automated syringe that 
can deliver a bubble of gas or oil into the aqueous phase in the cuvette. There is a 
delivery-removal system of the cuvette that allows for the complete exchange of 
solution (described in Chapter 2). The drop shape is continuously projected on a 
camera, and the image analyzed by the computer can give a continuous measure 
of drop volume, surface area, and surface tension.  
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Typical amphipathic α-helix (Wang et al., 2003) and β-strand (Wang and 
Small, 2004) consensus peptides derived from human apolipoproteins have been 
studied using these protocols. The results showed that both amphipathic α-helix 
and β-strand peptides bind rapidly to the triolein/water interface, but helical 
peptides are pushed off by moderately high surface pressures, whereas there is 
no evidence that the β-strand peptides are pushed off (Wang et al., 2003; Wang 
and Small, 2004). Tensiometric studies of full-length apoA-I and apoB revealed 
that apoA-I showed similar features to helical peptides, while apoB acted as a 
combination of α-helix and β-strand (Wang et al., 2005; Wang et al., 2006). Our 
goal was to analyze the time course of lipoprotein interactions and possible fusion 
with the lipid droplet surface and the specific steps involved, such as protein or 
lipoprotein adhesion and fusion with the surface, or apolipoprotein displacement 
from it. 
To investigate these specific steps, VLDL, LDL or HDL were added to the 
cuvette that contained triolein drop in 2 mM Na phosphate buffer at pH 7.4. The 
surface area and tension of triolein/water interface were monitored simultaneously 
by Windrop tensiometer. When the surface tension reached a plateau, the excess 
lipoproteins in aqueous phase were washed out by buffer exchange. Triolein drop 
was then alternately compressed and expanded and the surface response was 
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monitored. 
The results in Figure A.2 show that the addition of VLDL, LDL or HDL led to a 
decrease of surface tension that reached plateau within 2 hours or less. Whether 
or not this decrease involved lipoprotein fusion with the triolein droplets was 
unclear, because the changes in the surface area resulting from such fusion were 
too small to be detected.  
To test whether lipoproteins fused with the triolein droplet, we added excess 
amount of VLDL solution (1.31 mg/ml protein concentration). Assuming that all 
VLDL particles can fuse with the droplet, 42 μl of such solution is needed for a 
volume increase by 2 μl that can be readily detected. In our experiment, I added 
200 μl of VLDL solution to ensure that the volume change upon fusion could be 
detected.   
The results of this experiment showed a significant volume increase, 
indicating VLDL fusion with the triolein drop. Interestingly, two phases were 
observed in this process. Within 0.5 h upon the addition of VLDL, the surface 
tension decreased and reached a plateau, suggesting saturated VLDL adsorption 
(Figure A.3, inset). However, no significant volume change of triolein drop was 
detected until 4 h later. After 24 hours, the volume was increased by ~0.4 μl. If this  
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Figure A.2  Lipoprotein adsorption to the triolein/water interface and its 
response to stress compression and re-expansion. The initial volume of the TO 
drop was 16 ul in all experiments. The buffer was 2 mM Na phosphate at pH 7.4 
with various lipoproteins. (A) VLDL, protein concentration 2.6×10-8 M. (B) LDL, 
                  
A
C
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protein concentration 1.7×10-8 M. (C) HDL, protein concentration 5.2×10-8 M. In 
all experiments, lipoproteins were added into the cuvette at time t=0. Stripe bars 
indicate the periods of buffer exchange. After buffer exchange, TO drop was first 
compressed and then expanded by 2, 4, 8, 12, and 12 ul. The decreased volume 
was held for approximately 5 min and was then returned to 16 ul and held for 
approximately 5 min. The changes in triolein/water surface area (magenta) and 
tension (black) are shown. 
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Figure A.3  VLDL adsorption to the trolein/water interface and the volume 
change of triolein drop due to fusion. The initial volume of the triolein drop was 6 
ul. VLDL was added into cuvette at time=0. The buffer in the curvette was 2 mM 
Na phosphate at pH 7.4, VLDL protein concentration was 4.0×10-6 M. The 
changes in the volume of triolein drop (blue) and triolein/water surface tension 
(black) are shown. Changes during the initial 2 hours are shown in the inset. 
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increase was due to whole-particle VLDL fusion, then 1.0×10-9 moles of VLDL 
particles had to fuse to account for it, which is only a fraction of the total amount of 
VLDL present in the buffer (2.4×10-8 moles). This result suggests a possible 
2-step mechanism for lipoprotein interactions with lipid droplets. First, 
water-soluable molecules (such as exchangeable apolipoproteins and free fatty 
acids) adsorb to lipid droplet in a relatively fast phase, leading to the decrease of 
surface tension and destabilization of lipoproteins. In the second phase, the lipids 
fuse with the lipid droplets.  
In the future, we plan to repeat these experiments with VLDL and carry out 
similar studies of other lipoproteins (Figure A.2B and A.2C). The results may 
provide insights into the general mechanism for lipoprotein interactions with lipid 
droplets.  
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